cyclosporine has been researched along with Recrudescence in 775 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 247 (31.87) | 18.2507 |
| 2000's | 287 (37.03) | 29.6817 |
| 2010's | 207 (26.71) | 24.3611 |
| 2020's | 34 (4.39) | 2.80 |
| Authors | Studies |
|---|---|
| Beisse, F; Biermann, J; Bosche, F; Eter, N | 1 |
| Aljurf, M; Bazarbachi, A; Bondarenko, S; Bourhis, JH; Brissot, E; Bug, G; Canaani, J; Choi, G; Ciceri, F; Cornelissen, JJ; Dholaria, B; Esteve, J; Gedde-Dahl, T; Giebel, S; Koc, Y; Labopin, M; Meijer, E; Mohty, M; Nagler, A; Niittyvuopio, R; Savani, B; Socié, G; Spyridonidis, A; Wu, D | 1 |
| Chen, YW; Cui, S; Lai, JJ; Li, TL; Ou, JY; Shan, HZ; Xiao, Y | 1 |
| Hanamura, I; Horio, T; Iida, Y; Kanasugi, J; Matsuhisa, A; Matsumoto, M; Matsumura, S; Mizuno, S; Murakami, S; Nakamura, A; Nakano, Y; Sakai, K; Shinohara, S; Takami, A; Takasugi, S; Uchino, K; Yamamoto, H | 1 |
| Jendoubi, F; Masson Regnault, M; Paul, C; Shourick, J; Tauber, M | 1 |
| Arcuri, LJ; Lerner, D; Tavares, RCBDS | 1 |
| Boswell, KL; Carroll, R; Darden, I; Gaudinski, M; Gordon, I; Groarke, EM; Jean-Baptiste, N; Koup, RA; Lin, BC; Lotter, J; Ma, X; McDermott, A; Moore, C; Naisan, M; Narpala, SR; Novik, L; Patel, BA; Prabhakaran, M; Rajput, RV; Rios, OJ; Serebryannyy, L; Superata, J; Trost, J; Wang, JL; Willis, J; Wu, CO; Young, NS | 1 |
| Benhamou, Y; Comparon, C; Coppo, P; Galicier, L; Rebibou, JM | 1 |
| Aggarwal, N; Durrani, J; Groarke, EM; Lotter, J; Manley, AL; Patel, BA; Rios, O; Shalhoub, R; Wu, CO; Young, NS | 1 |
| Andersen, NS; Friis, LS; Gjærde, LK; Kornblit, B; Petersen, SL; Schjødt, I; Sengeløv, H; Wegener, A | 1 |
| Fujinaga, S; Hirano, D; Nakagawa, M; Nishino, T; Umeda, C; Watanabe, Y | 1 |
| Cetinkaya, F; Hamuryudan, V; Hatemi, G; Melikoglu, M; Ozguler, Y; Seyahi, E; Tascilar, K; Ugurlu, S; Yazici, H | 1 |
| Chen, Y; Cong, Y; Dong, L; Omar, D | 1 |
| Goto, T; Julamanee, J; Kamoshita, S; Kiyoi, H; Koyama, D; Miyamura, K; Miyao, K; Murata, M; Nishida, T; Okuno, S; Ozawa, Y; Takagi, E; Terakura, S | 1 |
| Athanasopoulos, V; Behrens, G; Beyaert, R; Bogaert, DJ; Bordon, V; Cappello, J; De Bruyne, M; Dehoorne, J; Dullaers, M; Ellyard, J; Haerynck, F; Heissmeyer, V; Lambrecht, BN; Lamkanfi, M; Menten, B; Morris, LX; Naesens, L; Parthoens, E; Saeys, Y; Schelstraete, P; Staal, J; Tavernier, SJ; Van Coster, R; Van Gassen, S; Van Gorp, H; Van Isterdael, G; Verloo, P; Vinuesa, CG | 1 |
| Benvenuti, F; Doria, A; Gatto, M; Iaccarino, L; Larosa, M; Montesso, G; Saccon, F; Zen, M | 1 |
| Anguita, J; Bailén, R; Balsalobre, P; Buño, I; Díez-Martin, JL; Dorado, N; Gallardo-Morillo, AI; García Sola, A; Kwon, M; Martínez-Laperche, C; Muñoz, C; Pascual-Cascón, MJ; Serrano, D; Solán, L | 1 |
| Bavaharan, B; Kawali, A; Mahendradas, P; Mohan, A; Sanjay, S; Shetty, B | 1 |
| Katsarou, A; Lambrou, GI; Makris, M; Nakou, E; Nicolaidou, E; Stratigos, A; Tagka, A | 1 |
| Bertrand, Y; Bordigoni, P; Bruno, B; Cousin, E; Dalle, JH; de La Tour, RP; Drunat, S; Eliaou, JF; Freycon, C; Galambrun, C; Gandemer, V; Jonveaux, P; Oger, E; Paillard, C; Pertuisel, S; Pochon, C; Rohrlich, P; Schneider, P; Semana, G; Simon, P | 1 |
| Chen, M; Chen, Z; Han, B; Liu, X; Yang, C | 1 |
| Goto-Koshino, Y; Nakagawa, T; Ohno, K; Seno, T; Tani, A; Tomiyasu, H; Tsujimoto, H; Yokoyama, N | 1 |
| Demir, ME; Merhametsiz, O; Uyar, M | 1 |
| Belnou, P; Boillot, O; Bosch, A; Bruns, T; Carrat, F; Cazzagon, N; Chazouillères, O; Chopra, S; Conti, F; Corpechot, C; Donato, MF; Dumortier, J; Ebadi, M; Eurich, D; Floreani, A; Gerussi, A; Giostra, E; Goet, J; Hansen, B; Harms, M; Hirschfield, G; Jacob, D; Malinverno, F; Mason, A; McDowell, P; Montano-Loza, AJ; Nevens, F; Parés, A; Poupon, R; Rauchfuss, F; Reig, A; Reuken, P; Roccarina, D; Russo, FP; Schramm, C; Sterneck, M; Thorburn, D; Trivedi, P; van Buuren, H; Verhelst, X | 1 |
| Craig, JC; Hodson, EM; Larkins, NG; Liu, ID; Willis, NS | 1 |
| Cai, Q; Chen, C; Chen, J; Huang, X; Jiang, Y; Ke, R; Liu, J; Xu, F; Yang, F | 1 |
| AbdelRaheem, HG; Elsantiel, HIE; Elsherif, NHK; Makkeyah, SM; Ragab, IA; Tantawy, AAG | 1 |
| Brady, SL; le Chevoir, M; Woodward, AP | 1 |
| Chan, TC; Lee, MS; Tu, YK; Yeh, YC | 1 |
| Reamy, BV; Servey, JT; Williams, PM | 1 |
| Hirano, T; Komuta, K; Kumanogoh, A; Maeda, Y; Manabe, Y; Mizuno, Y; Morita, T; Nakabayashi, A; Nameki, S; Narazaki, M; Nishida, S; Nishide, M; Shibahara, T; Shima, Y; Takamatsu, H; Watanabe, A; Yagita, M; Yamaguchi, Y | 1 |
| Husein-ElAhmed, H; Steinhoff, M | 1 |
| Al-Shaibani, Z; Chen, C; Kim, DDH; Kumar, R; Lam, W; Law, AD; Lipton, JH; Loach, D; Mattsson, J; Michelis, FV; Nampoothiri, RV; Viswabandya, A | 1 |
| Brunello, L; Bruno, B; Busca, A; Butera, S; Cerrano, M; Dellacasa, CM; Faraci, DG; Giaccone, L; Mordini, N; Sorasio, R; Vassallo, S; Zallio, F | 1 |
| Kalisz, G; Śmiech, A; Szczepanik, M; Wilkołek, P | 1 |
| Güzelküçük, Z; Hacısalihoğlu, Ş; Işık, M; Kaçar, D; Özyörük, D; Yazal Erdem, A; Yozgat, AK | 1 |
| Balleari, E; Bernal, T; Beyne-Rauzy, O; Bordessoule, D; Calabuig, M; Cametti, G; Campelo, MD; Cheze, S; Cony-Makhoul, P; Dreyfus, F; Fenaux, P; Fensterl, J; Ferrero, D; Gaidano, G; Germing, U; Gioia, D; Götze, K; Guerci-Bresler, A; Hamel, JF; Kaivers, J; Kelaidi, C; Komrokji, R; Kotsianidis, I; Müller-Thomas, C; Pane, F; Park, S; Ramos, F; Roboz, GJ; Rose, C; Sanna, A; Santini, V; Sanz, GF; Sapena, R; Sekeres, MA; Stamatoullas, A; Steensma, DP; Thépot, S; Toma, A; Vey, N; Wattel, E | 1 |
| Alyea, EP; Bashey, A; Deeg, HJ; Devine, SM; Fernandez, HF; Geller, NL; Giralt, S; Hamadani, M; Horowitz, MM; Horwitz, ME; Le-Rademacher, J; Leifer, E; Logan, BR; Maziarz, RT; Mendizabal, AM; Pasquini, MC; Porter, DL; Scott, BL; Warlick, ED; Wu, J | 1 |
| Gao, H; Jia, YN; Li, SX; Shi, WY; Wang, YX; Xiang, DM; Zhai, HL | 1 |
| Baek, S; Choi, EJ; Choi, Y; Jeon, M; Jo, JC; Joo, YD; Kang, YA; Kang, YL; Kim, DY; Kim, H; Kim, SH; Ko, SH; Lee, JH; Lee, KH; Lee, YS; Lim, SN; Park, HS; Seol, M; Yun, SC | 1 |
| Imai, N; Kimura, K; Matsui, K; Sakurada, T; Shibagaki, Y; Shirai, S; Sueki, S; Tominaga, N; Yasuda, T | 1 |
| Fujita, N; Gotoh, Y; Kasahara, K; Kuroyanagi, Y; Nagano, C; Takeda, A; Uemura, O; Yamakawa, S; Yamamoto, M | 1 |
| Du, L; Kijlstra, A; Liang, L; Qi, J; Wang, C; Wu, L; Yang, P; Ye, Z; Zhou, Q | 1 |
| Arruda, GV; Fonseca, EC; Rocha, EM | 1 |
| Budde, K; Halleck, F; Khadzhynov, D; Staeck, O | 1 |
| Baer, MR; Ding, J; Hess, JR; Zimrin, AB | 1 |
| Chen, M; Han, B; Liu, C; Qiao, X; Zhou, D; Zhuang, J | 1 |
| Chang, YL; Chou, YC; Hsu, CC; Liao, HT; Tsai, CY; Wu, TH; Yang, TH | 1 |
| Cohen, RD; Dalal, S; Hanan, I; Hanauer, SB; Patel, P; Pekow, J; Raffals, LH; Rubin, DT; Sakuraba, A; Yarur, A | 1 |
| He, G; Hong, M; Li, J; Lu, R; Lu, X; Qiao, C; Shen, W; Wang, S; Wu, X; Wu, Y; Zhang, J; Zhu, Y | 1 |
| Kumari, R; Mohan, N; Saha, BC; Sinha, BP | 1 |
| Archilla, LR; Curto-Barredo, L; Giménez-Arnau, AM; Pujol, RM; Vives, GR | 1 |
| Didsbury, M; Francis, A; Kara, T; McCarthy, H | 1 |
| Chen, C; Chen, QH; Huang, JB; Lin, SF; Liu, S; Wang, J; Xue, HM; Zhang, BH | 1 |
| Endo, Y; Fujita, Y; Fukui, S; Hosono, Y; Ichinose, K; Igawa, T; Ishida, M; Iwamoto, N; Kawakami, A; Kawashiri, SY; Koga, T; Kuwana, M; Mimori, T; Nakamura, H; Nishino, A; Origuchi, T; Shimizu, T; Sumiyoshi, R; Takatani, A; Tamai, M; Tsuji, S; Umeda, M | 1 |
| Coyner, K; Rishniw, M; Tater, K | 1 |
| Honma, H; Komori, K; Matsuda, K; Morita, D; Nakazawa, H; Nakazawa, Y; Saito, T; Tanaka, M; Yanagisawa, R | 1 |
| Scheinberg, P | 1 |
| Dong, S; Gui, K; Liu, Y; Yang, C; Yang, R; Yuan, F; Zhao, M; Zhu, Y | 1 |
| Chen, T; Huang, H; Mao, Y; Yin, L; Zhou, W; Zhou, Z | 1 |
| Fernandez, AP; Hu, JZ; Husni, ME; Mazloom, SE; Warren, CB; Ya, J; Yan, D | 1 |
| Arslansoyu Camlar, S; Kavukçu, S; Soylu, A | 1 |
| El-Hamamsy, M; El-Meteini, M; Mansy, AE; Montasser, IF; Nabet, DE | 1 |
| Baran, R; Chiheb, S; Daniel, CR; Di Chiacchio, N; Gregoriou, S; Grover, C; Haneke, E; Iorizzo, M; Pasch, M; Piraccini, BM; Rich, P; Richert, B; Rigopoulos, D; Rompoti, N; Rubin, AI; Singal, A; Starace, M; Tosti, A; Triantafyllopoulou, I; Zaiac, M | 1 |
| Alhasan, KA; Alherbish, A; Almojalli, H; Kari, JA; Osman, A | 1 |
| Babushok, DV; Duke, JL; Huang, Y; Monos, DS; Olson, TS; Oved, JH; Stanley, N; Teachey, DT | 1 |
| Battipaglia, G; Bazarbachi, A; Belhocine, R; Brissot, E; Duléry, R; Ledraa, T; Malard, F; Médiavilla, C; Mohty, M; Mohty, R; Paviglianiti, A; Ruggeri, A; Sestili, S; Stocker, N; Vekhoff, A | 1 |
| Alashkar, F; Dührsen, U; Herich-Terhürne, D; Oelmüller, M; Röth, A; Schmitz, C; Turki, AT; Vance, C | 1 |
| Li, Q; Li, S; Tan, L; Wan, J; Yang, H; Zou, Q | 1 |
| Bayaraa, B; Imafuku, S; Ohga, Y | 1 |
| Navarro-Mira, MÁ; Rahhal-Ortuño, M; Roca-Ginés, J; Rodríguez-Serna, M; Torres-Navarro, I | 1 |
| Appelbaum, FR; Bethge, WA; Chauncey, TR; Flowers, MED; Gutman, JA; Kornblit, B; Langston, AA; Maloney, DG; Maris, MB; Martin, PJ; Mielcarek, M; Olesen, G; Petersen, SL; Pulsipher, MA; Sandmaier, BM; Storb, R; Storer, BE; Woolfrey, AE | 1 |
| Meneghim, RLFS; Natsuaki, KL; Oliveira, AC; Padovani, CR; Satto, LH; Schellini, SA; Viveiros, MMH | 1 |
| Dufour, C; Pierri, F | 1 |
| Duvoux, C; Firpi, R; Grazi, GL; Levy, G; Renner, E; Villamil, F | 1 |
| Abu El-Asrar, AM; Al Tamimi, M; Al-Mezaine, HS; Al-Muammar, A; Hemachandran, S; Kangave, D | 1 |
| Kosrirukvongs, P; Vichyanond, P | 1 |
| Amano, K; Chino, K; Ito, T; Kato, H; Kondo, T; Kurasawa, T; Nagasawa, H; Nishi, E; Nishimura, K; Ogawa, H; Okuyama, A; Sakai, R; Shibata, A; Takei, H | 1 |
| Das, S; Nair, V; Sharma, A; Sharma, S; Sondhi, V | 1 |
| Gerken, G; Herzer, K; Jochum, C; Papadopoulos-Köhn, A; Paul, A; Timm, J | 1 |
| Arora, M; Blazar, BR; Brunstein, CG; DeFor, TE; Fargen, AD; Rogosheske, JR; Warlick, E; Weisdorf, DJ | 1 |
| Cho, B; Chung, NG; Jeong, DC; Kim, HK; Kojima, S; Kosaka, Y; Muramatsu, H; Ohara, A; Ruan, M; Takahashi, Y; Yang, W; Zhu, X; Zou, Y | 1 |
| Hataya, H; Honda, M; Iijima, K; Ishikura, K; Ito, S; Kamei, K; Nagata, M; Nakamura, H; Nakanishi, K; Nozu, K; Oba, MS; Ohashi, Y; Ohwada, Y; Sako, M; Tanaka, R; Yata, N; Yoshikawa, N | 1 |
| Hiramoto, N; Iwasa, T; Matsuura, T; Ohashi, K; Shoji, M | 1 |
| Chiba, T; Fujimoto, Y; Hashi, S; Hashimoto, E; Ito, T; Kaido, T; Kawai, T; Kikuchi, M; Masuda, S; Matsubara, K; Nishioka, Y; Okuda, Y; Omura, T; Shinke, H; Takahashi, T; Ueda, Y; Uemoto, S; Uesugi, M; Yonezawa, A | 1 |
| Cairo, M; Camitta, BM; Carpenter, PA; Chan, KW; Diaz Perez, MA; Doyle, J; Eapen, M; Fraser, C; Gross, TG; He, W; Hitzler, JK; Horan, JT; Kennedy-Nasser, AA; Kitko, C; Kurtzberg, J; Lehmann, L; O'Brien, T; Pulsipher, MA; Smith, FO; Zhang, MJ | 1 |
| Hirohata, S; Ishigatsubo, Y; Kikuchi, H; Kuwana, M; Nagafuchi, H; Sawada, T; Takeno, M | 1 |
| Abdel Halim, MM; Al-Otaibi, T; Asif, P; Donia, F; Gheith, O; Nair, P; Nampoory, N; Nawas, M; Rashad, RH; Said, T | 1 |
| Brault, Y; Gallo, G; Germain, JM; Mallbris, L; Marino, V; Micali, G; Wilsmann-Theis, D | 1 |
| Ehara, Y; Fujita, M; Fujiwara, A; Hirawa, N; Kaneda, T; Katsumata, M; Kobayashi, Y; Okuyama, Y; Saka, S; Toya, Y; Umemura, S; Yamamoto, Y; Yasuda, G; Yatsu, K; Yutoh, J | 1 |
| Angelika, J; Ernst, SR; Florian, B | 1 |
| Ge, M; Huang, J; Huang, Z; Li, X; Nie, N; Shao, Y; Shi, J; Zhang, J; Zheng, Y | 1 |
| Czock, D; Eisenbach, C; Giese, T; Gotthardt, D; Roos, K; Schnitzler, P; Stremmel, W | 1 |
| Cardinale, I; Gilleaudeau, P; Guttman-Yassky, E; Khattri, S; Krueger, JG; Rozenblit, M; Shemer, A; Suarez-Farinas, M; Sullivan-Whalen, M; Xu, H; Zheng, X | 1 |
| Djulbegovic, B; Kharfan-Dabaja, M; Kumar, A; Mhaskar, R; Perkins, JB; Pidala, J; Reljic, T | 1 |
| Kanakry, CG; Luznik, L | 1 |
| Fukuhara, T; Ikegami, T; Itoh, S; Kato, M; Maehara, Y; Matsuura, Y; Nakamura, S; Shirabe, K; Yamamoto, S; Yoshizumi, T | 1 |
| Foroncewicz, B; Krawczyk, M; Lerut, J; Majewski, S; Mucha, K; Pączek, L | 1 |
| Bryan, J; Kadia, TM; Rexwinkle, A; Willis, L | 1 |
| Chen, Y; Liu, Z; Meng, J; Tao, R; Xv, J; Yong, X | 1 |
| Bascherini, V; Cantarini, L; Caso, F; Costa, L; Franceschini, R; Latronico, E; Rigante, D; Vitale, A | 1 |
| Fujimoto, S; Makino, H; Maruyama, S; Matsuo, S; Mori, N; Narita, I; Nishio, S; Okuda, S; Saito, T; Sato, H; Sugiyama, H; Ueda, Y; Yamagata, K; Yokoyama, H; Yuzawa, Y | 1 |
| Chen, HX; Chen, P; Lan, X; Liu, HM; Liu, MG; Wei, D; Zeng, W | 1 |
| Ando, T; Hamasaki, Y; Honda, M; Iijima, K; Ishikura, K; Ito, S; Matsuyama, T; Nakanishi, K; Nakazato, H; Sasaki, S; Yata, N; Yoshikawa, N | 1 |
| Abounader, D; Bolwell, B; Copelan, E; Dean, R; Duong, H; Haddad, H; Hamilton, BK; Hanna, R; Hill, BT; Kalaycio, M; Majhail, NS; Rybicki, L; Sobecks, R | 1 |
| Antonini, TM; Bonhomme-Faivre, L; Coilly, A; Duclos-Vallée, JC; Furlan, V; Haim-Boukobza, S; Roque-Afonso, AM; Samuel, D; Sebagh, M; Taburet, AM; Teicher, E; Vittecoq, D | 1 |
| Akiyama, M; Okuyama, R; Sugiura, K; Uchiyama, R | 1 |
| Chung, JS; Hong, J; Joo, YD; Lee, GW; Park, SH; Shin, HJ; Song, MK | 1 |
| Fujinaga, S; Ohtomo, Y; Sakuraya, K; Shimizu, T; Urushihara, Y; Yamada, A | 1 |
| Gupta, V; Hamad, N; Kim, DD; Kuruvilla, J; Lipton, JH; Messner, HA; Michelis, FV; Seftel, M; Shanavas, M; Uhm, J | 1 |
| Bigley, V; Collin, M; Dickinson, A; Hale, G; Jackson, G; Jardine, L; Pearce, K; Publicover, A | 1 |
| Hassan, K; Kristal, B | 1 |
| Del Bello, A; Grellier, J; Guilbeau-Frugier, C; Kamar, N; Milongo, D; Rostaing, L | 1 |
| Abou Chahla, W; Jissendi-Tchofo, P; Lolli, V; Pruvo, JP; Soto Ares, G | 1 |
| Arita, M; Furuta, K; Hotta, M; Ikeda, S; Ikeo, S; Ishida, T; Ito, A; Nishiyama, A | 1 |
| Cai, H; Cao, X; Chen, M; Duan, M; Han, B; Li, J; Liu, C; Wang, S; Xu, Y; Zhang, W; Zhou, D; Zhu, T; Zhuang, J; Zou, N | 1 |
| Abaalkhail, F; Al Hamoudi, W; Al Sebayel, M; Al-Kattan, W; Broering, D; Elsiesy, H; Selim, K; Yousif, S | 1 |
| Chung, YR; Lee, ES; Lee, K; Park, JY; Song, JH | 1 |
| Craig, FE; Greenlaw, N; Johnston, GA; Mason, JM; Mitchell, E; Norrie, J; Ormerod, AD; Thomas, KS; Walton, S; Williams, HC | 1 |
| Ge, M; Huang, J; Huang, Z; Li, X; Nie, N; Shao, Y; Shi, J; Wang, M; Zhang, J; Zheng, Y | 1 |
| Alarcón-Payer, C; García-Martín, P; Jurado, M; López-Fernández, E; Moratalla, L; Ríos, R; Romero, A; Sainz, J | 1 |
| Asero, R; Cugno, M; Marra, AM; Marzano, AV; Pinter, E; Tedeschi, A | 1 |
| Cooney, TM; Michelotti, MM; Prabhu, SS; Shtein, RM | 1 |
| Apostolski, SA; Basta, IZ; Lavrnić, DV; Nikolić, AV; Nikolić, DM | 1 |
| Haller, H; Hiss, M; Müller-Deile, J; Schiffer, L; Schiffer, M | 1 |
| Bagot, M; Barète, S; Battistella, M; Crickx, B; Deschamps, L; Flageul, B; Fraitag, S; Ingen-Housz-Oro, S; Janin, A; Kottler, D; Ortonne, N; Quéreux, G; Rybojad, M | 1 |
| Ding, K; Geng, L; Liu, H; Sun, G; Sun, Z; Tang, B; Wang, L; Wang, X; Zheng, C | 1 |
| Etter, M; Herfs, G; Vallelian, F | 1 |
| Damodar, S | 1 |
| Aragon, E; Chan, YH; Lau, YW; Loh, HL; Ng, KH; Resontoc, LP; Tan, PH; Yap, HK | 1 |
| Dankó, K; Farkas, F; Nagy-Vince, M; Szalmás, O | 1 |
| Miano, M | 1 |
| Choi, S; Hwang, S | 1 |
| Coppo, P; Froissart, A | 1 |
| Day, AS; Eliadou, E; Gearry, RB; Inns, SJ; Rowbotham, DS; Schultz, M; Thompson-Fawcett, MW; Walmsley, R | 1 |
| Ay, Y; Demirag, B; Ince, D; Karapinar, TH; Koker, SA; Moueminoglou, N; Oymak, Y; Ozcan, E; Toret, E; Vergin, C | 1 |
| Ulus, ND; Yücel, OE | 1 |
| Chen, CC; Teng, CL; Yeh, SP | 1 |
| Joko, T; Ogata, M; Ohashi, Y; Shiraishi, A | 1 |
| Alembo, DT; Lambert, SM; Lockwood, DN; Nigusse, SD; Walker, SL; Yamuah, LK | 1 |
| Belleannée, G; Capdepont, M; Chabrun, E; Fron, C; Laharie, D; Pierry, C; Poullenot, F; Subtil, C; Zerbib, F | 1 |
| Rudnicki, M | 1 |
| Dixit, A; Gupta, M; Madkaikar, M; Patil, V | 1 |
| Fendler, W; Lukamowicz, J; Miklaszewska, M; Tkaczyk, M | 1 |
| Iwasaki, K; Kobayashi, T; Kushihara, H; Kuzuya, T; Miwa, Y; Uchida, K; Watarai, Y; Yamada, K | 1 |
| Fujinaga, S; Hirano, D; Mizutani, A; Sakurai, S; Sakuraya, K; Shimizu, T; Yamada, A | 1 |
| Arai, M | 1 |
| Hwang, S; Joh, JW; Jung, BH; Kim, JM; Kwon, CD; Lee, HW; Lee, KW; Lee, SG; Lee, SK; Song, GW; Suh, KS; Yi, NJ | 1 |
| Earnshaw, I; Thachil, J | 1 |
| Huang, J; Jin, J; Ma, L; Mai, W; Mei, C; Meng, H; Qian, W; Ren, Y; Tong, H; Wei, J; Xu, W; Ye, L; Ye, X; Zhou, X | 1 |
| Beck, BB; Dötsch, J; Goebel, H; Hoppe, B; Liebau, MC; Nuesken, KD; Taylan, C; Weber, LT | 1 |
| Bautista, J; Calvo, M; Calvo, N; de la Manzanara, V; Delgado, J; Moreno, A; Perez-Flores, I; Rodriguez Cubillo, B; Rodriguez, B; Sanchez-Fructuoso, AI; Shabaka, A | 1 |
| Kolonko, A; Piecha, G; Więcek, A | 1 |
| Bhanji, RA; Mason, AL; Montano-Loza, AJ; Wasilenko, S | 1 |
| Dong, Y; Ren, J; Xie, L; Zhang, Y | 1 |
| Chong, JH; Koh, MJA | 1 |
| Aikata, H; Chayama, K; Imamura, M; Ishiyama, K; Kawakami, Y; Kawaoka, T; Morio, K; Nakamura, Y; Nelson Hayes, C; Ochi, H; Ohdan, H; Tsuge, M | 1 |
| Chen, X; Du, X; Gao, L; Kong, P; Li, H; Liu, H; Liu, J; Liu, Y; Peng, X; Su, Y; Sun, A; Zhang, C; Zhang, X; Zhang, Y; Zhong, J | 1 |
| Andreone, P; Berenguer, M; Calleja, JL; Cieciura, T; Donato, MF; Durlik, M; Fagiuoli, S; Forns, X; Herzer, K; Janssen, K; Jessner, W; Kalmeijer, R; Lenz, O; Mariño, Z; Ouwerkerk-Mahadevan, S; Peeters, M; Shukla, U; Sterneck, M; Verbinnen, T | 1 |
| Goumenos, DS | 1 |
| Naghashpour, M; Nichols, KE; Olin, RL; Shelly, B; Stadtmauer, EA; Vogl, DT; Wasik, M | 1 |
| Fukuma, Y; Hatae, K; Hisano, S; Iwasaki, H; Kaku, Y; Niimi, K; Saitoh, T; Segawa, Y; Takeshita, M | 1 |
| Nunez, O; Scheinberg, P; Wu, CO; Young, NS | 1 |
| Chawla, B; Sharma, N; Tandon, R; Titiyal, JS; Verma, K | 1 |
| Antolín, SC; Benito, MF; Cordero-Coma, M; Hernández, AM; Ruíz, JM | 1 |
| Akbas Kocaoglu, F; Burcu Nurozler, A; Duman, S; Ergun, G; Yalcin Tok, O | 1 |
| Marín Serra, J; Márquez Peiró, JF; Porta Oltra, B | 1 |
| Ansite, JD; Balamurugan, AN; Bansal-Pakala, P; Bellin, MD; Hering, BJ; Ihm, SH; Kandaswamy, R; Liu, B; Moran, A; Papas, K; Papas, KK; Parkey, J; Sutherland, DE; Witson, J; Zhang, HJ | 1 |
| Choudhary, DR; Kumar, R; Mahapatra, M; Mishra, P; Naithani, R; Saxena, R | 1 |
| Fujisaki, T; Joko, K; Kobayashi, Y; Muta, T; Takeshita, E; Tanaka, Y; Tokuyama, T; Ueda, Y; Yokota, E | 1 |
| Al-Hemidan, AI; Tabbara, KF | 1 |
| Aydin, A; Aykan, U; Bilge, AH; Can, G; Colakoglu, K; Karadayi, K | 1 |
| Brandwein, JM; Gupta, V; Kao, SY; Lipton, JH; Messner, HA; Minden, MD; Schimmer, AD; Schuh, AC; Xu, W; Yee, K | 1 |
| Boss, C; Nunez, O; Scheinberg, P; Sloand, EM; Wu, CO; Young, NS | 1 |
| Bacigalupo, A; Dickenson, A; Hows, J; Kelly, A; Lawler, M; Ljungman, P; Locasciulli, A; Marin, P; Marsh, JC; McCann, SR; O'Riordan, J; Passweg, JR; Ryan, J; Schrezenmeier, H; Socié, G; Tichelli, A; Vandenberghe, E | 1 |
| Passweg, JR; Tichelli, A | 1 |
| Inoue, D; Kimura, T; Kurata, M; Maruoka, H; Matsushita, A; Mori, M; Nagai, K; Nagai, Y; Shimoji, S; Tabata, S; Takahashi, T; Yamashita, E | 1 |
| Beckebaum, S; Broelsch, CE; Cicinnati, VR; Gerken, G; Klein, CG; Paul, A; Saner, F; Sotiropoulos, GC | 1 |
| Caimi, TM; Morra, E; Mostarda, G; Nosari, A; Redaelli, R | 1 |
| Knoll, GA; Mulay, AV; van Walraven, C | 1 |
| Bhatia, B; Gupta, V | 1 |
| Balduzzi, A; Cesaro, S; Dini, G; Favre, C; Lanino, E; Locatelli, F; Messina, C; Pession, A; Pollichieni, S; Rabusin, M; Rondelli, R; Santarone, S | 1 |
| Biagioli, M; Cantarini, L; Cimaz, R; Dal Canto, N; Fanti, F; Galeazzi, M; Martino, S; Miracco, C | 1 |
| Cescon, M; Cucchetti, A; Ercolani, G; Grazi, GL; Morelli, MC; Pinna, AD; Piscaglia, F; Ravaioli, M; Tamè, M; Vetrone, G | 1 |
| Kuźma-Mroczkowska, E; Pańczyk-Tomaszewska, M; Roszkowska-Blaim, M | 1 |
| Crosby, CV; Crosby, MB; Grossniklaus, HE; Wojno, TH | 1 |
| Alberti, C; Baudouin, V; Czernichow, P; Deschenes, G; Guest, G; Leroy, V; Loirat, C; Niaudet, P; Simon, D | 1 |
| Koltun, WA | 1 |
| Cheifetz, AS; Doherty, GA | 1 |
| Kautzner, J; Kubánek, M; Málek, I; Skalická, B; Vymětalová, J | 1 |
| Cheng, F; Kong, LB; Li, XC; Qin, JJ; Sun, BC; Wang, XH; Yu, MN; Zhang, F | 1 |
| Van Assche, G | 1 |
| Eguchi, A; Nitta, K; Takei, T; Tsuchiya, K; Yoshida, T | 1 |
| Cabrera, R; Chen, C; Clark, VC; Firpi, RJ; Levy, C; Michaels, A; Morelli, GG; Nelson, DR; Soldevila-Pico, C; Suman, A | 1 |
| Sharma, N; Sinha, R; Vajpayee, RB; Vishnu, S | 1 |
| Barba, P; Briones, J; Brunet, S; Delgado, J; Martino, R; Piñana, JL; Querol, L; Sierra, J; Sureda, A; Valcárcel, D | 1 |
| Auriault, C; Boleslowski, E; Carpentier, A; Conti, F; Delhem, N; Dharancy, S; Miroux, C; Moralès, O; Pancré, V; Podevin, P | 1 |
| den Hartigh, J; Egeler, RM; Lankester, AC; Press, RR; Vossen, JM; Willemze, AJ | 1 |
| Arnold, DM; Chan, H; Heddle, NM; Kelton, JG; Nazi, I; Santos, A; Warkentin, TE | 1 |
| Carrion, AP; Fuentes, GM; Garcia-Pose, A; Hijosa, MM; Melgar, AA; Meseguer, CG; Torres, MN | 1 |
| Iijima, K; Ito, S; Kaito, H; Kamei, K; Kikuchi, E; Matsuoka, K; Nagata, M; Ogura, M | 1 |
| Fujinaga, S; Hirano, D; Ito, S; Kamei, K; Kaneko, K; Nishizaki, N; Ohtomo, Y; Shimizu, T | 1 |
| Alkhalifah, A; Alsantali, A; McElwee, KJ; Shapiro, J; Wang, E | 1 |
| Brown, RM; Chai, PF; Foster, K; Kelly, DA; Lee, WS; McKiernan, PJ; McPartland, JL | 1 |
| Hammel, N; Huna-Baron, R; Lee, AG; Stiebel-Kalish, H; van Everdingen, J | 1 |
| Bintner, J; Mason, AL; Montano-Loza, AJ; Wasilenko, S | 2 |
| Arnold, R; Dörken, B; Hemmati, PG; le Coutre, P; Massenkeil, G; Neuburger, S; Terwey, TH; Vuong, LG | 1 |
| Chen, LZ; Jiang, XY; Lu, HY; Mo, Y; Zhang, QL | 1 |
| Allen, U; Clarizia, NA; Dipchand, AI; Holmes, C; Manlhiot, C; McCrindle, BW; Ngan, BY; Pollock-Barziv, SM; Weitzman, S | 1 |
| Grenda, R; Jarmużek, W; Piątosa, B; Rubik, J | 1 |
| Ala-Houhala, M; Arikoski, P; Hölttä, T; Jahnukainen, T; Jauhola, O; Koskimies, O; Nuutinen, M; Ormälä, T; Rajantie, J; Ronkainen, J | 1 |
| Beccastrini, E; Benedetta Silvestri, E; Chiodi, M; Di Paolo, C; Emmi, G; Emmi, L; Liotta, F; Maggi, E; Massi, D | 1 |
| Boulinguez, S | 1 |
| Ando, T; Hattori, S; Honda, M; Iijima, K; Ishikura, K; Matsuyama, T; Nakanishi, K; Sasaki, S; Yata, N; Yoshikawa, N | 1 |
| Canaud, G; Legendre, C; Mamzer, MF; Martinez, F; Niaudet, P; Noël, LH | 1 |
| Gejyo, F; Imai, N; Ito, Y; Nakagawa, Y; Narita, I; Nishi, S; Saito, K; Takahashi, K; Tasaki, M | 1 |
| Iwakiri, R; Kitayama, A; Misago, N; Narisawa, Y; Okawa, T | 1 |
| Appelbaum, FR; Deeg, HJ; Flowers, ME; Maloney, DG; Martin, PJ; Mielcarek, M; Peffer, A; Rotta, M; Sandmaier, BM; Storb, R; Storer, BE; Vernon, MS | 1 |
| Akl, KF; Samara, OA | 1 |
| Hayami, Y; Ito, R; Iwagaitsu, S; Maeda, S; Naniwa, T; Sasaki, K; Watanabe, M | 1 |
| du Toit, C; McDonald, A; Novitzky, N; Thomas, V | 1 |
| Arantes, TE; Garcia, CR; Matos, K; Muccioli, C; Sabrosa, AS; Silva, TG | 1 |
| Aguilera, V; Benlloch, S; Berenguer, M; de Juan, M; López-Andujar, R; Mir, J; Montalva, E; Moya, A; Pareja, E; Prieto, M; Rubin, A; San Juan, F; Yago, M | 1 |
| Iwasawa, H; Matsumoto, H; Nagaoka, Y; Nakao, T; Okada, T; Tomaru, R; Wada, T | 1 |
| Janczak, D; Marczak, J; Plonek, T; Pupka, A; Skora, J; Szydełko, T | 1 |
| Basta-Jovanovic, G; Jovanovic, D; Marinkovic, J; Naumovic, R; Pavlovic, S; Stosovic, M | 1 |
| Fujinaga, S; Hirano, D; Kaneko, K; Nishizaki, N; Ohtomo, Y; Ohtsuka, Y; Shimizu, T; Someya, T | 1 |
| Goumenos, DS; Kalliakmani, P; Koutroulia, E; Sotsiou, F; Vlachojannis, JG | 1 |
| Shigidi, MM | 1 |
| Fujinaga, S; Hara, S; Hirano, D; Kanai, H; Nishizaki, N; Ohtomo, Y; Umino, D | 1 |
| Bernard, O; Choulot, JJ; Fabre, M; Gori, L; Jacquemin, E; Maggiore, G; Pacifico, L; Resti, M; Sciveres, M | 1 |
| Bessho, F; Hama, A; Ito, E; Kamio, T; Kaneko, T; Kikuta, A; Kojima, S; Kosaka, Y; Morimoto, A; Mugishima, H; Muramatsu, H; Nagasawa, M; Nakahata, T; Ohara, A; Ohga, S; Osugi, Y; Tsuchida, M; Tsukimoto, I; Yabe, H; Yagasaki, H | 1 |
| Bertz, H; Bethge, WA; Bornhäuser, M; Egger, M; Einsele, H; Finke, J; Grishina, O; Heim, DA; Holler, E; Kolb, HJ; Kolbe, K; Koza, V; Linkesch, W; Maertens, JA; Mayer, J; Ottinger, HD; Ruutu, T; Schmoor, C; Schwerdtfeger, R; Socié, G; Stelljes, M; Volin, L; Zander, AR | 1 |
| He, G; Sun, A; Wang, X; Wu, D; Zhang, X | 1 |
| Advani, A; Afable, MG; Clemente, M; Elson, P; Kalaycio, M; Lichtin, A; Maciejewski, JP; Makishima, H; O'Keefe, CL; Sekeres, MA; Shaik, M; Sugimoto, Y; Tiu, RV | 1 |
| Ballarin, R; Cautero, N; Cocchi, S; Codeluppi, M; D'Amico, G; De Ruvo, N; Di Benedetto, F; Gerunda, GE; Guaraldi, G; Guerrini, GP; Iemmolo, RM; Mimmo, A; Montalti, R; Rompianesi, G; Serra, V; Smerieri, N; Spaggiari, M; Tarantino, G | 1 |
| Berenguer, M | 1 |
| Actis, GC; Daperno, M | 1 |
| Inagaki, J; Nagatoshi, Y; Nomura, Y; Okamura, J; Sakiyama, M; Teranishi, H; Yanai, F | 1 |
| Antin, JH | 1 |
| Amemiya, N; Itabashi, M; Kojima, C; Nitta, K; Nokiba, H; Takei, T | 1 |
| Trotter, JF | 1 |
| Baron, J; Lin, H; Penumalli, V; Rezania, K; Soliven, B; van Besien, K | 1 |
| Bonini, S; Deligianni, V; Lambiase, A; Leonardi, A; Sacchetti, M; Sposato, S | 1 |
| Clifford, R; Danby, R; Ellis, A; Hatton, C; Littlewood, T; Malladi, R; Medd, P; Monk, I; Peniket, A; Roberts, D; Vyas, P | 1 |
| Esaki, S; Gondo, A; Hayashi, A; Matsumoto, H; Miyaoka, Y; Nagaoka, Y; Nakao, T; Okada, T; Wada, T | 1 |
| Burroughs, AK; Germani, G; Samonakis, DN | 1 |
| Bennett, MR; Biessen, EA; Bot, I; Bot, M; Overkleeft, H; Sliedregt, K; van Berkel, TJ; van der Marel, GA; van Heiningen, SH; Xu, X; Yu, H | 1 |
| Fujiki, Y; Hanafusa, T; Hata, K; Makino, S; Ozaki, T; Takeuchi, T; Yoshida, S; Yoshikawa, A | 1 |
| Amrolia, P; Bonney, D; Carey, P; Connor, P; Gibson, B; Goulden, N; Hiwarkar, P; Hough, R; Keogh, S; Lawson, S; Meyer, S; Norton, A; Pelidis, M; Qureshi, A; Rao, K; Saif, MA; Samarasinghe, S; Skinner, R; Steward, C; Stewart, G; Stubbs, M; Veys, P; Vora, A; Webb, D; Wynn, R | 1 |
| Bertz, H; Christopoulos, P; Finke, J; Ihorst, G; Marks, R; Wäsch, R | 1 |
| Aglietta, M; Boccadoro, M; Bruno, B; Casini, M; Cavattoni, I; Console, G; Festuccia, M; Filippi, AR; Gallamini, A; Giaccone, L; Gigli, F; Irrera, G; Levis, A; Messina, G; Montanari, M; Mordini, N; Passera, R; Pastano, R; Pini, M; Ricardi, U; Risitano, AM; Schianca, FC; Scortechini, I; Selleri, C; Sorasio, R | 1 |
| Craig, FF; Mason, JM; Mitchell, EJ; Norrie, J; Ormerod, AD; Thomas, KS; Williams, HC | 1 |
| Boillot, O; Botta-Fridlund, D; Boudjema, K; Calmus, Y; Chazouillères, O; Dharancy, S; Durand, F; Duvoux, C; Gugenheim, J; Néau-Cransac, M; Pageaux, G; Rostaing, L; Samelson, L; Samuel, D; Vanlemmens, C; Wolf, P | 1 |
| Kher, A; Kher, V | 1 |
| Chen, Y; Du, L; Fu, H; Liu, A; Mao, J; Shen, H; Wang, D; Wang, W; Xia, Y | 1 |
| Fujieda, M; Hayashi, A; Ishihara, M; Morita, T; Ohta, T; Okada, S; Sakano, T; Wakiguchi, H | 1 |
| Ando, T; Honda, M; Iijima, K; Ishikura, K; Ito, S; Matsuyama, T; Nakanishi, K; Nakazato, H; Sasaki, S; Yata, N; Yoshikawa, N | 1 |
| Fujii, K; Kitamura, Y; Koyama, Y; Osugi, Y; Ota, T | 1 |
| Antonini, TM; Barau, C; Bonhomme-Faivre, L; Coilly, A; Duclos-Vallée, JC; Furlan, V; Noël, C; Roche, B; Roque-Afonso, AM; Samuel, D; Taburet, AM | 1 |
| Chu, K; Jeon, D; Jung, S; Kim, BS; Lee, SK; Yang, H | 1 |
| Nozue, T; Pan, Q; Sato, Y; Tsunoda, S; Wakasugi, H; Yoshimura, A | 1 |
| Hiraoka, S; Kato, J; Suzuki, H; Yamamoto, K | 1 |
| Horiike, S; Kiyota, M; Kobayashi, T; Kuroda, J; Matsumoto, Y; Matsumura, Y; Shimura, Y; Taniwaki, M; Yamamoto-Sugitani, M | 1 |
| Fujinaga, S; Iijima, K; Ito, S; Kamei, K; Ogura, M; Saito, M; Sako, M; Udagawa, T | 1 |
| Heiligenhaus, A; Heinz, C; Hennig, M; Rammrath, D; Roesel, M; Zurek-Imhoff, B | 1 |
| Garcia-Saenz-de-Sicilia, M; Mukherjee, S | 1 |
| Cetiner, M; Eskazan, AE; Ferhanoglu, B; Kara, E; Taninmis, H; Unsal, A; Yilmaz, M | 1 |
| Blaise, D; Siddiqi, T | 1 |
| Collins, PW | 1 |
| Cravedi, P; Kopp, JB; Remuzzi, G | 1 |
| Hamasaki, Y; Honda, M; Iijima, K; Ishikura, K; Ito, S; Kaneko, T; Matsuyama, T; Nakanishi, K; Nakazato, H; Sasaki, S; Yoshikawa, N | 1 |
| Cho, BS; Cho, SG; Eom, KS; Kim, DW; Kim, HJ; Kim, YJ; Lee, JW; Lee, S; Lee, SE; Min, CK; Min, WS; Park, CW; Shin, SH; Yahng, SA; Yoon, JH | 1 |
| Cantin, B; Chan, MC; Hunt, SA; Kwok, BW; Shiba, N; Valantine, HA | 2 |
| Hamano, Y; Ikeda, Y; Ishihara, D; Kawamura, J; Mori, T; Okamoto, S; Sato, N; Watanabe, R | 1 |
| García-Suárez, J; Krsnik, I; López-Rubio, M; Santana, A | 1 |
| Berdichevski, RH; Berger, M; Comerlato, L; Denicol, NT; Gonçalves, LF; Koff, WJ; Manfro, RC; Ribeiro, AR; Saitovitch, D | 1 |
| Böswald, M; Brandis, M; Bulla, M; Burghard, R; Dippell, J; Greiner, C; Jungraithmayr, T; Kirste, G; Klare, B; Klaus, G; Leichter, H; Misselwitz, J; Patzer, L; Querfeld, U; Rascher, W; Staskewitz, A; Tönshoff, B; Wiesel, M; Zimmerhackl, LB | 1 |
| Everson, GT | 1 |
| Cesana, B; Montagnino, G; Ponticelli, C; Tarantino, A; Villa, M | 1 |
| Bakran, A; Hammad, A; Rustom, R; Sells, RA; Sharma, AK; Sinha, S; Smith, D | 1 |
| Frickhofen, N; Heimpel, H; Kaltwasser, JP; Schrezenmeier, H | 1 |
| Aschan, J; Barkholt, L; Eriksson, B; Hentschke, P; Holmberg, K; Myrbäck, KE; Remberger, M; Ringdén, O; Svahn, BM | 1 |
| Bernuzzi, P; Corneo, R; Morra, E; Muti, G; Nosari, A; Pungolino, E; Rossi, V | 1 |
| Hardie, RJ; McAnulty, JE; Patricelli, AJ | 1 |
| Bahra, M; Berg, T; Harren, M; Jacob, D; Langrehr, JM; Neuhaus, P; Neuhaus, R; Neumann, UP | 1 |
| Bernal, I; Boix, J; Cabré, E; Domènech, E; Fluvià, L; Garcia-Planella, E; Gassull, MA; Rosinach, M | 1 |
| Kim, YJ; Kim, YL | 1 |
| Chen, HR; Ji, SQ; Liu, J; Wang, HX; Xue, M; Xun, CQ; Yan, HM; Zhu, L | 1 |
| Chen, J; Chen, L; Feng, C; Gong, X; Xie, H | 1 |
| Aoki, K; Chiba, S; Goyama, S; Hirai, H; Kanda, Y; Kandabashi, K; Kawazu, M; Komeno, Y; Kurokawa, M; Motokura, T; Nakamoto, T; Nannya, Y; Niino, M; Ogawa, S; Takeshita, M; Tsujino, S | 1 |
| Bader, P; Beck, LF; Dückers, G; Greil, J; Hoelle, W; Kerst, G; Klingebiel, T; Kreyenberg, H; Lang, P; Niethammer, D | 1 |
| Follmann, D; Nunez, O; Rosenfeld, S; Young, NS | 1 |
| Bar-Nathan, N; Ben-Ari, Z; Mor, E; Shaharabani, E; Shapira, Z; Tur-Kaspa, R | 1 |
| Badid, C; Fouque, D; Harzallah, K; Laville, M; Lefrancois, N; Touraine, JL | 1 |
| Gagnadoux, MF; Niaudet, P; Salomon, R | 1 |
| Folwaczny, C; Rath, HC | 1 |
| Birsan, T; Deviatko, E; Klepetko, W; Reichart, B; Reichenspurner, H; Treede, H; Zuckermann, A | 1 |
| Kato, K; Kojima, S; Kudo, K; Matsuyama, T; Nakamoto, C; Nakamura, Y; Yoshimi, A | 1 |
| Bamberger, E; Kessel, A; Toubi, E | 1 |
| Cohen, SM; Hart, J; Levitsky, J; Te, HS | 1 |
| Briggs, D; Dudley, C; Pattison, J; Pfeffer, P; Rowe, P; Salmela, K; Tydén, G | 1 |
| Atra, A; Goyal, S; Horton, C; Kulkarni, S; Mehta, J; Meller, S; Ortin, M; Pinkerton, CR; Powles, R; Rudin, C; Sankpal, S; Saso, R; Singhal, S; Sirohi, B; Treleaven, J | 1 |
| Pariente, A | 1 |
| Berghaus, A; Bloching, M; Born, S; Welzel, C | 1 |
| Albitar, M; Cortes, J; Estey, E; Faderl, S; Garcia-Manero, G; Giles, FJ; Kantarjian, H; Thomas, D; Tsimberidou, A; Verstovsek, S | 1 |
| Buchler, M; Durand, D; Izopet, J; Kamar, N; Rostaing, L; Sandres-Saune, K; Toupance, O | 1 |
| de Leeuw, FE; Kiemeneij, IM; Ramos, LM; van Gijn, J | 1 |
| Ghoneim, MA; Mohamed, NA; Refaie, AF; Sheashaa, HA; Sherif, AM; Sobh, MA | 1 |
| Ahn, MJ; Cho, KS; Choi, IY; Choi, JH; Im, SA; Jung, CW; Jung, SY; Ki, M; Kim, BK; Kim, IS; Kim, SR; Lee, JA; Lee, JH; Lee, YY; Oh, D; Park, SY; Son, HJ; Suh, C; Sung, JM; Yoon, HJ; Yoon, SS; Yuh, YJ | 1 |
| Cortes, JE; Estey, E; Faderl, S; Ferrajoli, A; Garcia-Manero, G; Giles, FJ; Kantarjian, HM; Keating, MJ; O'Brien, S; Thomas, DA; Tsimberidou, AM; Verstovsek, S | 1 |
| Hamada, H; Higaki, J; Hiwada, K; Irita, J; Ito, R; Kadowaki, T; Katayama, H; Kukita, H; Mutsukado, Y; Onishi, H; Watanabe, A; Yokoyama, A | 1 |
| Amemiya, S; Iino, Y; Iizuka, M; Katayama, Y; Utsumi, K | 1 |
| Charlton, M | 1 |
| Bagga, A; Hari, P; Jordan, SC; Moudgil, A | 1 |
| Bai, J; Cao, YR; Cui, ZZ; Fu, R; He, GS; Liu, H; Qin, TJ; Shao, ZH; Shi, J; Wu, YH; Yang, CL; Yang, TY | 1 |
| Cimino, L; Finzi, G; Gandolfi, SA; Mora, P; Orsoni, JG; Zavota, L | 1 |
| Gellermann, J; Querfeld, U | 1 |
| Gleeson, M; Guney, S; McCaughan, GW; Zekry, A | 1 |
| Goumenos, DS; Kalliakmani, P; Sotsiou, F; Tsakas, S; Vlachojannis, JG | 1 |
| Chaudhary, UB; Eberwine, SF; Hege, KM | 1 |
| Bulla, M; Kemper, MJ; Kuwertz-Broeking, E; Mueller-Wiefel, DE; Neuhaus, TJ | 1 |
| Atsuta, Y; Furukawa, T; Hamajima, N; Hirabayashi, N; Hirai, H; Hiraoka, A; Iseki, T; Iwato, K; Izutsu, K; Kanda, Y; Kasai, M; Kawa, K; Kodera, Y; Maruta, A; Mitsui, H; Okamoto, S; Sakamaki, H | 1 |
| Actis, GC; Fadda, M; Lagget, M; Morino, F; Palmo, A; Pinna-Pintor, M; Rizzetto, M | 1 |
| Gunson, B; Hubscher, S; Neuberger, J; Nightingale, P | 1 |
| Finlay, AY; Lewis, JJ; Salek, MS; Sumner, MI | 1 |
| Newman, P; Rademaker, M; Stanway, A | 1 |
| Chao, TY; Dai, MS; Kao, WY; Shyu, RY | 1 |
| Barese, CN; Litvak, E; Podestá, M; Rivas, EM; Villa, M | 1 |
| Freeman, AF; Shulman, ST | 1 |
| Ito, E; Nakahata, T; Tanaka, H | 1 |
| Ferrer, L; Fondati, A; Gruet, P; Horn, J; Noli, C; Steffan, J; Strehlau, G | 1 |
| Alomar, A; Gilaberte, M; Puig, L; Vidal, D | 1 |
| Diven, SC; Kalia, A; Raafat, RH; Travis, LB | 1 |
| Escuín, F; García de Miguel, A; Jiménez, C; Olea, T; Ros, S; Sanz, A | 1 |
| Ballarín, JA; Cabezas, A; Calero, F; García Camín, RM | 1 |
| Aguilar, P; Muñoz Díaz, AB | 1 |
| Besisik, F; Boztas, G; Cakaloglu, Y; Danalioglu, A; Demir, K; Durakoglu, Z; Karaca, C; Kaymakoglu, S; Mungan, Z; Okyen, A | 1 |
| Job-Deslandre, C; Kahan, A; Sornay-Soares, C | 1 |
| Daenen, S; Ferrant, A; Huijgens, PC; Kramer, MH; Löwenberg, B; Schouten, HC; Sonneveld, P; Steijaert, MM; van den Berg, E; van der Holt, B; van Marwijk Kooy, R; Verdonck, LF; Verhoef, GE; Wijermans, PW | 1 |
| Choi, SJ; Kim, S; Kim, WK; Lee, JH; Lee, JS; Lee, KH; Lee, YS; Seol, M | 1 |
| Busuttil, RW; Crippin, JS; Fitzsimmons, WE; Goldstein, RM; Klintmalm, GB; Martin, P; Uleman, C | 1 |
| Bischoff, SC; Fleig, W; Reissmann, A | 1 |
| Iwasawa, H; Matsumoto, H; Nagaoka, Y; Nakao, T; Okada, T; Takeguchi, F; Tomaru, R | 1 |
| Pollard, S | 1 |
| Fridlender, ZG; Rottenberg, Y | 1 |
| Correa, H; Gardner, RV; Lee, JW; Ode, DL; Velez, MC | 1 |
| Hommann, M; Kornberg, A; Küpper, B; Scheele, J; Tannapfel, A | 1 |
| Bermejo, J; Bouza, E; Carbone, J; Catalan, P; Fernández-Cruz, E; Fernàndez-Yáñez, J; Muñoz, P; Palomo, J; Rodríguez-Molina, JJ; Sarmiento, E | 1 |
| Agnes, S; Burra, P; Callea, F; De Carlis, L; Fassati, LR; Ferrara, R; Filipponi, F; Grazi, GL; Pisati, R; Risaliti, A; Rossi, M; Salizzoni, M; Valente, U | 1 |
| Li, X; Wu, J; Zhang, L; Zhu, H | 1 |
| Kamińska, A; Minkiewicz-Timler, G; Pawluczyk-Dyjecińska, M; Smolarek, M; Sybilska, M; Szaflik, J | 1 |
| Bakis, S; Zagarella, S | 1 |
| Gregory, SP; Hardie, RJ; Ladlow, J; Lipscomb, V; Sturgeon, C; Tomlin, J | 1 |
| De Saeger, S; De Vos, MM; Honraet, K; Nelis, HJ; Summerbell, RC; van Kempen, I; Van Peteghem, C; Vermeersch, H | 1 |
| Böhm, M; Ecker, KW; Giese, T; Jüngling, B; Kindermann, I; Moser, C; Püschel, W; Schäfers, HJ; Stallmach, A; Zeuzem, S | 1 |
| Hasegawa, N; Iwasaki, N; Izumi, I; Kanemoto, K; Nakahara, C | 1 |
| Catovsky, D; Dearden, C; Matutes, E; Osuji, N | 1 |
| Diaconescu, R; Maloney, DG; Maris, MB; McSweeney, P; Parikh, CR; Sandmaier, BM; Schrier, RW; Sorror, ML; Storb, R; Storer, B | 1 |
| Kreis, H; Legendre, C; Mamzer-Bruneel, MF; Morelon, E; Noel, LH; Peraldi, MN; Skhiri, H | 1 |
| Burroughs, AK; Davidson, BR; Davies, S; Dhillon, AP; Emery, V; Griffiths, P; Leandro, G; Papatheodoridis, GV; Patch, DW; Quaglia, A; Rolando, N; Rolles, K; Sabin, CA; Samonakis, DN; Teixeira, R; Thalheimer, U; Triantos, CK | 1 |
| Balon, J; Bieniaszewska, M; Bieniaszewski, L; Hałaburda, K; Hellmann, A; Pawłowski, R; Piekarska, A; Reichert, M | 1 |
| Fenk, R; Germing, U; Graef, T; Haas, R; Hinke, A; Kobbe, G; Neumann, F; Steidl, U; Tapprich, C; Vaupel, M | 1 |
| Inoue, K; Yoshiba, M | 1 |
| Brandis, M; Häffner, K; Pohl, M; von Schnakenburg, C; Zimmerhackl, LB | 1 |
| Joseph, K; Kaplan, AP; Marsland, AM; Soundararajan, S | 1 |
| Reiter, A; Schrappe, M; Schrauder, A; Sykora, KW; Teuffel, O; Welte, K; Zimmermann, M | 1 |
| Angelico, M; Anselmo, A; D'Andria, D; de Liguori Carino, N; de'Liguori Carino, N; Ielpo, B; Manzia, T; Muzi, F; Orlando, G; Sabato Ceraldi, S; Tariciotti, L; Tisone, G | 1 |
| Bonhagen, K; Brück, W; Hohnstein, T; Kamradt, T; Nogai, A; Pfueller, CF; Siffrin, V; Stadelmann, C; Volkmer-Engert, R | 1 |
| Hosoya, M; Isome, M; Kawasaki, Y; Kobayashi, S; Ohara, S; Onishi, N; Suzuki, H; Takahashi, A | 1 |
| Cohen, JB; Maize, JC | 1 |
| Akashi, M; Hirano, T; Iwahori, T; Nakabayashi, I; Oka, K; Watanabe, T; Yoshida, M; Yoshikawa, N | 1 |
| André, JL; Cochat, P; Deschênes, G; Guyot, C; Loirat, C; Nathanson, S; Nivet, H | 1 |
| Ito, E; Kudo, M; Nakahata, T; Suzuki, K; Tanaka, H; Tsugawa, K; Waga, S | 1 |
| Honda, M; Iijima, I; Ikeda, M; Nakamura, H; Nakanishi, K; Ootomo, Y; Sako, M; Sekine, K; Wada, N; Yoshikawa, N | 1 |
| Maciejewski, JP; Risitano, AM | 1 |
| Muñoz, H; Núñez, T; Pedraza, D; Valdés, E | 1 |
| Conrad, C; Trüeb, RM | 1 |
| Davis, GL | 1 |
| Angelico, M; Anselmo, A; Baiocchi, L; Cardillo, A; Lionetti, R; Manzia, TM; Orlando, G; Palmieri, G; Tisone, G; Toti, L | 1 |
| Aguilera, V; Benlloch, S; Berenguer, J; Berenguer, M; Prieto, M; Rayón, JM; San Juan, F | 2 |
| Baliellas, C; Castellote, J; Fabregat, J; Figueras, J; Garcia-Gil, A; Gonzalez-Pinto, I; Lladó, L; Memba, R; Rafecas, A; Ramos, E; Serrano, T; Torras, J; Xiol, X | 1 |
| Lake, JR | 1 |
| Garola, RE; Jalanko, H; Kestila, M; Ruotsalainen, V; Savin, VJ; Sharma, M; Srivastava, T; Tryggvason, K; Warady, BA | 1 |
| Baba, HA; Beckebaum, S; Broelsch, CE; Gerken, G; Hilgard, P; Kahraman, A; Lehmann, N; Malago, M; Ross, RS; Seltmann, C | 1 |
| Abreu, MT; Cohen, R; Lichtenstein, GR; Tremaine, W | 1 |
| Brodeh, J; Hoyer, PF | 1 |
| Rao, SN | 1 |
| Baron, F; Bruno, B; Burroughs, L; Chauncey, TR; Flowers, ME; Forman, SJ; Leisenring, W; Maloney, DG; Martin, PJ; Mielcarek, M; Sandmaier, BM; Storb, R | 1 |
| Fukuhara, T; Maekawa, I; Miyake, T; Onozawa, M; Shigematsu, A; Takahata, M; Yamamoto, Y | 1 |
| Alessandrino, PE; Bacigalupo, A; Barisione, G; Bosi, A; Bruno, B; Bruzzi, P; di Bartolomeo, P; Guidi, S; Lamparelli, T; Oneto, R; Sacchi, N; van Lint, MT | 1 |
| Cataland, SR; George, JN; Jin, M; Wu, HM; Zheng, XL | 1 |
| Nunez, O; Scheinberg, P; Wu, C; Young, NS | 1 |
| Nunez, O; Scheinberg, P; Young, NS | 1 |
| Lin, SF; Yang, WC | 1 |
| Joshi, SR; Kotwal, VS; Lanjewar, DN; Ramraje, NN; Shedge, RT; Shenoy, VV | 1 |
| Davies, K; Holt, S; Tomlinson, L; Wright, DA | 1 |
| Höcker, B; Knüppel, T; Schaefer, F; Tönshoff, B; Waldherr, R; Weber, S | 1 |
| Cruysberg, LP; Csaky, KG; Edelhauser, HF; Gilger, BC; Harrington, SM; Hayat, M; Kim, H; Kim, J; Kim, S; Lee, SS; Murray, PR; Robinson, MR; Salmon, JH; Wilkie, DA; Yuan, P | 1 |
| Goumenos, DS; Kalliakmani, P; Savidaki, I; Tsakas, S; Vlachojannis, JG | 1 |
| Iida, H; Kitaori, K; Kohno, A; Matsuo, K; Morishita, Y; Ozeki, K; Sakamaki, H; Sao, H; Yokozawa, T | 1 |
| Hoshika, A; Kashiwagi, Y; Kawashima, H; Kuboshima, S; Sato, S; Takekuma, K; Watanabe, K | 1 |
| Fujii, H; Goto, H; Ikuta, K; Isaki, S; Kajiwara, R; Kuroki, F; Takahashi, H; Yanagimachi, M; Yokota, S | 1 |
| Alexopoulos, E; Leontsini, M; Memmos, D; Papagianni, A; Tsamelashvili, M | 1 |
| Ito, E; Shimada, J; Suzuki, K; Tanaka, H; Tsugawa, K; Tsuruga, K | 1 |
| Pietruczuk, M; Wasilewska, A; Zoch-Zwierz, W | 1 |
| Papp, KA; Rosoph, L; Toth, D | 1 |
| Cillo, U; Grazi, GL; Lake, J; Leonardi, L; Levy, G; Mies, S; Mühlbacher, F; Munn, S; Rossi, M; Samuel, D; Sanjuan, F; Villamil, F | 1 |
| Tenderenda, E; Tobolczyk, J; Wasilewska, A; Zoch-Zwierz, W | 1 |
| Dengler, T; Giese, T; Konstandin, M; Meuer, S; Schmidt, J; Sommerer, C; Zeier, M | 1 |
| Deneuche, A; Desbois, C; Fayolle, P; Hidalgo, A; Klein, A; Moissonnier, P; Scotti, S; Tessier, D; Viateau, V; Zylberstein, L | 1 |
| Berenguer, M; Royuela, A; Zamora, J | 1 |
| Chambers, B; Donnan, G; Ierino, FL; Lim, AK | 1 |
| Boura, P; Kamali, S; Sarantopoulos, A; Skendros, P; Topouzis, F; Tselios, K | 1 |
| Cross, DC; Van Der Berg, HM | 1 |
| Akash, N | 1 |
| Abeyagunawardena, AS; Hindmarsh, P; Trompeter, RS | 1 |
| Baumann, I; Bergsträsser, E; Fischer, A; Führer, M; Göbel, U; Gross-Wieltsch, U; Klingebiel, T; Niemeyer, C; Nöllke, P; Sykora, KW; van den Heuvel-Eibrink, MM; Yoshimi, A | 1 |
| Fekete, A; Reusz, G; Szabó, A | 1 |
| Actis, GC; David, E; Fadda, M; Sapino, A | 1 |
| Dafnis, E; Goumenos, DS; Katopodis, KP; Liakopoulos, V; Passadakis, P; Siamopoulos, KC; Stefanidis, I; Vardaki, E; Vargemezis, V; Vlachojannis, JG | 1 |
| Colin, J; Ghiringhelli, C; Schweitzer, C; Touboul, D | 1 |
| Blaszczyk, M; Cwikla, J; Kolacinska-Strasz, Z; Labecka, H; Natorska, U; Olszewska, M; Sulej, J | 1 |
| Aslan, E; Dissemond, J; Grabbe, S; Körber, A | 1 |
| Aoudjehane, L; Batteux, F; Calmus, Y; Conti, F; Dharancy, S; Podevin, P; Rosenberg, AR; Soubrane, O | 1 |
| Dick, AD; Hogan, AC; Lee, RW; McAvoy, CE | 1 |
| Hanafusa, T; Hata, A; Kagitani, M; Kotani, T; Makino, S; Shoda, T; Tabushi, Y; Takeuchi, T | 1 |
| Bahamondes, C; Godoy, J | 1 |
| Ağan, M; Aktan, M; Dinçol, G; Diz-Küçükkaya, R; Doğan, O; Nalçaci, M; Oztürk, S; Palanduz, S; Yavuz, S | 1 |
| Essen, E; Haytac, CM; Ozcelik, O; Ustun, Y | 1 |
| Bärthel, E; Hommann, M; Kornberg, A; Küpper, B; Settmacher, U; Tannapfel, A; Thrum, K; Wilberg, J | 1 |
| Cantú-Rodríguez, OG; Gómez-Almaguer, D; Gonzalez-Llano, O; Gutierrez-Aguirre, CH; Jaime-Pérez, JC; Martinez-González, O; Morales-Toquero, A; Ruiz-Argüelles, GJ; Salazar-Riojas, R; Tarín-Arzaga, LC | 1 |
| Jeong, HJ; Kim, JH; Kim, PK; Lee, JS; Shin, JI | 1 |
| Enami, T; Goto, D; Hayashi, T; Ito, S; Mamura, M; Matsumoto, I; Sugihara, M; Sumida, T; Suzuki, T; Tsutsumi, A; Yoshimi, A | 1 |
| Gallegos-Orozco, JF; Olivera-Martínez, MA | 1 |
| Bessho, M; Dan, K; Fujishima, N; Hirokawa, M; Nakao, S; Omine, M; Ozawa, K; Sawada, K; Teramura, M; Tsurumi, H; Urabe, A | 1 |
| Blanche, S; de Saint Basile, G; Fischer, A; Mahlaoui, N; Neven, B; Ouachée-Chardin, M; Picard, C | 1 |
| Appel, G; Busch, J; Crew, RJ; D'Agati, V; Markowitz, G; Stokes, B; Valeri, A; Waldman, M | 1 |
| Cataland, SR; George, JN; Jin, M; Kennedy, MS; Kraut, EH; Lin, S; Wu, HM | 1 |
| Koo, J; Maskatia, ZK | 1 |
| Guardiola, J; Rodríguez-Moranta, F; Soriano-Izquierdo, A | 1 |
| Bleid, D; Caridi, G; Coccia, C; Gambini, C; Garaventa, A; Ghiggeri, GM; Perfumo, F | 1 |
| Dalal, L | 1 |
| Dudley, T; Haydon, G; Mutimer, D; Nightingale, P; Oo, YH | 1 |
| Bacigalupo, A; Del Vecchio, GC; Dufour, C; Iori, AP; Locasciulli, A; Longoni, D; Quarello, P; Ramenghi, U; Saracco, P; Svahn, J; Varotto, S; Zecca, M | 1 |
| Clover, L; Grubneac, A; Irani, SR; Jacob, S; Rajabally, YA; Vincent, A; Walters, RJ; Yazaki, M | 1 |
| Bertz, H; Finke, J; Grüllich, C; Müller, CI; Spyridonidis, A | 1 |
| Jacob, SE; Kerdel, FA; Weisman, RS | 1 |
| Bozkurt, B; Irkec, M; Sahin, A | 1 |
| Fujinaga, S; Kaneko, K; Ohtomo, Y; Shimizu, T; Someya, T; Yamashiro, Y | 1 |
| Metselaar, HJ; van der Laan, LJ; Watashi, K | 1 |
| Bereczki, C; Haszon, I; Papp, F; Sümegi, V; Túri, S | 1 |
| Andreone, P; Bernardi, M; Bertoletti, A; Bihl, F; Biselli, M; Brander, C; Chisholm, JV; Cursaro, C; Loggi, E; Morelli, MC; Terrault, NA | 1 |
| Alegre de Miguel, V; Martínez Casimiro, L; Sánchez Carazo, JL | 1 |
| Chandra, J; Dutta, AK; Naithani, R; Narayan, S; Pemde, H; Ravi, R; Sharma, S; Singh, V | 1 |
| Ando, T; Goto, H; Ishiguro, K; Ishikawa, D; Maeda, O; Nishio, Y; Niwa, Y; Ohmiya, N; Takahashi, H; Watanabe, O | 1 |
| Kane, SV; Kornbluth, AA; Murphy, SJ; Present, DH; Reddy, D | 1 |
| Afanetti, M; Baudouin, V; Bouissou, F; Dallocchio, A; Dehennault, M; Groothoff, J; Guigonis, V; Hachon-Le Camus, C; Llanas, B; Niaudet, P; Nivet, H; Raynaud, N; Ronco, P; Taque, S | 1 |
| Goerz, G; Milde, P; Ruzicka, T; Schuppe, HC; Zumdick, M | 1 |
| Diener, P; Link, H; Mustafa, M; Olsson, T; Sun, JB | 1 |
| Berkley, LM; Bolton, EM; Bradley, JA; Briggs, JD; Gibbs, P | 1 |
| Albani, AP; Doglia, M; Fassati, LR; Ferla, G; Galmarini, D; Gatti, S; Orsenigo, R; Reggiani, P | 1 |
| Bechstein, WO; Blumhardt, G; Hopf, U; Knoop, M; Langrehr, JM; Lemmens, HP; Lohmann, R; Neuhaus, R; Schattenfroh, N; Verschl, J | 1 |
| Abe, M; Akamatsu, M; Babazono, T; Haruguchi, H; Hirotani, S; Kimikawa, M; Kitajima, K; Koike, T; Shinkai, M; Teraoka, S | 1 |
| Kang, CM; Kim, HS; Kim, MJ; Kim, SG; Lee, HY | 1 |
| Anzai, S; Fujimaki, K; Fujisawa, S; Fukawa, H; Hattori, M; Motomura, S; Okubo, T | 1 |
| Ito, H; Kitano, Y; Nakamura, H; Tanaka, R; Yoshikawa, N | 2 |
| Appel, GB; Kunis, C; Radhakrishnan, J; Valeri, A | 1 |
| Diem, E; Gotschim, A; Maier, H; Ortel, B | 1 |
| Chan, GL; Vijayanagar, RR; Weinstein, SS | 1 |
| Arnold, R; Bunjes, D; Duncker, C; Heimpel, H; Heit, W; Hertenstein, B; Novotny, J; Stefanic, M; Wiesneth, M | 1 |
| Bachmann, H; Christophers, E; Färber, L; Henneicke-von Zepelin, HH; Mrowietz, U; Welzel, D | 1 |
| Baudet, S; Casellas, F; Guarner, L; Malagelada, JR; Santos, J; Vilaseca, J | 1 |
| Berth-Jones, J; Graham-Brown, RA; Smith, SG | 1 |
| Jendrisak, MD; Marsh, JW; Perdrizet, GA; So, S; White, HM; Woodle, ES | 1 |
| Jackson, LD; Song, E | 1 |
| Cahen, R; Dijoud, F; François, B; Megri, K; Trolliet, P | 1 |
| Benedetti, A; Lorenzi, S; Martini, P; Peonia, G | 1 |
| Cohen, J; Davis, PM; Hyams, JS; Justinich, CJ; Treem, WR | 1 |
| Friedmann, PS; Levell, NJ; Munro, CS; Shuster, S | 1 |
| Erkko, P; Granlund, H; Reitamo, S; Sinisalo, M | 1 |
| Colon, S; Couchoud, C; Pouteil-Noble, C; Touraine, JL | 1 |
| Steen Olsen, T; Zachariae, H | 1 |
| Ingulli, E; Tejani, A | 1 |
| Hymes, LC | 1 |
| Baudet, JA; Casellas, FJ; Guarner, LA; Malagelada, JR; Santos, JV; Vilaseca, JM | 1 |
| Armstrong, G; Johnson, RW; Jos, V; Kalra, PA; Mamtora, H; O'Donoghue, DJ; Routledge, R; Sinnott, PJ; Waldek, S; Wood, GN | 1 |
| Adams, PC; Ghent, CN; Grant, DR; McAlister, VC; Roy, A; Wall, WJ | 1 |
| Chrysomallis, F; Ioannides, D; Minas, A; Panagiotidou, D; Teknetzis, A | 1 |
| Färber, L; Mahrle, G; Schulze, HJ; Steigleder, GK; Weidinger, G | 1 |
| Jin, XY; Zhao, JC | 1 |
| Habib, R; Niaudet, P | 1 |
| Gonzalo, A; Mampaso, F; Marcen, R; Navarro, JF; Orofino, L; Ortuño, J; Teruel, JL | 1 |
| Stark, ME; Tremaine, WJ | 1 |
| Abla, O; Arcese, W; Boni, L; Di Bartolomeo, P; Dini, G; Iori, AP; Locatelli, F; Polchi, P; Rossetti, F; Uderzo, C | 1 |
| Glicklich, DG; Iskaros, BF; Khan, GA; Posner, L | 1 |
| Berte, R; Buscarini, E; Buscarini, L; Cavanna, L; Civardi, G; Di Stasi, M; Fornari, F; Vallisa, D | 1 |
| Barratt, TM; Dillon, MJ; Hulton, SA; Neuhaus, TJ | 1 |
| Beelen, DW; Liedtke, W; Quabeck, K; Schaefer, UW; Straeten, V | 1 |
| Chuhjo, T; Kaneshige, T; Matsuda, T; Mizoguchi, H; Nakao, S; Shiobara, S; Takamatsu, H; Ueda, M | 1 |
| Appel, GB; D'Agati, V; Kunis, CL; Radhakrishnan, J | 1 |
| Niaudet, P | 2 |
| Favre, H; Lemoine, R; Miescher, PA | 1 |
| Ellison, GW; Ke, D; Leake, BD; Mickey, MR; Myers, LW; Syndulko, K; Tourtellotte, WW | 1 |
| Burke, JF; Pirsch, JD; Ramos, EL; Salomon, DR; Stablein, DM; Van Buren, DH; West, JC | 1 |
| Aschan, J; Ljungman, P; Lönnqvist, B; Markling, L; Remberger, M; Ringden, O | 1 |
| Atmaca, LS; Batioğlu, F | 1 |
| Kim, YS; Oh, CK; Park, K | 1 |
| Furuse, A; Kubota, H; Otsuka, T; Takeshita, M; van Breda Vriesman, PJ; Yagyu, K | 1 |
| Ito, H; Kimura, Y; Nakamura, H; Nomura, N; Otaka, M; Sakai, N; Shirota, T; Suzuki, A; Toyama, K; Uchida, H | 1 |
| Amylon, MD; Chao, NJ; Long, GD; Nademanee, AP; Negrin, RS; O'Donnell, MR; Parker, PM; Smith, EP; Snyder, DS; Stein, AS | 1 |
| Hirose, M; Kuroda, Y; Ninomiya, T; Okamoto, Y; Sano, T; Takahashi, Y; Ushiroguchi, Y; Watanabe, T | 1 |
| Catamo, F; Garcovich, A; Gatti, M; Olivetti, G; Pompili, A | 1 |
| Barlan, M; Berlakovich, GA; Herbst, F; Mittlböck, M; Mühlbacher, F; Steininger, R | 1 |
| Andrews, W; Atkison, P; Moore, P; Sommerauer, JF; Wall, W | 1 |
| Broyer, M; Gagnadoux, MF; Habib, R | 1 |
| Hattori, M; Ito, K; Kawaguchi, H; Ota, K; Takahashi, K | 1 |
| Feldmann, R; Masgrau-Peya, E; Mesheit, J; Salomon, D; Saurat, JH | 1 |
| Diven, SC; Gugliuzza, KK; Kalia, A; Rajaraman, S; Srivastava, RN; Travis, LB | 1 |
| Küchle, M; Naumann, GO; Nguyen, NX | 1 |
| Altieri, P; Confalonieri, R; Edefonti, A; Ghio, L; Gusmano, R; Lama, G; Ponticelli, C; Rinaldi, S; Rizzoni, G; Zacchello, G | 1 |
| Ben-Amitai, D; David, M; Katzenelson, V; Lapidoth, M; Lustig, S; Sandbank, M | 1 |
| Eherer, A; Krejs, GJ; Petritsch, W; Reicht, G; Wenzl, H | 1 |
| Bacigalupo, A; Clavio, M; Fagioli, F; Frassoni, F; Gualandi, F; Lamparelli, T; Occhini, D; Sogno, G; Van Lint, MT; Vitale, V | 1 |
| Brodehl, J | 1 |
| Allegri, L; Banfi, G; Bignardi, L; Fogazzi, GB | 1 |
| Arcese, W; Bandini, G; Bosi, A; Carreras, E; Frassoni, F; Gahrton, G; Gratwohl, A; Hermans, J; Niederwieser, D; Vernant, JP | 1 |
| Hughes, RA | 1 |
| Barratt, TM; Dillon, MJ; Hulton, SA; Piqueras, AI; Shah, V | 1 |
| Dunn, DL; Gillingham, KJ; Kramer, MA; Mayoral, JL; Sawyer, MD | 1 |
| Appelbaum, FR; Bakke, L; Bensinger, WI; Bianco, JA; Bowden, RA; Buckner, CD; Clift, RA; McDonald, GB; Schubert, M; Singer, JW | 1 |
| Amylon, MD; Chao, NJ; Dagis, AC; Long, GD; Nademanee, AP; Negrin, RS; Niland, JC; O'Donnell, MR; Parker, PM; Schmidt, GM | 1 |
| Aurer, I; Bogdanić, V; Kovacević-Metelko, J; Labar, B; Maravić, N; Mrsić, M; Nemet, D; Radman, I; Zupancić-Salek, S | 1 |
| Cohen, A; Ettenger, R; Hogg, R; Marik, J; Mowry, J; Sahney, S | 1 |
| Abdulaziz, M; Luan, FL; Paroli, MP; Pivetti Pezzi, P; Priori, R; Valesini, G | 1 |
| Anderle, SK; Brown, RR; Schlievert, PM; Schwab, JH | 1 |
| Hanauer, SB; Smith, MB | 1 |
| Lackner, H; Mache, C; Schwinger, W; Urban, C | 1 |
| Leznoff, A | 1 |
| Kaan, G; Ozden, O | 1 |
| Burke, JR; Sargent, P; Webb, KL | 1 |
| Baur, R; Dartsch, PC; Höher, M; Hombach, V; Osterhues, H; Seitzer, U; Voisard, R | 1 |
| Ezaki, K; Hirano, M; Kojima, H; Maruyama, F; Tsuzuki, M | 1 |
| Barratt, TM; Callard, RE; Neuhaus, TJ; Shah, V | 1 |
| Anasetti, C; Anderson, JE; Appelbaum, FR; Bensinger, WI; Bryant, E; Buckner, CD; Chauncey, T; Clift, RA; Gooley, T; Schoch, G | 1 |
| Cabanillas, F; Callendar, D; Hagemeister, F; Mansfield, P; McLaughlin, P; Mesina, O; Moore, D; North, L; Rodriguez, MA; Romaguera, J; Sarris, AH; Swan, F; Younes, A | 1 |
| Alloway, RR; Amiri, MH; Gaber, AO; Gaber, LW; Russell, WC; Vera, SR | 1 |
| Okumura, H; Takamatsu, H; Yoshida, T | 1 |
| Duerksen, DR; Jewell, LD; Ma, MM | 1 |
| Amato-Neto, V; Bacal, F; Bellotti, G; Bocchi, EA; Fiorelli, A; Higuchi, ML; Jatene, AD; Mocelin, AO; Pileggi, F; Stolf, NA; Uip, D | 1 |
| Guttmann, RD | 1 |
| Kim, MS; Kim, SI; Kim, YS; Oh, CK; Park, K | 1 |
| Han, DJ; Lee, HM; Yoon, HS | 1 |
| Mampaso, F; Marcen, R; Navarro-Antolin, J; Orofino, L; Ortuño, J; Rivera, ME; Teruel, JL | 1 |
| Hassall, E; Israel, DM; Mahdi, G | 1 |
| McDiarmid, SV | 1 |
| Drozdz, D; Kwinta-Rybicka, J; Nowak, J; Sancewicz-Pach, K; Słowiaczek, E; Wilkosz, K | 1 |
| Boubenider, K; Charpentier, B; Hestin, D; Hiesse, C; Kessler, M; Mayeux, D | 1 |
| Lémann, M | 1 |
| Brodehl, J; Hoyer, PF; Kardorff, R; Maibücher, A; Melter, M; Rodeck, B | 1 |
| Athanassiou, P; Georganas, C; Iatrou, C; Iliadou, K; Ioakimidis, D; Kontomerkos, T; Vidalaki, B | 1 |
| Dmitrewski, J; Hubscher, SG; Mayer, AD; Neuberger, JM | 1 |
| Cavallo, T; First, MR | 1 |
| Berth-Jones, J | 1 |
| Allen, BR; Emerson, R; Zaki, I | 1 |
| Abecassis, M; Kaplan, B; Kaufman, DB; Stuart, FP; Wang, Z | 1 |
| Eriksson, E; Erkko, P; Granlund, H; Reitamo, S | 1 |
| Raez, LE; Saldana, M; Temple, JD | 1 |
| Bacigalupo, A; Fiere, D; Frassoni, F; Gluckman, E; Gorin, NC; Harrousseau, JL; Jouet, JP; Labopin, M; Reiffers, J; Ringdén, O; Vernant, JP | 1 |
| Berg, T; Fukomoto, T; Haller, GW; Hopf, U; Lemmens, HP; Lobeck, H; Mueller, AR; Naumann, U; Neuhaus, P; Platz, KP | 1 |
| Bechstein, WO; Berg, T; Fukomoto, T; Guckelberger, O; Hopf, U; Lobeck, H; Mueller, AR; Neuhaus, P; Neuhaus, R; Platz, KP | 1 |
| Jacob, N; Maiolo, E; Pattin, M; Rearte, A; Sabbatiello, R; Schiavelli, R; Vazquez, MC | 1 |
| Kierkuś, J; Ksiazyk, J; Lyszkowska, M; Popińska, K; Socha, J | 1 |
| Belaïche, J; Boruchowicz, A; Carbonnel, F; Colombel, JF; Cosnes, J; Duclos, B; Gendre, JP; Lémann, M; Lerebours, E; Soulé, JC | 1 |
| Constantinou, C; Devereux, L; Fernandez, E; Goldberg, J; Goldman, N; Grana, G; Gryn, J; Hageboutros, A; Harrer, W; Johnson, E; Viner, E | 1 |
| Broyer, M; Chérif, N; Droz, D; Gagnadoux, MF; Gubler, MC; Jan, D; Juresco, A; Lehnert, A; Niaudet, P; Ranchin, B | 1 |
| Cantarovich, M; Deschênes, J; Rocha, G | 1 |
| Ahsan, N; Dabbs, DJ; Gifford, RR; Manning, EC; Yang, HC | 1 |
| Kiyohara, A; Niizuma, N; Ogawa, H; Takamori, K | 1 |
| Barrett, AJ; Brown, KE; Dunbar, CE; Tisdale, J; Young, NS | 1 |
| McCarthy, ET; Mowry, JA | 1 |
| Anasetti, C; Appelbaum, FR; Boeckh, M; Chauncey, TR; Deeg, HJ; Doney, K; Flowers, M; Leisenring, W; Lin, D; Martin, P; Nash, R; Schoch, G; Storb, R; Sullivan, KM; Witherspoon, RP | 1 |
| Andersson, BS; Champlin, RE; Cleary, K; de Lima, M; Dyer, C; Gajewski, JL; Giralt, SA; Khouri, IF; Mehra, R; Moore, DF; Przepiorka, D; Rondón, G; van Besien, KW | 1 |
| Escobar, FS; Kupin, WL; Lee, MW; Mozes, MF; Nakhleh, RE; Venkat, KK; Wiener, Y | 1 |
| Flemming, C; Guttmann, RD | 1 |
| Reinhard, T; Sundmacher, R | 1 |
| Kulkarni, S; Mehta, J; Powles, R; Singhal, S; Treleaven, J | 1 |
| Alonso, EM; Kelly, SM; Newell, KA; Rubin, CM; Thistlethwaite, JR; Whitington, PF | 1 |
| Eguchi, K; Kawabe, Y; Kita, A; Mizokami, A; Nagataki, S; Nakane, S; Yamasaki, H | 1 |
| Cantarovich, M; Latter, DA; Loertscher, R | 1 |
| Aichbichler, B; Fickert, P; Hinterleitner, TA; Krejs, GJ; Petritsch, W; Ranner, G | 1 |
| Iida, S; Kagami, Y; Miura, K; Morishima, Y; Nakamura, S; Ogura, M; Seto, M; Suzuki, R; Taji, H; Yatabe, Y | 1 |
| Devlin, J; Donaldson, P; Heaton, N; Portmann, B; Tan, KC; Williams, R | 1 |
| Anasetti, C; Appelbaum, FR; Bensinger, W; Buckner, CD; Chauncey, T; Clift, R; Deeg, HJ; Doney, K; Flowers, ME; Hansen, JA; Leisenring, W; Martin, P; Pepe, M; Pettinger, M; Sanders, J; Storb, R; Sullivan, KM; Thomas, ED; Witherspoon, R | 1 |
| Ghandour, FZ; Hricik, DE; Knauss, TC; Mulligan, DC; Schulak, JA | 1 |
| Berg, T; Guckelberger, O; Hopf, U; Lobeck, H; Mueller, AR; Neuhaus, P; Neuhaus, R; Platz, KP | 1 |
| Bakr, MA; el-Agroudy, A; el-Baz, M; el-Mekresh, M; Fouda, MA; Ghoneim, MA; Moustafa, F; Sally, S; Sobh, M; Wafa, E | 1 |
| Alheit, B; Bardin, PG; Joubert, JR; van Schalkwyk, EM; Wyser, CP | 1 |
| Brezin, JH; Kaplan, BS; Papadimitriou, M; Tomlanovich, SJ | 1 |
| Choi, IJ; Kim, JH; Kim, KS; Kim, PK; Pai, KS | 1 |
| Lozada-Nur, F; Miranda, C | 1 |
| Chikkappa, G; DaSilva, K; Lansing, L; Pasquale, D; Tsan, MF; Vidhya, R | 1 |
| Chow, CW; Kleinert, S; Weintraub, RG; Wilkinson, JL | 1 |
| Beelen, DW; Elmaagacli, AH; Schaefer, UW | 1 |
| Davis, JH; Hand, JP; Lawlor, ER; Yong, CK | 1 |
| Beppu, M; Hosaka, M; Ito, S; Nomura, T; Uchida, J | 1 |
| Andrade, SG; Andrade, ZA; Carneiro Filho, A; de Lima, ES; de Souza, AJ | 1 |
| Altrogge, H; Amon, O; Kemper, MJ; Müller-Wiefel, DE; Timmermann, K | 1 |
| Bocker, T; Görnig, M; Kaatz, M; Wollina, U; Zouboulis, CC | 1 |
| Althaus, C; Stammen, J; Sundmacher, R | 1 |
| Bouillon, R; Casteels, K; Laureys, J; Mathieu, C; Valckx, D; Waer, M | 1 |
| Barnett, MH; Davies, L; McLeod, JG; Pollard, JD | 1 |
| Baumann, R; Duclos, B; Reimund, JM | 1 |
| Hirabayashi, N; Ikeda, Y; Ishida, A; Matsuoka, S; Moriki, T; Okamoto, S; Wakui, M; Watanabe, R | 1 |
| Amend, WJ; Criswell, LA; Millward, CL; Olson, JL; Stone, JH | 1 |
| Bacigalupo, A; Berisso, G; Bregante, S; De Stefano, F; Frassoni, F; Gualandi, F; Lamparelli, T; Mordini, N; Occhini, D; Soracco, M; Van Lint, MT; Vitale, V; Zikos, P | 1 |
| Fragulidis, GP; Kato, T; Khan, MF; Miller, J; Nery, JR; Pinna, AD; Reddy, KR; Torres, MB; Tzakis, AG; Weppler, D; Zervos, XA | 2 |
| Bellotti, G; Bocchi, EA; Fiorelli, A; Higuchi, ML; Jatene, A; Pileggi, F; Stolf, N; Uip, D; Vieira, ML | 1 |
| Bakalska, M; Deleva, D; Filchev, N; Zaprianova, E | 1 |
| Aichbichler, BW; Fleischmann, G; Hinterleitner, TA; Krejs, GJ; Petritsch, W; Wenzl, HH | 1 |
| Berenguer, J; Berenguer, M; Carrasco, D; Córdoba, J; Gobernado, M; Mir, J; Olaso, V; Prieto, M; Rayón, JM; San-Juan, F | 1 |
| Al-Awwa, IA; First, MR; Hariharan, S | 1 |
| Berg, T; Hopf, U; Lobeck, H; Mansoorian, B; Mueller, AR; Neuhaus, P; Neuhaus, R; Platz, KP; Willimski, C | 1 |
| Arnout, W; Busuttil, RW; Colquhoun, S; Drazan, K; Farmer, DG; Ghobrial, RM; Goldstein, LI; Goss, J; Hollis, P; Holt, CD; Imagawa, D; Markman, JF; Markowitz, J; Martin, P; Pakrasi, A; Ponthieux, S; Rosen, H; Seu, P; Shackleton, CR; Singer, J; Stribling, R; Yersiz, H | 1 |
| Bruce, DS; Cronin, DC; Grewal, HP; Josephson, MA; Loss, GE; Millis, JM; Newell, KA; Pellar, S; Siegel, CT; Thistlethwaite, JR; Woodle, ES | 1 |
| Qunibi, W; Sabeel, A | 1 |
| Cienfuegos, JA; Civeira, MP; de la Peña, A; García, N; Herrero, JI; Prieto, J; Quiroga, J; Sangro, B; Sola, I | 1 |
| Barnes, PD; duPlessis, AJ; Gleeson, JG; Riviello, JJ | 1 |
| Avila, D; Cicciarelli, J; Iwaki, Y; Mendez, R; Sather, H | 1 |
| Afonso, R; Bastos, J; Gunson, B; McMaster, P; Min, X | 1 |
| Caccamo, L; Colledan, M; Fassati, LR; Gridelli, B; Maggi, U; Reggiani, P; Rossi, G | 1 |
| Bechstein, WO; Jonas, S; Naumann, U; Neuhaus, P; Neuhaus, R; Nüssler, NC; Rayes, N; Serke, S; Tullius, SG | 1 |
| Berg, T; Hopf, U; Mansoorian, B; Mueller, AR; Neuhaus, P; Neuhaus, R; Platz, KP; Radke, C; Willimski, C | 1 |
| Fuchshuber, A; Michalk, D; Müller-Berghaus, J; Querfeld, U; Tenbrock, K | 1 |
| Antin, JH; Avalos, B; Buell, DN; Christiansen, NP; Devine, SM; Fay, JW; Fitzsimmons, WE; Herzig, RH; Karanes, C; Klein, JL; Litzow, MR; Longo, WL; Maher, RM; Nademanee, A; Nash, RA; Petersen, FB; Przepiorka, D; Ratanatharathorn, V; Storb, R; van der Jagt, R; Weisdorf, D; Wingard, JR; Wolff, SN | 1 |
| Bessell, EM; Byrne, JL; Haynes, AP; Hyde, H; Miflin, G; Russell, NH; Stainer, C | 1 |
| Fydryk, J; Mehls, O; Schaefer, F; Schärer, K; Wiesel, M; Wühl, E | 1 |
| Dejaco, C; Gangl, A; Gasché, C; Moser, G; Novacek, G; Reinisch, W; Tillinger, W; Vogelsang, H | 1 |
| Deleva, D; Filchev, A; Zaprianova, E | 1 |
| Tremaine, WJ | 1 |
| Kim, MS; Kim, SI; Kim, YS; Moon, JI; Park, K | 1 |
| Matsutani, H; Niimura, F; Ohgushi, H; Takeda, A | 1 |
| Broyer, M; Gagnadoux, MF; Niaudet, P | 1 |
| Akhlaghi, F; Brown, KF; Keogh, AM | 1 |
| Bradstock, K; Brandenburg, U; Gottlieb, D | 1 |
| Bennett, JM; Lee, S; Paietta, E; Rowe, JM; Sikic, BI; Tallman, MS; Wiernik, PH | 1 |
| Bacigalupo, A; Gratwohl, A; Henry-Amar, M; Hows, J; Ljungman, P; Locasciulli, A; Marin, P; Marsh, J; McCann, S; Passweg, J; Raghavachar, A; Schrezenmeier, H; Socié, G; Tichelli, A | 1 |
| Champigneulles, J; Frimat, L; Hestin, D; Kessler, M; Renoult, E | 1 |
| Appel, G; Klein, M; Radhakrishnan, J | 1 |
| Aquino, A; Currier, C; Ghasemian, SR; Light, JA; Sasaki, TM | 1 |
| Archimbaud, E; Belhabri, A; Fière, D; Guyotat, D; Michallet, M; Molina, L; Nicolini, F; Perrin, MC; Sotto, JJ; Tigaud, JD | 1 |
| Franki, N; Futterweit, S; Savin, V; Sharma, M; Sharma, R; Singhal, PC; Trachtman, H | 1 |
| Kogure, K; Matsumoto, Y; Shin, T; Tanuma, N | 1 |
| Beelen, DW; Elmaagacli, AH; Nahler, M; Schaefer, UW; Schmidt, O; Trenn, G | 1 |
| Isonokami, M; Itoh, Y; Kozuka, T; Kurachi, K; Matsumoto, Y; Miura, H; Tanabe, N; Tani, M | 1 |
| Ito, M; Iwatsuki, K; Kaise, S; Kasukawa, R; Miyata, M; Nihei, Y; Nishimaki, T; Ohira, H; Sakuma, H; Sato, Y; Suzuki, T | 1 |
| Hanauer, SB; Stein, RB | 1 |
| Bernard, O; Debray, D; Girardet, JP; Maggiore, G; Mallet, E | 1 |
| Bedani, PL; Calastrini, C; Gilli, P; Stabellini, G | 1 |
| Bobadilla, J; ten Kate, FJ; Tytgat, GN; van der Hulst, RW | 1 |
| Albrecht, G; Atakan, N; Clarke, P; Griffiths, CE; Ho, VC; León-Dorantes, G; Mørk, NJ; Ohannesson, A; Paul, C; Pfister, P; Reitamo, S; Vanaclocha, F | 1 |
| Korelitz, BI | 1 |
| Das, KM; Gialanella, RJ; Griffel, LH; Gurudu, SR | 1 |
| Aschan, J; Carlens, S; Dilber, M; Remberger, M; Ringdén, O | 1 |
| Elgie, AW; Lewandowicz, GM; Sargent, JM; Taylor, CG; Williamson, CJ | 1 |
| Falk, R; Hogan, SL; Jennette, JC; Nachman, PH; Satterly, KK; Segelmark, M; Westman, K | 1 |
| Atilla, G; Baylas, H; Ilgenli, T | 1 |
| Bogatcheva, N; Kryjanovskii, O; Litvinov, D; Maschan, A; Mitiushkina, T; Rumiantsev, A; Samotchatova, E; Shneider, M; Timakov, A; Timakova, M | 1 |
| Amylon, MD; Blume, KG; Chao, NJ; Dagis, AC; Forman, SJ; Long, GD; Nademanee, AP; Negrin, RS; Niland, JC; O'Donnell, MR; Parker, PM; Ross, M; Schmidt, GM; Smith, EP; Snyder, DS; Stein, AS; Wong, RM | 1 |
| Angelico, M; Bellanova, G; Buonomo, O; Casciani, CU; Laria, G; Orlando, G; Palmieri, GP; Pisani, F; Tisone, G; Torri, E | 1 |
| Ahmed, I; Barclay, G; Beard, AL; Berth-Jones, J; Cork, MJ; Finlay, AY; Graham-Brown, RA; Harper, JI; Hoeger, P; Lacour, M; Sowden, JM; Sumner, MJ; Wilson, NJ | 1 |
| Bacigalupo, A; Barra, S; Berisso, G; Bregante, S; Corvò, R; Frassoni, F; Gualandi, F; Lamparelli, T; Mordini, N; Raiola, AM; Van Lint, MT; Vitale, V | 1 |
| Frickhofen, N; Rosenfeld, SJ | 1 |
| Arcese, W; Bacigalupo, A; Barbui, T; Broccia, G; Bruno, B; Carotenuto, M; Coser, P; Di Bona, E; Dufour, C; Ferster, A; Gabbas, A; Leoni, P; Locasciulli, A; Locatelli, F; Saracco, P; Testi, G | 1 |
| Boyne, MS; Dye, KR | 1 |
| Arceci, RJ; Brophy, N; Chang, M; Dahl, GV; Dunussi-Joannopoulos, K; Lacayo, NJ; Sikic, BI; Weinstein, HJ | 1 |
| Chejfec, G; Gaweco, AS; Hamdani, R; Harig, J; McClatchey, KD; Porayko, M; Rustgi, VK; Van Thiel, DH; Wiesner, RH; Yong, S | 1 |
| Crusius, JB; Meijer, JW; Mulder, CJ; Uil, JJ; Wahab, PJ | 1 |
| Kanemoto, K; Kinugasa, H; Kusakari, J; Matsui, A; Nagata, M; Nakahara, C; Sibasaki, M; Wada, T | 1 |
| Hinterreiter, M; Knoflach, P; Stadler, B | 1 |
| Alderson, DJ; Lancaster, J; McCormick, M | 1 |
| Sheiner, PA | 1 |
| Araujo, AA; Dick, AD; Forrester, JV; Wells, AP | 1 |
| Ehrich, JH; Filler, G; Franke, D; Wolfish, N; Zimmering, M | 1 |
| Brugarolas, A; Calvo, JP; Gonzalez Manzano, R; Jimenez, MM; Lopez-Picazo, JM; Ordoñez Tres, JM | 1 |
| Elonen, E; Juvonen, E; Parkkali, T; Ruutu, T; Volin, L | 1 |
| Chakrabarti, S; Chakraverty, RK; Chopra, R; de Elvira, MC; Devereux, S; Goldstone, AH; Hale, G; Kottaridis, PD; Linch, DC; Mackinnon, S; Mahendra, P; Marsh, JC; Milligan, DW; Morgan, GJ; Peggs, K; Pettengell, R; Robinson, S; Schey, S; Verfuerth, S; Waldmann, H; Williams, CD | 1 |
| Chen, J; Chen, L; Gong, X; Lin, Y; Liu, Z; Wang, Z; Xie, H; Yang, B | 1 |
| Benedetto, BJ; Braden, GL; Germain, MJ; Lipkowitz, GS; Madden, RL; Mulhern, JG; O'Shaughnessy, J; O'Shea, MH | 1 |
| Cederna, PS; Jejurikar, SS; Kuzon, WM | 1 |
| Bechstein, WO; Glanemann, M; Mueller, AR; Neuhaus, P; Nüssler, NC; Platz, KP; Rayes, N; Schumacher, G; Spree, E | 1 |
| Han, DJ; Jang, HJ; Jung, JG; Kang, CH; Kim, SC; Kim, SK; Kim, TH | 1 |
| Ho, MC; Hu, RH; Lai, HS; Lai, MY; Lee, PH; Tsai, MK; Yang, PM | 1 |
| Kamondi, A; Papp, A; Seres, A; Szegedi, A; Szirmai, I | 1 |
| Abraham, KA; Dorman, AM; Little, MA; Walshe, JJ | 1 |
| Egan, LJ; Lipsky, JJ; Mays, DC; Sandborn, WJ; Tremaine, WJ | 1 |
| Furuichi, K; Iwata, Y; Kobayashi, K; Sakai, N; Shimizu, M; Wada, T; Yokoyama, H; Yoshimoto, K | 1 |
| Rosario, AM; Young, JB | 1 |
| Althaus, C; Hillenkamp, J; Kersten, A; Sundmacher, R | 1 |
| de Witte, T; Linssen, P; Masereeuw, R; Muus, P; Raymakers, R; Smeets, M; Vierwinden, G | 1 |
| Boruczkowski, D; Jólkowska, J; Ladon, D; Leda, M; Pieczonka, A; Wachowiak, J; Witt, M | 1 |
| Appel, GB; Cattran, DC; Hebert, LA; Hoy, WE; Hunsicker, LG; Kunis, CL; Maxwell, DR; Pohl, MA | 1 |
| Calise, F; Ceriello, A; Cozzolino, S; Cuomo, O; Mancini, A; Mezza, F; Pettinato, G; Santaniello, W | 1 |
| Cantú, OG; Gómez-Almaguer, D; González-Llano, O; Jaime-Pérez, JC; Ruiz-Argüelles, A; Ruiz-Argüelles, GJ | 1 |
| Cohen, AD; Vardy, DA | 1 |
| Kaklamani, VG; Kaklamanis, PG | 1 |
| Craig, JC; Durkan, AM; Hodson, EM; Willis, NS | 1 |
| Barros, J; De Bonis, M; Madden, BP; Reynolds, L | 1 |
| Allende, E; Bilbao, I; Charco, R; Hidalgo, E; Lázaro, JL; Margarit, C; Pou, L | 1 |
| Basara, N; Bischoff, M; Blau, W; Fauser, AA; Günzelmann, S; Kiehl, MG; Kirsten, D; Römer, E; Schmetzer, B | 1 |
| Borzi, MT; Castagneto, M; Citterio, F; Di Pinto, A; Foco, M; Pozzetto, U; Scatà, MC | 1 |
| Bouillon, R; Gysemans, C; Mathieu, C; van Etten, E; Verstuyf, A | 1 |
| Amerika, D; Bicans, J; Chapenko, S; Folkmane, I; Murovska, M; Rosentals, R | 1 |
| Faggian, G; Forni, A; Lamascese, N; Lamasciese, N; Luciani, GB; Mazzucco, A | 1 |
| Arisaka, O; Hoshi, M; Kano, K; Nishikura, K; Yamada, Y | 1 |
| Chandy, M; Danda, D; George, B; Mathews, V; Srivastava, A | 1 |
| Chatila, T; Kim, J; Raman, V; Sharkey, A | 1 |
| Go, RS; Li, CY; Phyliky, RL; Tefferi, A | 1 |
| Eom, KS; Kim, CC; Kim, DW; Lee, JW; Lee, S; Min, CK; Min, WS | 1 |
| Inoue , K; Kawahito, Y; Sano, H; Yoshikawa, T | 1 |
| Aftimos, G; Meguerian-Bedoyan, Z | 1 |
| Dohy, H; Hiraoka, A; Kanamaru, A; Kodera, Y; Masaoka, T; Moriyama, Y; Nagao, T; Ohashi, Y; Okamoto, S | 1 |
| Douglas, JF; McGeown, MG; Middleton, D | 1 |
| Diagileva, OA; Iadrikhinskaia, VN; Kokhno, AV; Kozinets, DI; Kulikov, SM; Maslova, ER; Mikhaĭlova, EA; Savchenko, VG; Sokolov, AN; Tikhonova, LIu; Tiurina, NG; Ustinova, EN | 1 |
| Bevan, DH; Gordon-Smith, EC; Griffiths, R; Hale, G; Killick, SB; Lucas, G; Marsh, JC; Ouwehand, W; Waldmann, H; Willis, F | 1 |
| Mizusawa, Y; Simoda, M; Takeda, A; Takimoto, H | 1 |
| Hillenkamp, J; Reinhard, T; Sundmacher, R | 1 |
| Bader-Meunier, B; Galambrun, C; Koné-Paut, I; Mouy, R; Prieur, AM; Stéphan, JL | 1 |
| Bicigalupo, A; Bregante, S; di Grazia, C; Dominietto, A; Frassoni, F; Gualandi, F; Lamparelli, T; Occhini, D; Raiola, A; Romagnani, C; van Lint, MT | 1 |
| Benedetti, F; Bordignon, C; Bregni, M; Ciceri, F; Corradini, P; Dodero, A; Falda, M; Gianni, AM; Ladetto, M; Lucesole, M; Olivieri, A; Pileri, A; Rambaldi, A; Sajeva, MR; Tarella, C; Tresoldi, M; Voena, C; Zallio, F | 1 |
| Dudzik, B; Kaczmarczyk, I; Radziszewski, A; Sułowicz, W | 1 |
| Barrett, AJ; Carter, C; Childs, R; de Witte, M; Kang, EM; Leitman, SF; Little, R; Malech, H; Morgan, RA; Phang, S; Tisdale, JF | 1 |
| Chakrabarti, S; Collingham, KE; Fegan, CD; Milligan, DW; Osman, H | 1 |
| Akpek, EK; Baltatzis, S; Foster, CS; Yang, J | 1 |
| Jing, L; Liu, H; Shao, Z | 1 |
| Fujimi, S; Ikeda, K; Katafuchi, R; Nakayama, M; Tanaka, H; Yanase, T | 1 |
| Amenábar, JJ; Gaínza, FJ; Gómez-Ullate, P; Lampreabe, I; Urbizu, JM; Zárraga, S | 1 |
| Bouillon, R; Gysemans, C; Mathieu, C; Overbergh, L; Van Etten, E; Verstuyf, A; Waer, M | 1 |
| Czaja, AJ | 1 |
| Bondartschuk, K; Fricke, B; Friedrich, R; Illéssy, A; Klein, S | 1 |
| Apperley, J; Barrett, AJ; Cullis, JO; Hows, JM; Hughes, TP; Kelly, S; Mackinnon, S; Marks, DI; Schwarer, AP; Szydlo, R | 1 |
| Imanishi, K; Nagashima, M; Sagawa, Y; Shiohara, T | 1 |
| Cámara, R; Fernández-Villalta, MJ; Ferro, T; Figuera, A; Kassack, JJ; Lamana, M; López, J; Serrano, F; Steegmann, JL; Vázquez, L | 1 |
| Bennett, M; Collins, RH; Fay, JW; Kumar, V; Nikein, A; Rogers, ZR | 1 |
| Burger, HR; Fanconi, A; Klingler, M; Leumann, EP; Neuhaus, TJ | 1 |
| Bökenkamp, A; Brodehl, J; Helmchen, U; Hoyer, PF; Offner, G | 1 |
| Guasch, A; Hall, BM; Myers, BD; Newton, L; Suranyi, M | 1 |
| Bessell, EM; Hunter, AE; Russell, NH | 1 |
| Friedrich, R; Müller, WA; Simon, HU; Sych, FJ | 1 |
| Barras, MH; Guignard, JP | 1 |
| Ellis, CN; Griffiths, CE; Lazarus, GS; Matis, WL | 1 |
| Ansell, BM | 1 |
| Bonet, J; Borrás, M; Caralps, A; Lauzurica, R; Serra, A; Torguet, P; Vaquero, M | 1 |
| Amend, W; Artero, M; Biava, C; Tomlanovich, S; Vincenti, F | 1 |
| Chavers, B; Gores, P; Kashtan, C; Matas, AJ; Mauer, SM; Najarian, JS; Nevins, T; Stephanian, E; Sutherland, DE | 1 |
| Goldman, JM | 1 |
| McCombe, PA; Pender, MP; van der Kreek, SA | 1 |
| Borel, JF; Chabannes, D; Ryffel, B | 1 |
| Raghavachar, A; Schlander, M; Schrezenmeier, H | 1 |
| Brown, H; Haimovici, R; Kervick, GN; Pflugfelder, SC; Tozman, E; Yee, R | 1 |
| McCluskey, P; Wakefield, D | 1 |
| Bauditz, J; Bechstein, WO; Blumhardt, G; Hopf, U; König, V; Küther, S; Lobeck, H; Neuhaus, P; Neuhaus, R; Steffen, R | 1 |
| Bonan, P; Campolmi, P; Fabbri, P; Lotti, T; Palleschi, GM; Panconesi, E | 1 |
| Bender-Götze, C; Dopfer, R; Ebell, W; Ehninger, G; Friedrich, W; Gadner, H; Henze, G; Klingebiel, T; Peters, C; Riehm, H | 1 |
85 review(s) available for cyclosporine and Recrudescence
| Article | Year |
|---|---|
Evaluation of efficacy of rituximab for membranous nephropathy: A systematic review and meta-analysis of 11 studies.
Topics: Autoantibodies; Autoantigens; Cyclophosphamide; Cyclosporine; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Receptors, Phospholipase A2; Recurrence; Rituximab | 2022 |
Successful preventive treatment with cyclosporine in a patient with relapsed/refractory immune-mediated thrombotic thrombocytopenic purpura: a case report and review of the literature.
Topics: ADAMTS13 Protein; Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Methylprednisolone; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Recurrence; Rituximab; Young Adult | 2022 |
Time to Relapse After Discontinuing Systemic Treatment for Psoriasis: A Systematic Review.
Topics: Chronic Disease; Cyclosporine; Humans; Interleukin-17; Interleukin-23; Methotrexate; Psoriasis; Recurrence; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor Inhibitors | 2022 |
Glucocorticoids and steroid sparing medications monotherapies or in combination for IgG4-RD: a systematic review and network meta-analysis.
Topics: Antirheumatic Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Glucocorticoids; Humans; Immunoglobulin G4-Related Disease; Immunosuppressive Agents; Maintenance Chemotherapy; Mercaptopurine; Methotrexate; Mycophenolic Acid; Network Meta-Analysis; Odds Ratio; Recurrence; Remission Induction; Rituximab; Tacrolimus | 2020 |
Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
Topics: Adolescent; Alkylating Agents; Azathioprine; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Infant; Levamisole; Mycophenolic Acid; Nephrotic Syndrome; Prednisolone; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Ribonucleosides; Rituximab; Secondary Prevention | 2020 |
Risk factors for recurrent autoimmune liver diseases after liver transplantation: A meta-analysis.
Topics: Adult; Calcineurin Inhibitors; Cholangiocarcinoma; Cholangitis, Sclerosing; Colectomy; Cyclosporine; End Stage Liver Disease; Enzyme Inhibitors; Female; Graft Rejection; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Recurrence; Retrospective Studies; Risk Factors; Survival Rate; Tacrolimus | 2020 |
Network meta-analysis-based comparison of first-line steroid-sparing adjuvants in the treatment of pemphigus vulgaris and pemphigus foliaceus.
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Humans; Immunologic Factors; Mycophenolic Acid; Network Meta-Analysis; Pemphigus; Randomized Controlled Trials as Topic; Recurrence; Rituximab; Steroids | 2021 |
Henoch-Schönlein Purpura (IgA Vasculitis): Rapid Evidence Review.
Topics: Acetaminophen; Adrenal Cortex Hormones; Adult; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Child; Cyclosporine; Disease Progression; Glomerulonephritis; Humans; IgA Vasculitis; Immunosuppressive Agents; Mycophenolic Acid; Nephrology; Recurrence; Referral and Consultation; Remission, Spontaneous; Urinalysis | 2020 |
Recovery from prolonged thrombocytopenia in patients with TAFRO syndrome: case series and literature review.
Topics: Adrenal Cortex Hormones; Castleman Disease; Cyclosporine; Disease Management; Disease Susceptibility; Humans; Immunosuppressive Agents; Patient Outcome Assessment; Platelet Count; Recurrence; Thrombocytopenia | 2020 |
Efficacy and predictive factors of cyclosporine A in alopecia areata: a systematic review with meta-analysis.
Topics: Adrenal Cortex Hormones; Alopecia; Alopecia Areata; Cyclosporine; Humans; Recurrence | 2022 |
Successful treatment of multiple relapsed-refractory Langerhans cell histiocytosis with cyclosporine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Drug Resistance, Neoplasm; Histiocytosis, Langerhans-Cell; Histocytochemistry; Humans; Immunosuppressive Agents; Infant; Male; Radiography, Thoracic; Recurrence; Retreatment; Tomography, X-Ray Computed; Treatment Outcome | 2021 |
Comparison among adjuvant treatments for primary pterygium: a network meta-analysis.
Topics: Adjuvants, Immunologic; Alkylating Agents; Chemotherapy, Adjuvant; Conjunctiva; Cyclosporine; Fluorouracil; Humans; Immunosuppressive Agents; Mitomycin; Network Meta-Analysis; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Pterygium; Randomized Controlled Trials as Topic; Recurrence; Transplantation, Autologous | 2018 |
Recent Advances and Long-Term Results of Medical Treatment of Acquired Aplastic Anemia: Are Patients Cured?
Topics: Alemtuzumab; Anemia, Aplastic; Animals; Antilymphocyte Serum; Benzoates; Cyclosporine; Humans; Hydrazines; Immunosuppression Therapy; Immunosuppressive Agents; Pyrazoles; Recurrence; Treatment Outcome | 2018 |
Cyclosporine in Pediatric Nephrology.
Topics: Calcineurin Inhibitors; Child; Cyclosporine; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation; Nephrotic Syndrome; Recurrence; Tacrolimus | 2018 |
Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: A dermatologist and nail expert group consensus.
Topics: Acitretin; Administration, Oral; Administration, Topical; Adult; Aged; Biological Products; Consensus; Cyclosporine; Dermatologic Agents; Disease Management; Expert Testimony; Female; Humans; Injections, Intralesional; Male; Methotrexate; Middle Aged; Nail Diseases; Practice Guidelines as Topic; Psoriasis; Recurrence; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2019 |
Efficacy and acceptability of immunosuppressive agents for pediatric frequently-relapsing and steroid-dependent nephrotic syndrome: A network meta-analysis of randomized controlled trials.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infant; Levamisole; Male; Nephrotic Syndrome; Network Meta-Analysis; Randomized Controlled Trials as Topic; Recurrence; Rituximab; Secondary Prevention; Treatment Outcome | 2019 |
Management of aplastic anemia after failure of frontline immunosuppression.
Topics: Alemtuzumab; Androgens; Anemia, Aplastic; Antilymphocyte Serum; Clinical Trials as Topic; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cyclosporine; Disease Management; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Peptides; Practice Guidelines as Topic; Recurrence; Remission Induction; Survival Analysis; Unrelated Donors | 2019 |
Recurrent hepatitis C virus infection post liver transplantation: impact of choice of calcineurin inhibitor.
Topics: Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Fibrosis; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Insulin Resistance; Liver Transplantation; Recurrence; Virus Replication | 2013 |
Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis.
Topics: Allergens; Conjunctiva; Conjunctivitis, Allergic; Cyclosporine; Cytokines; Epithelium, Corneal; Humans; Immunosuppressive Agents; Ophthalmic Solutions; Recurrence; Tacrolimus | 2013 |
Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation.
Topics: Allografts; Calcineurin Inhibitors; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Randomized Controlled Trials as Topic; Recurrence; Tacrolimus | 2014 |
Recent developments in drug therapy for aplastic anemia.
Topics: Alemtuzumab; Anemia, Aplastic; Animals; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Benzoates; Clinical Trials as Topic; Cyclosporine; Daclizumab; Humans; Hydrazines; Immunoglobulin G; Immunosuppressive Agents; Pyrazoles; Recurrence; Salvage Therapy; Survival Rate | 2014 |
Tacrolimus-based versus cyclosporine-based immunosuppression in hepatitis C virus-infected patients after liver transplantation: a meta-analysis and systematic review.
Topics: Cyclosporine; Graft Rejection; Graft Survival; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Recurrence; Survival Rate; Tacrolimus | 2014 |
Efficacy of immunosuppression monotherapy after liver transplantation: a meta-analysis.
Topics: Chi-Square Distribution; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Hepacivirus; Hepatitis C; Humans; Immunocompromised Host; Immunosuppressive Agents; Liver Transplantation; Mycophenolic Acid; Recurrence; Steroids; Tacrolimus; Time Factors; Treatment Outcome | 2014 |
Current challenges and controversies in the management of chronic spontaneous urticaria.
Topics: Adrenal Cortex Hormones; Animals; Chronic Disease; Cyclosporine; Humans; Omalizumab; Prevalence; Recurrence; Treatment Failure; Urticaria | 2015 |
[CME: Adult Still disease].
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Biological Products; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Long-Term Care; Prognosis; Recurrence; Still's Disease, Adult-Onset | 2015 |
How I manage Evans Syndrome and AIHA cases in children.
Topics: Alemtuzumab; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Humanized; Bortezomib; Child; Cyclophosphamide; Cyclosporine; Drug Resistance; Erythrocyte Transfusion; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Mycophenolic Acid; Recurrence; Rituximab; Sirolimus; Splenectomy; Stem Cell Transplantation; Steroids; Thrombocytopenia | 2016 |
Treatment of thrombotic thrombocytopenic purpura beyond therapeutic plasma exchange.
Topics: Acetylcysteine; ADAM Proteins; ADAMTS13 Protein; Bortezomib; Clinical Trials as Topic; Cyclophosphamide; Cyclosporine; Humans; Plasma Exchange; Platelet Aggregation Inhibitors; Prognosis; Purpura, Thrombotic Thrombocytopenic; Recombinant Proteins; Recurrence; Risk; Rituximab; Splenectomy; Steroids; Treatment Outcome; Vincristine; von Willebrand Factor | 2015 |
Relapsed and refractory subcutaneous panniculitis-like T-cell lymphoma with excellent response to cyclosporine: a case report and literature review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclosporine; Cytarabine; Deoxycytidine; Dexamethasone; Drug Resistance, Neoplasm; Etoposide; Gemcitabine; Humans; Immunosuppressive Agents; Lymphoma, T-Cell, Cutaneous; Male; Methylprednisolone; Multimodal Imaging; Panniculitis; Positron-Emission Tomography; Recurrence; Remission Induction; Salvage Therapy; Skin Neoplasms; Subcutaneous Fat; Tomography, X-Ray Computed | 2016 |
FSGS Recurrence in Adults after Renal Transplantation.
Topics: Adult; Age Factors; Animals; Child; Cyclosporine; Disease Models, Animal; Disease Progression; Glomerulosclerosis, Focal Segmental; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mutation; Podocytes; Postoperative Complications; Rats; Recurrence; Registries; Renin-Angiotensin System; Risk Factors; Rituximab | 2016 |
Systematic review: recurrent autoimmune liver diseases after liver transplantation.
Topics: Adult; Clinical Trials as Topic; Cyclosporine; Female; Graft Survival; Hepatitis, Autoimmune; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Recurrence; Steroids; Survival Rate; Tacrolimus; Ursodeoxycholic Acid | 2017 |
Non-topical management of recalcitrant paediatric atopic dermatitis.
Topics: Azathioprine; Child; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Humans; Immunosuppressive Agents; Medicine, Chinese Traditional; Methotrexate; Mycophenolic Acid; Phototherapy; Prebiotics; Probiotics; Recurrence; Ultraviolet Therapy | 2017 |
What have we learned from the use of ciclosporin A in the treatment of nephrotic patients with idiopathic membranous nephropathy?
Topics: Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Nephrotic Syndrome; Recurrence; Time Factors | 2008 |
Management of acute severe ulcerative colitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Clinical Protocols; Colitis, Ulcerative; Colonic Pouches; Cyclosporine; Digestive System Surgical Procedures; Drug Resistance; Gastrointestinal Agents; Humans; Infliximab; Patient Selection; Proctocolectomy, Restorative; Recurrence; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2009 |
Optimizing the benefit to risk ratio of medical therapy of inflammatory bowel diseases.
Topics: Cyclosporine; Drug Resistance; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Recurrence; Remission Induction; Risk Assessment | 2008 |
Alopecia areata update: part II. Treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia Areata; Animals; Child; Cyclopropanes; Cyclosporine; Hair; Haptens; Humans; Immunotherapy; Injections, Intralesional; Laser Therapy; Methotrexate; Minoxidil; Photochemotherapy; Randomized Controlled Trials as Topic; Rats; Recurrence; Research Design; Social Support; Sulfasalazine; Treatment Outcome; Triamcinolone Acetonide | 2010 |
[Efficacy and safety of cyclosporine A in treatment of refractory nephrotic syndrome in children: a systematic review of randomized controlled trials].
Topics: Child; Cyclosporine; Humans; Immunosuppressive Agents; Nephrotic Syndrome; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome | 2009 |
[Prescription and surveillance of treatment by a systemic agent or biotherapy in psoriasis].
Topics: Biological Products; Contraindications; Cyclosporine; Drug Administration Routes; Drug Monitoring; Female; Folic Acid; Humans; Immunosuppressive Agents; Kidney Diseases; Latent Tuberculosis; Liver Cirrhosis; Medical History Taking; Methotrexate; Pregnancy; Pregnancy Complications; Psoriasis; Pulmonary Fibrosis; Recurrence; Tumor Necrosis Factor-alpha; Vaccination | 2010 |
Therapeutic approach to focal and segmental glomerulosclerosis recurrence in kidney transplant recipients.
Topics: Cyclosporine; Glomerulosclerosis, Focal Segmental; Humans; Kidney Transplantation; Plasma Exchange; Recurrence; Risk Factors; Steroids | 2010 |
The treatment of relapse in adults with minimal change nephrotic syndrome: myths and facts.
Topics: Adult; Cyclophosphamide; Cyclosporine; Evidence-Based Medicine; Humans; Immunosuppressive Agents; Mycophenolic Acid; Nephrosis, Lipoid; Recurrence; Steroids; Treatment Outcome | 2011 |
Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature.
Topics: 2-Chloroadenosine; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cyclosporine; Deoxyadenosines; Fatal Outcome; Female; Humans; Lymphoma; Lymphoma, Follicular; Lymphoproliferative Disorders; Male; Middle Aged; Myasthenia Gravis; Paraneoplastic Syndromes, Nervous System; Prednisone; Pyridostigmine Bromide; Recurrence; Remission Induction; Rituximab; Waldenstrom Macroglobulinemia | 2012 |
Immunosuppression and HCV recurrence after liver transplantation.
Topics: Azathioprine; Cyclosporine; Graft Survival; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Recurrence; Tacrolimus | 2012 |
Immunotherapy in renal diseases.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Diseases; Methotrexate; Plasmapheresis; Prognosis; Recurrence; Rituximab | 2012 |
The adverse pharmacology of calcineurin inhibitors and their impact on hepatitis C recurrence after liver transplantation: implications for clinical practice.
Topics: Calcineurin Inhibitors; Cyclosporine; Graft Rejection; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Randomized Controlled Trials as Topic; Recurrence | 2012 |
Cyclosporin A therapy on idiopathic thrombotic thrombocytopenic purpura in the relapse setting: two case reports and a review of the literature.
Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Purpura, Thrombotic Thrombocytopenic; Recurrence | 2013 |
Does antithymocyte globulin have a place in reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation?
Topics: Adult; Antilymphocyte Serum; Child; Comorbidity; Cyclophosphamide; Cyclosporine; Graft vs Leukemia Effect; Hematology; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Middle Aged; Randomized Controlled Trials as Topic; Recurrence; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2012 |
Therapeutic challenges in acquired factor VIII deficiency.
Topics: Cyclosporine; Deamino Arginine Vasopressin; Factor VII; Factor VIII; Hemophilia A; Hemostasis; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Immunosuppressive Agents; Recombinant Proteins; Recurrence; Remission Induction; Steroids; Treatment Outcome | 2012 |
Recent progress in the pathophysiology and treatment of FSGS recurrence.
Topics: Animals; Antibodies, Monoclonal, Murine-Derived; Biopsy; Cyclosporine; Glomerulosclerosis, Focal Segmental; Graft Survival; Humans; Kidney Transplantation; Nephrology; Podocytes; Proteinuria; Rats; Recurrence; Renin-Angiotensin System; Rituximab | 2013 |
Impact of immunosuppressive therapy on recurrence of hepatitis C.
Topics: Cyclosporine; Disease Progression; Glucocorticoids; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Muromonab-CD3; Mycophenolic Acid; Receptors, Interleukin-2; Recurrence; Risk Assessment; Sirolimus; Tacrolimus | 2002 |
[Auto-immune hepatitis: therapeutic management].
Topics: Anti-Inflammatory Agents; Antimetabolites; Azathioprine; Calcineurin Inhibitors; Cyclophosphamide; Cyclosporine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Mycophenolic Acid; Recurrence; Remission Induction; Risk Factors; Steroids; Tacrolimus; Treatment Outcome | 2003 |
Liver biopsy, viral kinetics, and the impact of viremia on severity of hepatitis C virus recurrence.
Topics: Cyclosporine; Glucocorticoids; Graft Rejection; Hepacivirus; Humans; Immunosuppressive Agents; Methylprednisolone; Postoperative Period; Recurrence; RNA, Viral; Viral Load; Viremia; Virus Replication | 2003 |
Recurrent eosinophilic cystitis in a child with chronic granulomatous disease.
Topics: Cyclosporine; Cystitis; Eosinophilia; Granulomatous Disease, Chronic; Humans; Immunosuppressive Agents; Infant; Male; Molecular Sequence Data; Prednisone; Recurrence; Treatment Outcome; Ultrasonography; Urinary Bladder | 2004 |
Refractory Kawasaki disease.
Topics: Anti-Inflammatory Agents; Aspirin; Cyclosporine; Drug Therapy, Combination; Fever; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Recurrence | 2004 |
Calcineurin inhibition and disease recurrence in the hepatitis C virus-positive liver transplant recipient.
Topics: Calcineurin Inhibitors; Cyclosporine; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Liver Transplantation; Postoperative Complications; Recurrence; Virus Replication | 2004 |
Pyoderma gangrenosum.
Topics: Administration, Oral; Adrenal Cortex Hormones; Antibodies, Monoclonal; Biopsy; Cyclosporine; Dermatologic Agents; Diagnosis, Differential; Humans; Immunosuppressive Agents; Infliximab; Injections, Intravenous; Prognosis; Pyoderma Gangrenosum; Recurrence; Skin; Skin Transplantation | 2005 |
American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Drug Interactions; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Infliximab; Mercaptopurine; Methotrexate; Mycophenolic Acid; Recurrence | 2006 |
Immunosuppression with calcineurin inhibitors with respect to the outcome of HCV recurrence after liver transplantation: results of a meta-analysis.
Topics: Biopsy; Calcineurin Inhibitors; Clinical Trials as Topic; Cyclosporine; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Liver Failure; Liver Transplantation; Recurrence; Research Design; Risk; Tacrolimus; Treatment Outcome | 2007 |
[Nephrotic syndrome in childhood].
Topics: Adrenal Cortex Hormones; Biomarkers; Child; Cyclophosphamide; Cyclosporine; Diet, Sodium-Restricted; Dietary Proteins; Drug Resistance; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Kidney Transplantation; Levamisole; Mutation; Nephrotic Syndrome; Podocytes; Recurrence | 2006 |
Recurrent viral liver disease (hepatitis B and C) after liver transplantation.
Topics: Antiviral Agents; Cyclosporine; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Immune Tolerance; Immunization, Passive; Immunoglobulins; Liver Transplantation; Nucleic Acid Synthesis Inhibitors; Recurrence; Risk Factors | 2007 |
[Current status of treatment of inflammatory bowel disease].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Certolizumab Pegol; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colectomy; Colitis, Ulcerative; Colorectal Neoplasms; Controlled Clinical Trials as Topic; Crohn Disease; Cyclosporine; Gastrointestinal Agents; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Infusions, Intravenous; Mercaptopurine; Meta-Analysis as Topic; Polyethylene Glycols; Quality of Life; Rectal Fistula; Recurrence; Time Factors | 2007 |
Medical treatment of ulcerative colitis.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Colitis; Colitis, Ulcerative; Cyclosporine; Disease Progression; Humans; Immunologic Factors; Infliximab; Recurrence; Remission Induction | 2007 |
[Long-term control of psoriasis is necessary].
Topics: Acitretin; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Biological Products; Combined Modality Therapy; Comorbidity; Cyclosporine; Cytokines; Dermatologic Agents; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Middle Aged; Psoriasis; PUVA Therapy; Quality of Life; Recurrence | 2008 |
Value of colonoscopy for prediction of prognosis in patients with ulcerative colitis.
Topics: Colitis, Ulcerative; Colonoscopy; Cyclosporine; Endoscopy; Gastroenterology; Humans; Leukocytes; Microscopy, Confocal; Prognosis; Recurrence; Time Factors; Treatment Outcome | 2008 |
Use of cyclosporin in lupus nephritis.
Topics: Animals; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Lupus Nephritis; Recurrence | 1995 |
Efficacy of cyclosporin A (CyA) in psoriasis: an overview of dose/response, indications, contraindications and side-effects.
Topics: Biopsy; Contraindications; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Kidney Diseases; Male; Psoriasis; Recurrence | 1995 |
Focal segmental glomerulosclerosis in children.
Topics: Child; Cyclosporine; Glomerulosclerosis, Focal Segmental; Humans; Kidney Failure, Chronic; Kidney Transplantation; Recurrence; Treatment Outcome | 1995 |
Cyclosporine in the treatment of idiopathic nephrosis.
Topics: Adult; Child; Cyclosporine; Drug Resistance; Humans; Kidney; Kidney Transplantation; Nephrotic Syndrome; Prognosis; Recurrence; Steroids | 1994 |
Maintenance of symptomatic remission in patients with Crohn's disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Azathioprine; Clinical Trials as Topic; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Mesalamine; Methotrexate; Recurrence; Remission Induction; Sulfasalazine | 1993 |
Immunotherapy for multiple sclerosis.
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Female; Forecasting; Humans; Immunotherapy; Interferon-beta; Male; Multiple Sclerosis; Recurrence | 1994 |
Cyclosporine in glomerular disease.
Topics: Adult; Child; Clinical Trials as Topic; Cyclosporine; Glomerulonephritis; Humans; Immunosuppressive Agents; Prognosis; Recurrence | 1996 |
Oral lichen planus: topical and systemic therapy.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Biopsy; Clinical Protocols; Cyclosporine; Eating; Etretinate; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Keratolytic Agents; Lichen Planus, Oral; Prednisone; Recurrence; Treatment Failure; Tretinoin; Work | 1997 |
Liver transplantation: changing goals in immunosuppression.
Topics: Child; Cyclosporine; Graft Survival; Hepatitis B; Hepatitis C; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Recurrence; Survival Rate; Tacrolimus | 1998 |
Treatment of childhood steroid-resistant idiopathic nephrotic syndrome.
Topics: Adrenal Cortex Hormones; Child; Cyclosporine; Drug Resistance; Humans; Kidney Transplantation; Nephrotic Syndrome; Recurrence | 1998 |
Cyclosporine treatment of glomerular diseases.
Topics: Autoimmune Diseases; Azathioprine; Cyclosporine; Drug Combinations; Glomerulonephritis; Glomerulonephritis, IGA; Glomerulonephritis, Membranoproliferative; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Kidney; Lupus Nephritis; Nephrotic Syndrome; Recurrence; Steroids | 1999 |
Medical therapy for inflammatory bowel disease.
Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Recurrence; Salicylates; Severity of Illness Index; Steroids | 1999 |
Esophageal lichen planus.
Topics: Biopsy; Cyclosporine; Esophageal Diseases; Esophagoscopy; Esophagus; Female; Humans; Lichen Planus; Middle Aged; Mucous Membrane; Recurrence | 1999 |
Recurrent ANCA-associated small vessel vasculitis after transplantation: A pooled analysis.
Topics: Antibodies, Antineutrophil Cytoplasmic; Cyclosporine; Female; Glomerulonephritis; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; North Carolina; Recurrence; Sweden; Vasculitis | 1999 |
Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine.
Topics: Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Growth Substances; Humans; Immunosuppressive Agents; Recurrence; Treatment Outcome | 2000 |
Crohn's colitis and idiopathic thrombocytopenic purpura.
Topics: Adolescent; Chronic Disease; Crohn Disease; Cyclosporine; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Purpura, Thrombocytopenic, Idiopathic; Recurrence | 2000 |
Immunosuppressive agents in childhood nephrotic syndrome: a meta-analysis of randomized controlled trials.
Topics: Adolescent; Adrenal Cortex Hormones; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infant; Levamisole; Male; Nephrotic Syndrome; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome | 2001 |
[Prospects for therapy and prevention of adenovirus keratoconjunctivitis].
Topics: Adenovirus Infections, Human; Adolescent; Adrenal Cortex Hormones; Adult; Antiviral Agents; Child; Child, Preschool; Cidofovir; Cyclosporine; Cytosine; Humans; Immunosuppressive Agents; Interferons; Keratitis; Keratoconjunctivitis, Infectious; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Recurrence; Time Factors | 2001 |
[Use of Cyclosporine A and new immunosuppressive drugs in the therapy of glomerulonephritis].
Topics: Adult; Child; Clinical Trials as Topic; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glomerulonephritis; Humans; Immunosuppressive Agents; Mycophenolic Acid; Nephrotic Syndrome; Recurrence; Tacrolimus; Time Factors | 2001 |
[Presentation of cancers in recipients of a solid-organ transplant].
Topics: Carcinogens; Cell Transformation, Neoplastic; Cyclosporine; Genetic Predisposition to Disease; Humans; Immunocompromised Host; Immunosuppression Therapy; Incidence; Kidney Transplantation; Lymphoproliferative Disorders; Melanoma; Neoplasm Metastasis; Neoplasms; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neoplastic Stem Cells; Oncogenes; Postoperative Complications; Prevalence; Recurrence; Risk; Sarcoma, Kaposi; Skin Neoplasms; Transplantation; Tumor Virus Infections; Ultraviolet Rays | 2001 |
Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance.
Topics: Autoimmunity; Child; Cyclosporine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Transplantation; Molecular Mimicry; Recurrence; Self Tolerance; T-Lymphocytes; Tacrolimus | 2002 |
Juvenile dermatomyositis.
Topics: Adrenal Cortex Hormones; Calcinosis; Child, Preschool; Cyclosporine; Cytokines; Dermatomyositis; Disabled Persons; Humans; Prognosis; Recurrence; Virus Diseases | 1992 |
Bone marrow transplantation for chronic myeloid leukaemia.
Topics: Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Histocompatibility; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid, Chronic-Phase; Methotrexate; Recurrence; Time Factors; Transplantation, Homologous | 1992 |
156 trial(s) available for cyclosporine and Recrudescence
| Article | Year |
|---|---|
Alemtuzumab in relapsed immune severe aplastic anemia: Long-term results of a phase II study.
Topics: Adult; Alemtuzumab; Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Recurrence; Treatment Outcome | 2023 |
Triple-Drug Graft-versus-Host Disease Prophylaxis after HLA-Matched Unrelated Donor Nonmyeloablative Allogenic Hematopoietic Stem Cell Transplantation.
Topics: Adolescent; Adult; Aged; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycophenolic Acid; Recurrence; Sirolimus; Tacrolimus; Unrelated Donors | 2023 |
Assessment of chimerism and immunomodulation to prevent post-transplantation relapse in childhood acute myeloblastic leukemia: is it the right approach?
Topics: Allografts; Child; Cyclosporine; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunomodulation; Leukemia, Myeloid, Acute; Lymphocyte Transfusion; Male; Prospective Studies; Recurrence; Tissue Donors; Transplantation Chimera | 2020 |
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cause of Death; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Melphalan; Middle Aged; Myelodysplastic Syndromes; Recurrence; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation; Young Adult | 2017 |
Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
Topics: Acute Disease; Adolescent; Adult; Aged; Antilymphocyte Serum; Busulfan; Chronic Disease; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Multiple Myeloma; Myeloablative Agonists; Prospective Studies; Recurrence; Remission Induction; Siblings; Survival Analysis; Transplantation Conditioning; Transplantation, Haploidentical; Unrelated Donors; Vidarabine | 2017 |
Combined cyclosporine and prednisolone therapy using cyclosporine blood concentration monitoring for adult patients with new-onset minimal change nephrotic syndrome: a single-center pilot randomized trial.
Topics: Adult; Cyclosporine; Drug Monitoring; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Japan; Male; Middle Aged; Nephrosis, Lipoid; Pilot Projects; Predictive Value of Tests; Prednisolone; Recurrence; Remission Induction; Time Factors; Treatment Outcome; Young Adult | 2018 |
Tacrolimus versus Cyclosporine- Comparative Evaluation as First line drug in Vernal keratoconjuctivitis.
Topics: Child; Child, Preschool; Conjunctiva; Conjunctivitis, Allergic; Cornea; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Ointments; Ophthalmic Solutions; Prospective Studies; Recurrence; Tacrolimus; Treatment Outcome | 2017 |
Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.
Topics: Aged; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Recurrence; Sirolimus; Survival Rate; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2019 |
Topical cyclosporine A 0.05% before and after surgery to prevent pterygium recurrence.
Topics: Adult; Combined Modality Therapy; Conjunctiva; Corneal Diseases; Cyclosporine; Female; Fluorouracil; Humans; Immunosuppressive Agents; Male; Middle Aged; Ophthalmic Solutions; Postoperative Care; Preoperative Care; Prospective Studies; Pterygium; Recurrence; Surgical Flaps; Young Adult | 2019 |
Cyclosporine C2 monitoring for the treatment of frequently relapsing nephrotic syndrome in children: a multicenter randomized phase II trial.
Topics: Adolescent; Age Factors; Biomarkers; Biotransformation; Chemistry, Pharmaceutical; Child; Child, Preschool; Cyclosporine; Cyclosporins; Disease-Free Survival; Drug Monitoring; Emulsions; Female; Humans; Immunosuppressive Agents; Infant; Japan; Kaplan-Meier Estimate; Male; Nephrotic Syndrome; Predictive Value of Tests; Prospective Studies; Recurrence; Remission Induction; Treatment Outcome | 2014 |
Etanercept reduces symptoms and severity of psoriasis after cessation of cyclosporine therapy: results of the SCORE study.
Topics: Adult; Cyclosporine; Double-Blind Method; Drug Administration Schedule; Drug Substitution; Etanercept; Europe; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Male; Middle Aged; Psoriasis; Receptors, Tumor Necrosis Factor; Recurrence; Remission Induction; Severity of Illness Index; Time Factors; Treatment Outcome | 2015 |
Morbidity in children with frequently relapsing nephrosis: 10-year follow-up of a randomized controlled trial.
Topics: Child; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Prospective Studies; Recurrence; Time Factors | 2015 |
Positive role of rituximab in switching from cyclosporine to mycophenolate mofetil for children with high-dose steroid-dependent nephrotic syndrome.
Topics: Adolescent; Child; Cyclosporine; Drug Substitution; Female; Humans; Immunologic Factors; Immunosuppressive Agents; Male; Mycophenolic Acid; Nephrotic Syndrome; Recurrence; Rituximab | 2015 |
Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial.
Topics: Cyclosporine; Dermatologic Agents; Female; Humans; Male; Middle Aged; Patient Selection; Prednisolone; Pyoderma Gangrenosum; Quality of Life; Recurrence; Time Factors; Treatment Outcome; United Kingdom; Varicose Ulcer; Wound Healing | 2015 |
A Comparative Study of Topical Mitomycin C, Cyclosporine, and Bevacizumab after Primary Pterygium Surgery.
Topics: Administration, Topical; Aged; Aged, 80 and over; Alkylating Agents; Angiogenesis Inhibitors; Bevacizumab; Cell Count; Combined Modality Therapy; Cyclosporine; Double-Blind Method; Endothelium, Corneal; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Mitomycin; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Prospective Studies; Pterygium; Recurrence; Vascular Endothelial Growth Factor A | 2015 |
A Randomized Controlled Double Blind Trial of Ciclosporin versus Prednisolone in the Management of Leprosy Patients with New Type 1 Reaction, in Ethiopia.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Cyclosporine; Disease Management; Double-Blind Method; Drug Administration Schedule; Ethiopia; Female; Humans; Immunosuppressive Agents; Leprosy; Male; Middle Aged; Peripheral Nervous System Diseases; Prednisolone; Quality of Life; Recurrence; Treatment Outcome; Young Adult | 2016 |
Low incidence of acute graft-versus-host disease with short-term tacrolimus in haploidentical hematopoietic stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Child; Cyclosporine; Cytomegalovirus Infections; Disease-Free Survival; Female; Graft vs Host Disease; Haplotypes; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Lymphocyte Subsets; Male; Middle Aged; Premedication; Recurrence; Survival Rate; Tacrolimus; Young Adult | 2017 |
Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study.
Topics: Adult; Aged; Antiviral Agents; Carbamates; Cyclosporine; Drug Therapy, Combination; Female; Genotype; Graft Rejection; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Immunosuppressive Agents; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Pyrrolidines; Recurrence; Ribavirin; RNA, Viral; Simeprevir; Tacrolimus; Treatment Outcome; Valine; Viral Load | 2017 |
Topical cyclosporine A in the prevention of pterygium recurrence.
Topics: Administration, Topical; Aged; Aged, 80 and over; Cyclosporine; Disease-Free Survival; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Middle Aged; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Pterygium; Recurrence; Retrospective Studies; Turkey | 2008 |
Efficacy of cyclosporine as a single agent therapy in chronic idiopathic thrombocytopenic purpura.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Recurrence | 2008 |
[Effectiveness of topical ciclosporin A treatment after excision of primary pterygium and limbal conjunctival autograft].
Topics: Administration, Topical; Adolescent; Adult; Cicatrix; Corneal Transplantation; Cyclosporine; Female; Granuloma; Humans; Immunosuppressive Agents; Limbus Corneae; Male; Middle Aged; Pain Measurement; Pain, Postoperative; Postoperative Complications; Prospective Studies; Pterygium; Recurrence; Transplantation, Autologous; Young Adult | 2008 |
Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Animals; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Horses; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Recurrence; Sirolimus; Treatment Outcome; Young Adult | 2009 |
Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized study.
Topics: Adolescent; Child; Child, Preschool; Communicable Diseases; Cyclosporine; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Diseases; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Male; Postoperative Complications; Prospective Studies; Recurrence; Transplantation, Homologous | 2009 |
Combined cyclosporine and prednisolone therapy in adult patients with the first relapse of minimal-change nephrotic syndrome.
Topics: Adult; Cholesterol; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Nephrosis, Lipoid; Prednisolone; Proteinuria; Recurrence; Remission Induction; Treatment Outcome | 2010 |
The use of cyclosporine for recurrent hepatitis C after liver transplant: a randomized pilot study.
Topics: Antiviral Agents; Cyclosporine; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Liver; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; RNA, Viral; Tacrolimus | 2010 |
Topical cyclosporine.
Topics: Administration, Topical; Corneal Diseases; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Keratoplasty, Penetrating; Prospective Studies; Recurrence; Time Factors; Treatment Outcome; Visual Acuity | 2009 |
Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura.
Topics: Azathioprine; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Recurrence | 2010 |
Clinical course of extrarenal symptoms in Henoch-Schonlein purpura: a 6-month prospective study.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Epidemiologic Methods; Female; Gastrointestinal Diseases; Glucocorticoids; Humans; IgA Vasculitis; Infant; Joint Diseases; Male; Methylprednisolone; Orchitis; Prednisone; Prognosis; Recurrence; Serum Albumin; Streptococcal Infections; Treatment Outcome; Virus Diseases | 2010 |
Treatment with microemulsified cyclosporine in children with frequently relapsing nephrotic syndrome.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Emulsions; Female; Humans; Immunosuppressive Agents; Infant; Kidney; Male; Nephrotic Syndrome; Prospective Studies; Recurrence | 2010 |
Effect of calcineurin inhibitors in the outcome of liver transplantation in hepatitis C virus-positive recipients.
Topics: Adult; Aged; Antiviral Agents; Biopsy; Calcineurin Inhibitors; Chi-Square Distribution; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Graft Survival; Hepatitis C; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Prospective Studies; Recurrence; Risk Assessment; Risk Factors; Spain; Tacrolimus; Time Factors; Treatment Outcome | 2010 |
In situ revascularisation with silver-coated polyester prostheses and arterial homografts in patients with aortic graft infection--a prospective, comparative, single-centre study.
Topics: Acetates; Adult; Aged; Anti-Bacterial Agents; Blood Vessel Prosthesis; Coated Materials, Biocompatible; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Polyesters; Polyethylene Terephthalates; Postoperative Complications; Prospective Studies; Prosthesis Design; Prosthesis-Related Infections; Recurrence; Silver Compounds; Transplantation, Homologous | 2011 |
Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: A 3-year prospective study.
Topics: Adult; Azathioprine; Cyclosporine; Female; Follow-Up Studies; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Kidney Function Tests; Male; Middle Aged; Nephrotic Syndrome; Prospective Studies; Proteinuria; Recurrence; Risk Factors; Treatment Outcome | 2011 |
Benefit and cost from the long-term use of cyclosporine-A in idiopathic membranous nephropathy.
Topics: Adult; Aged; Cost-Benefit Analysis; Cyclosporine; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Middle Aged; Nephrotic Syndrome; Prednisolone; Recurrence; Remission Induction; Treatment Outcome | 2010 |
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius.
Topics: Adolescent; Adult; Antilymphocyte Serum; Chronic Disease; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Recurrence; Survival Rate; Time Factors; Transplantation Conditioning; Transplantation, Homologous | 2011 |
Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Animals; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Cytokines; Female; Horses; Humans; Immunosuppressive Agents; Male; Middle Aged; Polymorphism, Genetic; Rabbits; Recurrence; Survival Analysis; Treatment Outcome; Young Adult | 2011 |
Topical cyclosporine prevents seasonal recurrences of vernal keratoconjunctivitis in a randomized, double-masked, controlled 2-year study.
Topics: Administration, Topical; Adolescent; Adult; Child; Conjunctivitis, Allergic; Cyclosporine; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Recurrence; Time Factors | 2011 |
UK Dermatology Clinical Trials Network's STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial.
Topics: Administration, Oral; Cost-Benefit Analysis; Cyclosporine; Dermatologic Agents; Drug Costs; Humans; Ireland; Patient Selection; Prednisolone; Pyoderma Gangrenosum; Quality of Life; Recurrence; Research Design; Time Factors; Treatment Outcome; United Kingdom; Wound Healing | 2012 |
Treatment of recurrent HCV infection following liver transplantation: results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirin.
Topics: Antiviral Agents; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Induction Chemotherapy; Interferon-alpha; Kidney; Liver Cirrhosis; Liver Transplantation; Logistic Models; Maintenance Chemotherapy; Male; Middle Aged; Placebos; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; Tacrolimus; Treatment Outcome; Viral Load | 2012 |
Effect of single-dose oral mizoribine pulse therapy twice per week for frequently relapsing steroid-dependent nephrotic syndrome.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infant; Japan; Male; Nephrotic Syndrome; Prednisolone; Pulse Therapy, Drug; Recurrence; Ribonucleosides; Steroids; Time Factors; Treatment Outcome | 2012 |
Two-year follow-up of a prospective clinical trial of cyclosporine for frequently relapsing nephrotic syndrome in children.
Topics: Adolescent; Age Factors; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Japan; Kaplan-Meier Estimate; Male; Nephrotic Syndrome; Prospective Studies; Recurrence; Risk Factors; Time Factors; Treatment Outcome | 2012 |
Everolimus for the treatment of uveitis refractory to cyclosporine A: a pilot study.
Topics: Adult; Chronic Disease; Cyclosporine; Everolimus; Female; Flow Cytometry; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Photometry; Pilot Projects; Prospective Studies; Recurrence; Sirolimus; Treatment Outcome; Uveitis; Visual Acuity; Young Adult | 2013 |
Prospective 5-year follow-up of cyclosporine treatment in children with steroid-resistant nephrosis.
Topics: Adolescent; Child; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Japan; Kidney; Kidney Failure, Chronic; Male; Methylprednisolone; Nephrosis, Lipoid; Nephrotic Syndrome; Prospective Studies; Recurrence; Remission Induction; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome; Young Adult | 2013 |
Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia.
Topics: Anemia, Aplastic; Antilymphocyte Serum; Blood Cell Count; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Follow-Up Studies; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Kinetics; Leukemia; Methylprednisolone; Myelodysplastic Syndromes; Neoplasms; Recurrence; Remission Induction; Salvage Therapy; Survival Rate | 2003 |
Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care.
Topics: Adolescent; Adult; Analgesics; Cause of Death; Costs and Cost Analysis; Cyclosporine; Drug Utilization; Erythrocyte Transfusion; Female; Fever; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Home Nursing; Hospitalization; Humans; Immunosuppressive Agents; Infection Control; Male; Methotrexate; Middle Aged; Pancytopenia; Parenteral Nutrition, Total; Patient Care Team; Patient Isolation; Prednisolone; Quality of Life; Recurrence; Survival Rate; Sweden; Transplantation Conditioning; Treatment Outcome | 2002 |
Cyclosporine and ketoconazole for the treatment of perianal fistulas in dogs.
Topics: Administration, Oral; Animals; Cyclosporine; Dog Diseases; Dogs; Drug Interactions; Drug Therapy, Combination; Female; Immunosuppressive Agents; Ketoconazole; Male; Perianal Glands; Rectal Fistula; Recurrence; Treatment Outcome | 2002 |
Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome.
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Blood Cell Count; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Recurrence; Survival Analysis; T-Lymphocytes; Treatment Outcome | 2003 |
Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Injections, Intravenous; Kidney Failure, Chronic; Kidney Transplantation; Nephrotic Syndrome; Postoperative Complications; Prospective Studies; Proteinuria; Recurrence; Time Factors; Treatment Outcome | 2003 |
Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial.
Topics: Acute Disease; Adult; Aged; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lung Transplantation; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Prospective Studies; Recurrence; Survival Rate; Tacrolimus; Time Factors | 2003 |
Effects of immediate switch from cyclosporine microemulsion to tacrolimus at first acute rejection in renal allograft recipients.
Topics: Adult; Cyclosporine; Disease-Free Survival; Emulsions; Europe; Female; Graft Rejection; Humans; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Recurrence; Tacrolimus; Time Factors; Transplantation, Homologous | 2003 |
Gemtuzumab ozogamicin, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD33+ primary resistant or relapsed acute myeloid leukemia.
Topics: Acute Disease; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Cytarabine; Drug Resistance, Neoplasm; Female; Gemtuzumab; Humans; Leukemia, Myeloid; Male; Middle Aged; Platelet Count; Recurrence; Remission Induction; Sialic Acid Binding Ig-like Lectin 3; Survival Rate; Vidarabine | 2003 |
Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: multicenter trial.
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Transplantation; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Multivariate Analysis; Prognosis; Recurrence; Severity of Illness Index; Survival Rate; Treatment Outcome | 2003 |
Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
Topics: Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Female; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Infant; Levamisole; Male; Mycophenolic Acid; Nephrotic Syndrome; Prednisolone; Prospective Studies; Recurrence; Remission Induction; Safety; Treatment Outcome | 2003 |
Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil.
Topics: Adolescent; Child; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Nephrotic Syndrome; Recurrence; Treatment Outcome | 2004 |
The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy.
Topics: Biopsy; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney; Male; Middle Aged; Nephrotic Syndrome; Prednisolone; Recurrence; Remission Induction | 2004 |
Remission of the clinical signs of atopic dermatitis in dogs after cessation of treatment with cyclosporin A or methylprednisolone.
Topics: Animals; Anti-Inflammatory Agents; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Dog Diseases; Dogs; Double-Blind Method; Follow-Up Studies; Methylprednisolone; Pruritus; Recurrence; Risk Factors; Severity of Illness Index; Skin; Treatment Outcome | 2004 |
High-dose oral cyclosporin therapy for recurrent focal segmental glomerulosclerosis in children.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Female; Follow-Up Studies; Gingival Hypertrophy; Glomerulosclerosis, Focal Segmental; Hirsutism; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Nephrotic Syndrome; Recurrence; Remission Induction | 2004 |
Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Prognosis; Recurrence; Regression Analysis; Survival Analysis; Treatment Outcome | 2004 |
Cyclosporine alone vs cyclosporine plus methotrexate for post-transplant immunosuppression after HLA-identical sibling bone marrow transplantation: a randomized prospective study.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; HLA Antigens; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Prospective Studies; Recurrence; Siblings; Survival Rate; Tissue Donors | 2004 |
Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: a prospective, randomized trial.
Topics: Adult; Biopsy, Needle; Cyclosporine; Female; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Prospective Studies; Recurrence; RNA, Viral; Tacrolimus; Treatment Outcome | 2004 |
Favorable outcome of low-dose cyclosporine after pulse methylprednisolone in Japanese adult minimal-change nephrotic syndrome.
Topics: Adult; Cyclosporine; Dose-Response Relationship, Drug; Humans; Immunosuppressive Agents; Japan; Methylprednisolone; Nephrosis, Lipoid; Prospective Studies; Pulse Therapy, Drug; Recurrence; Remission Induction; Treatment Outcome | 2004 |
Impact of mycophenolate mofetil versus azathioprine on early recurrence of hepatitis C after liver transplantation.
Topics: Adult; Azathioprine; Cyclosporine; Female; Fibrosis; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Incidence; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Recurrence; Severity of Illness Index | 2005 |
Hypogammaglobulinemia after heart transplantation: use of intravenous immunoglobulin replacement therapy in relapsing CMV disease.
Topics: Agammaglobulinemia; Antilymphocyte Serum; Antiviral Agents; Azathioprine; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Ganciclovir; Heart Transplantation; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Prednisone; Recurrence; Tacrolimus | 2005 |
Double-blind comparison of hepatitis C histological recurrence Rate in HCV+ Liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporine and azathioprine.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Azathioprine; Basiliximab; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Female; Graft Survival; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Placebos; Recombinant Fusion Proteins; Recurrence; Time Factors; Virus Replication | 2004 |
[Clinical study on reversal of multidrug resistance in refractory and relapsed acute leukemias by cyclosporin A].
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Leukemia; Male; Recurrence | 1997 |
Interferon combined with cyclosporine treatment as an effective countermeasure against hepatitis C virus recurrence in liver transplant patients with end-stage hepatitis C virus related disease.
Topics: Adult; Aged; Antiviral Agents; Cyclosporine; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon-beta; Liver Failure; Liver Transplantation; Male; Middle Aged; Recurrence; RNA, Viral; Safety; Viral Load | 2005 |
Lymphocyte drug sensitivity is useful for prediction of the antiproteinuric effect and relapse rate in cyclosporine treatment for frequent-relapse minimal change nephrotic syndrome.
Topics: Adolescent; Adult; Aged; Cell Division; Cyclosporine; Female; Humans; Immunosuppressive Agents; Inhibitory Concentration 50; Lymphocytes; Male; Middle Aged; Nephrosis, Lipoid; Predictive Value of Tests; Proteinuria; Recurrence; Remission Induction; Sensitivity and Specificity | 2005 |
C1-C2 point monitoring of low-dose cyclosporin a given as a single daily dose in children with steroid-dependent relapsing nephrotic syndrome.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Cyclosporine; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Prednisolone; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome | 2005 |
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence.
Topics: Aged; Cyclosporine; Disease Progression; Female; Hepacivirus; Hepatitis C; Humans; Immunocompetence; Immunosuppression Therapy; Immunosuppressive Agents; Liver; Liver Transplantation; Male; Middle Aged; Recurrence; Regression Analysis; RNA, Messenger; RNA, Viral | 2006 |
Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: results from a prospective multicenter randomized study.
Topics: Adult; Aged; Antibodies, Monoclonal; Basiliximab; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Hepacivirus; Hepatitis C; Humans; Hypertension; Immunosuppression Therapy; Immunosuppressive Agents; Liver; Liver Transplantation; Male; Middle Aged; Prednisone; Prospective Studies; Recombinant Fusion Proteins; Recurrence; Steroids; Survival Rate; Treatment Outcome | 2006 |
Effect of calcineurin inhibitors on survival and histologic disease severity in HCV-infected liver transplant recipients.
Topics: Adult; Aged; Calcineurin Inhibitors; Cyclosporine; Female; Hepatitis C; Humans; Immunosuppressive Agents; Liver; Liver Transplantation; Male; Middle Aged; Prospective Studies; Recurrence; Tacrolimus | 2006 |
Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Drug Tolerance; Glucocorticoids; Humans; Immunosuppressive Agents; Nephrotic Syndrome; Prednisone; Prospective Studies; Recurrence; Risk Factors; Safety; Time Factors | 2006 |
Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.
Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Cause of Death; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Forced Expiratory Volume; Graft vs Host Disease; Humans; Immunosuppressive Agents; Incidence; Karnofsky Performance Status; Leukemia; Life Tables; Lung Diseases; Male; Methotrexate; Middle Aged; Neural Tube Defects; Premedication; Prospective Studies; Recurrence; Survival Analysis; T-Lymphocytes; Transplantation, Homologous; Treatment Outcome; Vital Capacity | 2006 |
Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Myelodysplastic Syndromes; Recurrence; Survival Analysis; Treatment Outcome | 2006 |
A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis.
Topics: Absorbable Implants; Animals; Cyclosporine; Drug Delivery Systems; Feasibility Studies; Horse Diseases; Horses; Humans; Immunosuppressive Agents; Leptospira interrogans; Microbial Sensitivity Tests; Panuveitis; Permeability; Recurrence; Sclera; Treatment Outcome | 2006 |
Low-dose cyclosporin A with short-term methotrexate for graft-versus-host disease prophylaxis in allogeneic bone marrow transplantation from human leukocyte antigen-identical siblings: a prospective phase II study in Japanese patients.
Topics: Adolescent; Adult; Asian People; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; HLA Antigens; Humans; Immunosuppressive Agents; Japan; Male; Methotrexate; Middle Aged; Prospective Studies; Recurrence; Siblings; Transplantation, Homologous | 2006 |
Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
Topics: Cyclosporine; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Long-Term Care; Male; Middle Aged; Nephrotic Syndrome; Prednisolone; Recurrence; Treatment Outcome | 2006 |
Approaches to discontinuing efalizumab: an open-label study of therapies for managing inflammatory recurrence.
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pilot Projects; Prospective Studies; Psoriasis; Recurrence; Retinoids; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Withholding Treatment | 2006 |
Long-term outcomes in liver transplant patients with hepatic C infection receiving tacrolimus or cyclosporine.
Topics: Adult; Carcinoma, Hepatocellular; Cyclosporine; Female; Follow-Up Studies; Hepatitis C; Humans; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Recurrence; Risk Factors; Tacrolimus; Time Factors; Treatment Outcome | 2006 |
Preoperative immunosuppressive therapy and surgery as a treatment for anal furunculosis.
Topics: Anal Sacs; Animals; Anus Diseases; Combined Modality Therapy; Cyclosporine; Dog Diseases; Dogs; Female; Furunculosis; Immunosuppressive Agents; Ketoconazole; Male; Preoperative Care; Recurrence; Treatment Outcome | 2006 |
Adrenocortical suppression increases the risk of relapse in nephrotic syndrome.
Topics: Adolescent; Child; Child, Preschool; Cosyntropin; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Levamisole; Male; Nephrotic Syndrome; Pituitary-Adrenal System; Prednisolone; Recurrence | 2007 |
Treatment of acquired severe aplastic anemia with antilymphocyte globulin, cyclosporin A, methyprednisolone, and granulocyte colony-stimulating factor.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Animals; Antilymphocyte Serum; Cyclosporine; Female; Glucocorticoids; Granulocyte-Macrophage Colony-Stimulating Factor; Horses; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Neutrophils; Recurrence; Survival Analysis; Time Factors; Treatment Outcome | 2007 |
Conversion to mycophenolate mofetil for modulating recurrent hepatitis C in liver transplant recipients.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Kidney Function Tests; Liver Transplantation; Middle Aged; Mycophenolic Acid; Recurrence; Treatment Outcome | 2007 |
Non-myeloablative hematopoietic stem cell transplantation is of limited value in advanced or refractory acute myeloblastic leukemia. The Mexican experience.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Mexico; Middle Aged; Recurrence; Salvage Therapy; Transplantation Conditioning; Treatment Outcome; Vidarabine | 2007 |
A fludarabine, thiotepa reduced toxicity conditioning regimen designed specifically for allogeneic second haematopoietic cell transplantation after failure of previous autologous or allogeneic transplantation.
Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Survival Rate; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Failure; Vidarabine | 2008 |
Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD19; B-Lymphocytes; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunologic Factors; Immunosuppressive Agents; Infant; Male; Nephrotic Syndrome; Prospective Studies; Proteinuria; Recurrence; Remission Induction; Rituximab; Severity of Illness Index; Steroids; Substance Withdrawal Syndrome | 2008 |
Effect of rescue therapy using FK 506 on relapsing rejection after combined pancreas and kidney transplantation.
Topics: Adult; Amylases; Biomarkers; Blood Glucose; Cadaver; Creatinine; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Follow-Up Studies; Glucose Tolerance Test; Glycated Hemoglobin; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Pancreas Transplantation; Recurrence; Tacrolimus; Time Factors; Tissue Donors; Urine | 1995 |
The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
Topics: Adolescent; Adult; Cyclosporine; Drug Therapy, Combination; Female; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Immunosuppressive Agents; Korea; Male; Middle Aged; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisolone; Prospective Studies; Recurrence; Treatment Outcome | 1995 |
Long-term cyclosporin in steroid-dependent nephrotic syndrome.
Topics: Adolescent; Analysis of Variance; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Prednisolone; Recurrence; Remission Induction | 1995 |
In vivo/ex vivo T cell depletion reduces the morbidity of allogeneic bone marrow transplantation in patients with acute leukaemias in first remission without increasing the risk of treatment failure: comparison with cyclosporin/methotrexate.
Topics: Acute Disease; Adolescent; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclosporine; Cytomegalovirus Infections; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; T-Lymphocytes; Transplantation, Homologous; Treatment Outcome | 1995 |
Long-term maintenance therapy with cyclosporine and posttreatment survey in severe psoriasis: results of a multicenter study. German Multicenter Study.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Creatinine; Cyclosporine; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Ointments; Psoriasis; Recurrence; Safety; Salicylates; Salicylic Acid; Time Factors; Triglycerides | 1995 |
Remission of ordinary psoriasis following a short clearance course of cyclosporin.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Aged; Anthralin; Arthritis; Blood Pressure; Creatinine; Cyclosporine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nail Diseases; Photochemotherapy; Psoriasis; Recurrence; Remission Induction; Ultraviolet Therapy | 1995 |
Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cyclosporine; Dermatitis, Atopic; Female; Follow-Up Studies; Humans; Male; Middle Aged; Recurrence; Remission Induction; Time Factors | 1995 |
Steroid-resistant, cyclosporine-responsive, relapsing nephrotic syndrome.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Drug Resistance; Female; Follow-Up Studies; Humans; Male; Nephrotic Syndrome; Prednisone; Recurrence | 1995 |
Intravenous cyclosporine for steroid-refractory attacks of Crohn's disease. Short- and long-term results.
Topics: Adolescent; Adult; Crohn Disease; Cyclosporine; Female; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Prospective Studies; Recurrence | 1995 |
Treatment of oral pemphigus vulgaris.
Topics: Adult; Aged; Cyclophosphamide; Cyclosporine; Drug Combinations; Female; Fluorescent Antibody Technique; Follow-Up Studies; Humans; Immunoglobulin G; Immunoglobulin M; Male; Middle Aged; Mouth Diseases; Mouth Mucosa; Pemphigus; Prednisone; Recurrence; Remission Induction; Skin | 1994 |
Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
Topics: Administration, Cutaneous; Adult; Anthralin; Arthritis, Psoriatic; Blood Pressure; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Etretinate; Female; Follow-Up Studies; Germany; Humans; Male; Middle Aged; Nail Diseases; Psoriasis; Recurrence; Severity of Illness Index; Skin; Time Factors; Treatment Outcome | 1995 |
Allogeneic bone marrow transplantation in children with acute myelogenous leukemia in first remission. Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO).
Topics: Adolescent; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility; Humans; Infant; Leukemia, Myeloid, Acute; Leukocytes; Male; Methotrexate; Multivariate Analysis; Recurrence; Remission Induction; Risk Factors; Transplantation, Homologous; Whole-Body Irradiation | 1994 |
Cyclosporine treatment of lupus membranous nephropathy.
Topics: Adult; Biopsy; Cyclosporine; Drug Administration Schedule; Female; Humans; Kidney; Lupus Nephritis; Male; Pilot Projects; Recurrence; Time Factors | 1994 |
Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. French Society of Pediatric Nephrology.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Kidney; Male; Nephrosis; Prednisone; Prospective Studies; Recurrence; Remission Induction; Time Factors | 1994 |
Use of cyclosporine in the treatment of autoimmune disorders.
Topics: Adult; Arthritis, Rheumatoid; Autoimmune Diseases; Cyclosporine; Female; Humans; Kidney; Lupus Erythematosus, Systemic; Male; Methotrexate; Myelodysplastic Syndromes; Recurrence | 1994 |
Long-term follow-up of a randomized trial comparing T-cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients.
Topics: Adult; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia; Lymphocyte Depletion; Methotrexate; Recurrence; Survival Analysis; T-Lymphocytes; Time Factors | 1994 |
Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cause of Death; Child; Chromosome Aberrations; Chromosome Disorders; Cyclosporine; Cytogenetics; Drug Therapy, Combination; Etoposide; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Methylprednisolone; Middle Aged; Recurrence; Survival Rate; Whole-Body Irradiation | 1994 |
Recurrence of focal glomerulosclerosis of allografts in children: the efficacy of intensive plasma exchange therapy before and after renal transplantation.
Topics: Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Female; Glomerulosclerosis, Focal Segmental; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Nephrotic Syndrome; Plasma Exchange; Proteinuria; Recurrence; Time Factors | 1994 |
Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Female; Humans; Male; Middle Aged; Nephrotic Syndrome; Recurrence; Remission Induction; Steroids; Substance-Related Disorders; Time Factors | 1993 |
Allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission: the effect of FAB classification and GVHD prophylaxis.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Humans; Infant; Leukemia, Myeloid; Male; Multivariate Analysis; Recurrence; Remission Induction; Retrospective Studies; Survival Rate; Time Factors; Transplantation, Homologous | 1994 |
Short- and long-term considerations concerning the management of plaque psoriasis with low-dose cyclosporin. Studio Italiano Multicentrico nella Psoriasi (SIMPSO).
Topics: Adult; Aged; Aged, 80 and over; Clinical Protocols; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Italy; Male; Middle Aged; Psoriasis; Recurrence; Remission Induction; Severity of Illness Index; Time Factors; Treatment Outcome | 1993 |
Management of erythrodermic psoriasis with low-dose cyclosporin. Studio Italiano Multicentrico nella Psoriasi (SIMPSO).
Topics: Adult; Aged; Cyclosporine; Dermatitis, Exfoliative; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Italy; Male; Middle Aged; Psoriasis; Recurrence; Remission Induction; Severity of Illness Index; Time Factors; Treatment Outcome | 1993 |
Cyclosporin versus etretinate: Italian multicenter comparative trial in severe plaque-form psoriasis. Italian Multicenter Study Group on Cyclosporin in Psoriasis.
Topics: Adolescent; Adult; Aged; Cyclosporine; Etretinate; Female; Follow-Up Studies; Humans; Italy; Male; Middle Aged; Psoriasis; Recurrence; Remission Induction; Severity of Illness Index; Time Factors | 1993 |
Treatment of recurrent cytomegalovirus disease in patients receiving solid organ transplants.
Topics: Acyclovir; Azathioprine; Cyclosporine; Cytomegalovirus Infections; Drug Tolerance; Ganciclovir; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Incidence; Injections, Intravenous; Kidney Transplantation; Pancreas Transplantation; Placebos; Prednisone; Prospective Studies; Recurrence; Survival Rate; Tissue Donors; Transplantation, Homologous | 1993 |
A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Cytomegalovirus Infections; Double-Blind Method; Fever; Graft vs Host Disease; Humans; Methotrexate; Middle Aged; Pentoxifylline; Placebos; Probability; Recurrence; Survival Analysis; Transplantation, Homologous; Whole-Body Irradiation | 1993 |
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Child; Child, Preschool; Chronic Disease; Cyclosporine; Drug Administration Schedule; Female; Graft vs Host Disease; Humans; Infant; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Regression Analysis; Treatment Outcome | 1993 |
Chemotherapy versus allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Survival Analysis; Transplantation, Homologous; Whole-Body Irradiation | 1993 |
T-lymphocyte activation in steroid-sensitive nephrotic syndrome in childhood.
Topics: Adolescent; Child; Cyclosporine; Female; Humans; Immunosuppressive Agents; Levamisole; Lipids; Male; Nephrotic Syndrome; Prospective Studies; Receptors, Interleukin-2; Recurrence; Remission Induction; Serum Albumin; Steroids; T-Lymphocyte Subsets | 1995 |
Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Humans; Immunosuppression Therapy; Infections; Karyotyping; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Prognosis; Recurrence; Regression Analysis; Survival Rate; Treatment Outcome; Whole-Body Irradiation | 1996 |
Cyclosporin A does not reverse clinical resistance to paclitaxel in patients with relapsed non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cimetidine; Cross-Over Studies; Cyclosporine; Dexamethasone; Dextropropoxyphene; Diphenhydramine; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Membrane Glycoproteins; Middle Aged; Neoplasm Proteins; Paclitaxel; Premedication; Recurrence; Remission Induction | 1996 |
Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
Topics: Adolescent; Adult; Amylases; Antilymphocyte Serum; Azathioprine; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Muromonab-CD3; Pancreas Transplantation; Recurrence; Steroids; Tacrolimus; Time Factors; Treatment Outcome | 1996 |
Treatment of steroid resistant acute rejection after renal transplantation.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Antilymphocyte Serum; Cyclosporine; Diphenhydramine; Drug Resistance; Graft Rejection; Histamine H1 Antagonists; Humans; Hydrocortisone; Immunosuppressive Agents; Kidney Transplantation; Methylprednisolone; Muromonab-CD3; Recurrence | 1996 |
Cyclosporine and 6-mercaptopurine for active, refractory Crohn's colitis in children.
Topics: Adolescent; Child; Child, Preschool; Colitis; Combined Modality Therapy; Crohn Disease; Cyclosporine; Female; Gastrointestinal Agents; Humans; Infant; Male; Mercaptopurine; Prospective Studies; Recurrence; Remission Induction; Time Factors | 1996 |
Rescue therapy with mycophenolate mofetil. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Cyclosporine; Female; Glucocorticoids; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Odds Ratio; Recurrence; Safety | 1996 |
Recurrence of primary biliary cirrhosis in the liver allograft: the effect of immunosuppression.
Topics: Adult; Biopsy; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Prospective Studies; Recurrence; Tacrolimus; Transplantation, Homologous | 1996 |
Clinical aspects: preliminary experience with a novel oral formulation of cyclosporin (Neoral).
Topics: Chemistry, Pharmaceutical; Chronic Disease; Cyclosporine; Dermatologic Agents; Emulsions; Follow-Up Studies; Humans; Psoriasis; Recurrence | 1996 |
Treatment of severe atopic dermatitis in childhood with cyclosporin.
Topics: Adolescent; Child; Child, Preschool; Creatinine; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Humans; Recurrence; Treatment Outcome | 1996 |
Comparison of cyclosporine and topical betamethasone-17,21-dipropionate in the treatment of severe chronic hand eczema.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Chronic Disease; Creatinine; Cyclosporine; Double-Blind Method; Drug Tolerance; Eczema; Female; Glucocorticoids; Hand Dermatoses; Humans; Immunosuppressive Agents; Male; Middle Aged; Ointments; Recurrence; Treatment Outcome | 1996 |
Intravenous cyclosporine in attacks of ulcerative colitis: short-term and long-term responses.
Topics: Adolescent; Adult; Colectomy; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome | 1996 |
Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Incidence; Infant; Infections; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Prospective Studies; Recurrence; Respiratory Insufficiency; Transplantation Conditioning; Treatment Outcome | 1997 |
Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: single-center experience of 32 adult patients.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunotherapy, Adoptive; Interferon alpha-2; Interferon-alpha; Interleukin-2; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukocytes; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins; Recurrence; Remission Induction | 1997 |
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Follow-Up Studies; Graft vs Host Disease; Humans; Karnofsky Performance Status; Methotrexate; Multivariate Analysis; Recurrence; Risk Factors; Time Factors; Transplantation Conditioning; Treatment Failure | 1997 |
Treatment of progressive pulmonary sarcoidosis with cyclosporin A. A randomized controlled trial.
Topics: Adult; Bronchoalveolar Lavage Fluid; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Prednisone; Prospective Studies; Radiography, Thoracic; Recurrence; Respiratory Mechanics; Sarcoidosis, Pulmonary; Treatment Failure | 1997 |
Cyclosporin A in resistant chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Adult; Aged; Chronic Disease; Cyclosporine; Demyelinating Diseases; Drug Resistance; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Neurologic Examination; Polyradiculoneuropathy; Recurrence; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 1998 |
Low transplant mortality in allogeneic bone marrow transplantation for acute myeloid leukemia: a randomized study of low-dose cyclosporin versus low-dose cyclosporin and low-dose methotrexate.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Recurrence; Survival Analysis; Time Factors | 1998 |
Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantation.
Topics: Adult; Aged; Cyclosporine; Emulsions; Female; Graft Rejection; Graft Survival; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Reoperation; RNA, Viral; Survival Rate; Tacrolimus | 1998 |
Comparison of tacrolimus with neoral as primary immunosuppression in hepatitis C patients after liver transplantation.
Topics: Adult; Aged; Cyclosporine; Female; Graft Rejection; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Incidence; Liver Neoplasms; Male; Methylprednisolone; Middle Aged; Recurrence; RNA, Viral; Tacrolimus | 1998 |
Levamisole treatment in steroid-sensitive and steroid-resistant nephrotic syndrome.
Topics: Adjuvants, Immunologic; Adolescent; Child; Child, Preschool; Cyclosporine; Drug Resistance; Female; Humans; Immunosuppressive Agents; Levamisole; Male; Nephrotic Syndrome; Proteinuria; Recurrence; Steroids | 1998 |
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility; Humans; Hyperglycemia; Hypertension; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Nuclear Family; Recurrence; Survival Analysis; Tacrolimus; Tissue Donors; Transplantation, Homologous; Treatment Outcome | 1998 |
Impact of recurrent nephrotic syndrome after renal transplantation in young patients.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Drug Resistance; Female; Glomerulosclerosis, Focal Segmental; Graft Survival; Humans; Immunosuppressive Agents; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Male; Nephrotic Syndrome; Plasma Exchange; Prognosis; Recurrence; Steroids | 1998 |
Long-term effects of immunosuppressants in steroid-dependent nephrotic syndrome.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Cyclosporine; Drug Resistance; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney; Male; Nephrotic Syndrome; Prednisolone; Recurrence; Retrospective Studies | 1998 |
Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Humans; Lung Diseases, Interstitial; Male; Methylprednisolone; Middle Aged; Postoperative Complications; Recurrence; Risk Factors; Survival Rate; Transplantation, Homologous | 1999 |
Urinary glycosaminoglycans in recurrent urinary tract infections in kidney transplant patients.
Topics: Aged; Creatinine; Cyclosporine; Female; Glycosaminoglycans; Humans; Immunoglobulin A; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Recurrence; Urinary Tract Infections | 1999 |
Intermittent short courses of cyclosporin (Neoral(R)) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study. The PISCES Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Pressure; Creatinine; Cyclosporine; Dermatologic Agents; Dose-Response Relationship, Drug; Humans; Hypertension; Middle Aged; Prospective Studies; Psoriasis; Recurrence; Treatment Outcome | 1999 |
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival.
Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Chronic Disease; Communicable Diseases; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Leukemia; Longitudinal Studies; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Survival Rate; Transplantation, Homologous | 1999 |
Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Female; Humans; Male; Prospective Studies; Quality of Life; Recurrence; Treatment Outcome | 2000 |
Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Sever
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Glycosylphosphatidylinositols; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Infant; Male; Middle Aged; Prednisolone; Recurrence; Time Factors | 2000 |
Mitoxantrone, etoposide, and cyclosporine therapy in pediatric patients with recurrent or refractory acute myeloid leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclosporine; Drug Resistance, Multiple; Etoposide; Female; Flow Cytometry; Genes, MDR; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome | 2000 |
Cyclosporin in the treatment of adults with refractory coeliac disease--an open pilot study.
Topics: Adult; Aged; Celiac Disease; Cyclosporine; Female; Humans; Immunosuppressive Agents; Intestinal Mucosa; Intestine, Small; Male; Middle Aged; Pilot Projects; Recurrence; Treatment Outcome | 2000 |
Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study.
Topics: Acute Disease; Adolescent; Adult; Blood Transfusion; Bone and Bones; Bone Marrow Transplantation; Cause of Death; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility Testing; Hospitalization; Humans; Infections; Male; Methotrexate; Methylprednisolone; Middle Aged; Necrosis; Nuclear Family; Prospective Studies; Recurrence; Survival Rate | 2000 |
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation.
Topics: Adolescent; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Melphalan; Methotrexate; Microsatellite Repeats; Middle Aged; Nuclear Family; Polymerase Chain Reaction; Recurrence; Transplantation Chimera; Transplantation Conditioning; Treatment Outcome; Vidarabine | 2000 |
Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.
Topics: Adult; Cyclosporine; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Prospective Studies; Proteinuria; Recurrence; Retreatment; Single-Blind Method; Steroids; Treatment Outcome | 2001 |
Azithromycin treatment of gingival hyperplasia in kidney transplant recipients is effective and safe.
Topics: Anti-Bacterial Agents; Area Under Curve; Azithromycin; Creatinine; Cyclosporine; Follow-Up Studies; Gingival Hyperplasia; Humans; Immunosuppressive Agents; Kidney Transplantation; Postoperative Complications; Recurrence; Time Factors; Treatment Outcome | 2001 |
beta-herpesvirus activation after kidney transplantation with mycophenolate mofetil-based maintenance immunosuppression.
Topics: Adult; Azathioprine; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Drug Therapy, Combination; Herpesviridae Infections; Herpesvirus 7, Human; Humans; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Polymerase Chain Reaction; Postoperative Complications; Prednisolone; Recurrence; Virus Activation | 2001 |
Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Incidence; Leukemia; Lymphocyte Depletion; Male; Nuclear Family; Recurrence; Survival Rate; Tacrolimus; Time Factors; Transplantation, Homologous | 2001 |
Increased risk of leukemia relapse with high dose cyclosporine after allogeneic marrow transplantation for acute leukemia: 10 year follow-up of a randomized study.
Topics: Adolescent; Adult; Age Factors; Bone Marrow Transplantation; Child; Child, Preschool; Cohort Studies; Cyclosporine; Disease-Free Survival; Follow-Up Studies; Humans; Immunosuppressive Agents; Infant; Leukemia; Life Tables; Middle Aged; Recurrence; Risk; Transplantation, Homologous | 2001 |
[The effectiveness of cyclosporin A in the treatment of autoimmune hemolytic anemia and Evans syndrome].
Topics: Adolescent; Adult; Aged; Anemia, Hemolytic, Autoimmune; Cyclosporine; Danazol; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prednisone; Recurrence; Treatment Outcome | 2001 |
Differential effects of cyclosporine and etretinate on serum cytokine levels in patients with psoriasis.
Topics: Administration, Oral; Adult; Aged; Cyclosporine; Etretinate; Female; Humans; Interferon-gamma; Interleukin-1; Male; Middle Aged; Psoriasis; Recurrence; Remission Induction; Tumor Necrosis Factor-alpha | 1992 |
Fractionated TBI and methotrexate-cyclosporin do not seem to increase relapses in BMT for first chronic phase CML patients: results of a single centre study.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Methotrexate; Pulmonary Fibrosis; Recurrence; Whole-Body Irradiation | 1992 |
Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. The French Society of Paediatric Nephrology.
Topics: Adolescent; Child; Child, Preschool; Chlorambucil; Creatinine; Cyclosporine; Drug Administration Schedule; Female; Humans; Infant; Male; Nephrotic Syndrome; Prednisone; Prospective Studies; Recurrence; Remission Induction | 1992 |
Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Daunorubicin; Etoposide; Follow-Up Studies; Graft vs Host Disease; Humans; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Time Factors; Transplantation, Homologous; Vincristine; Whole-Body Irradiation | 1991 |
534 other study(ies) available for cyclosporine and Recrudescence
| Article | Year |
|---|---|
Treating Severe Pediatric Keratoconjunctivitis with Topical Cyclosporine A.
Topics: Administration, Topical; Adult; Child; Conjunctivitis, Allergic; Cyclosporine; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Recurrence | 2022 |
Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation.
Topics: Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Methotrexate; Prospective Studies; Recurrence; Siblings; Transplantation Conditioning; United States | 2022 |
Lower levels of cyclosporine between days 0 and +21 may reduce later relapses without increasing graft-versus-host disease in children and adolescents with acute lymphoblastic leukemia who undergo myeloablative TBI-based allogeneic hematopoietic cell tran
Topics: Acute Disease; Adolescent; Child; Chronic Disease; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Recurrence; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous | 2022 |
Clinical outcomes and immune responses to SARS-CoV-2 vaccination in severe aplastic anaemia.
Topics: Anemia, Aplastic; COVID-19; COVID-19 Vaccines; Cyclosporine; Humans; Immunity; Immunosuppressive Agents; Recurrence; SARS-CoV-2; Vaccination | 2022 |
Preemptive cyclosporin A in immune-mediated thrombotic thrombocytopenic purpura.
Topics: ADAMTS13 Protein; Autoantibodies; Cyclosporine; Humans; Purpura, Thrombotic Thrombocytopenic; Recurrence; Rituximab | 2023 |
Long-term outcome of Japanese children with complicated minimal change nephrotic syndrome treated with mycophenolate mofetil after cyclosporine.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Japan; Longitudinal Studies; Male; Mycophenolic Acid; Nephrosis, Lipoid; Nephrotic Syndrome; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Secondary Prevention; Time Factors; Treatment Outcome; Young Adult | 2019 |
Clinical course of acute deep vein thrombosis of the legs in Behçet's syndrome.
Topics: Adult; Azathioprine; Behcet Syndrome; Cyclophosphamide; Cyclosporine; Disease Progression; Female; Femoral Vein; Glucocorticoids; Humans; Iliac Vein; Immunosuppressive Agents; Interferon-alpha; Lower Extremity; Male; Methylprednisolone; Popliteal Vein; Prednisolone; Proportional Hazards Models; Recurrence; Treatment Outcome; Ultrasonography, Doppler; Vena Cava, Inferior; Venous Thrombosis; Young Adult | 2020 |
Donor single nucleotide polymorphism in ACAT1 affects the incidence of graft-versus-host disease after bone marrow transplantation.
Topics: Acetyl-CoA C-Acetyltransferase; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; HLA Antigens; Humans; Incidence; Japan; Male; Methotrexate; Middle Aged; Polymorphism, Single Nucleotide; Recurrence; Siblings; Survival Rate; T-Lymphocytes; Tissue Donors; Transplantation, Homologous; Treatment Outcome; Young Adult | 2020 |
A human immune dysregulation syndrome characterized by severe hyperinflammation with a homozygous nonsense Roquin-1 mutation.
Topics: Adolescent; Animals; Codon, Nonsense; Consanguinity; Cyclosporine; Eosinophilia; Homozygote; Humans; Immunophenotyping; Immunosuppressive Agents; Inducible T-Cell Co-Stimulator Protein; Lymphohistiocytosis, Hemophagocytic; Male; Mice; Monocytes; Receptors, OX40; Recurrence; RNA-Binding Proteins; T-Lymphocytes; T-Lymphocytes, Regulatory; Ubiquitin-Protein Ligases | 2019 |
Prevalence and predictors of flare after immunosuppressant discontinuation in patients with systemic lupus erythematosus in remission.
Topics: Adult; Antimalarials; Antirheumatic Agents; Azathioprine; Cyclosporine; Deprescriptions; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Protective Factors; Recurrence; Remission Induction; Risk Factors; Symptom Flare Up; Time Factors | 2020 |
Posttransplant cyclophosphamide vs cyclosporin A and methotrexate as GVHD prophylaxis in matched sibling transplantation.
Topics: Adolescent; Adult; Aged; Blood Cell Count; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Middle Aged; Recurrence; Severity of Illness Index; Siblings; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Unrelated Donors; Young Adult | 2019 |
A Long-Term Follow-up of Retinal Vasculitis - Do They Develop Systemic Disease?
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Psoriasis; Recurrence; Retinal Vasculitis; Retrospective Studies; Tuberculin Test; Tuberculosis, Ocular; Visual Acuity; Vitreous Hemorrhage | 2020 |
Omalizumab in the Treatment of Chronic Urticaria: The Effect of Drug Co-Administration and Co-Morbidities.
Topics: Anti-Allergic Agents; Chronic Urticaria; Comorbidity; Cyclosporine; Dapsone; Drug Therapy, Combination; Female; Histamine Antagonists; Humans; Male; Omalizumab; Recurrence; Sex Factors | 2021 |
Successful sirolimus treatment of patients with pure red cell aplasia complicated with renal insufficiency.
Topics: Adult; Aged; Aged, 80 and over; Creatinine; Cyclosporine; Drug Eruptions; Drug Evaluation; Drug Substitution; Female; Humans; Hyperglycemia; Hypertriglyceridemia; Immunosuppressive Agents; Male; Middle Aged; Recurrence; Red-Cell Aplasia, Pure; Remission Induction; Renal Insufficiency; Retrospective Studies; Sirolimus; Treatment Outcome | 2020 |
Comparison of the efficacy of cyclosporine and leflunomide in treating inflammatory colorectal polyps in miniature dachshunds.
Topics: Animals; Colonic Polyps; Cyclosporine; Dog Diseases; Dogs; Female; Immunosuppressive Agents; Japan; Leflunomide; Male; Recurrence; Retrospective Studies; Treatment Outcome | 2020 |
Combination of High-Dose Intravenous Cyclosporine and Plasma Exchange Treatment Is Effective in Post-Transplant Recurrent Focal Segmental Glomerulosclerosis: Results of Case Series.
Topics: Administration, Intravenous; Adult; Combined Modality Therapy; Cyclosporine; Female; Glomerulosclerosis, Focal Segmental; Humans; Kidney Transplantation; Male; Middle Aged; Plasma Exchange; Postoperative Complications; Prospective Studies; Proteinuria; Recurrence; Treatment Outcome | 2020 |
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis.
Topics: Aged; Cholagogues and Choleretics; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Risk; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid | 2020 |
Egyptian experience in Langerhans cells histiocytosis: frequent multisystem affection and reactivation rates.
Topics: Child; Child, Preschool; Cladribine; Cyclosporine; Disease Progression; Egypt; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Langerhans Cells; Liver; Lymph Nodes; Lymphohistiocytosis, Hemophagocytic; Male; Recurrence; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome | 2020 |
Survival time and relapse in dogs with meningoencephalomyelitis of unknown origin treated with prednisolone and ciclosporin: a retrospective study.
Topics: Animals; Cyclosporine; Dog Diseases; Dogs; Meningoencephalitis; Prednisolone; Recurrence; Retrospective Studies | 2020 |
Predictors of Outcomes of Therapy-Related Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation.
Topics: Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Recurrence; Retrospective Studies; Transplantation Conditioning; Unrelated Donors | 2022 |
Impact of anti-thymocyte globulin dose for graft-versus-host disease prophylaxis in allogeneic hematopoietic cell transplantation from matched unrelated donors: a multicenter experience.
Topics: Adult; Allografts; Antilymphocyte Serum; Cyclosporine; Disease-Free Survival; Dose-Response Relationship, Immunologic; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Incidence; Infections; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Recurrence; Retrospective Studies; T-Lymphocytes; Unrelated Donors | 2021 |
Non-thymoma-associated exfoliative dermatitis in a European shorthair cat: A case report.
Topics: Animals; Cat Diseases; Cats; Cyclosporine; Dermatitis, Exfoliative; Epidermis; Female; Immunosuppressive Agents; Recurrence | 2021 |
Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents.
Topics: Aged; Aged, 80 and over; Anemia; Antilymphocyte Serum; Antineoplastic Agents; Arsenic; Azacitidine; Chromosome Deletion; Chromosomes, Human, Pair 5; Cyclosporine; Cytarabine; Decitabine; Disease Progression; Enzyme Inhibitors; Erythrocyte Transfusion; Female; Hematinics; Humans; Hydroxyurea; Immunologic Factors; Lenalidomide; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Recurrence; Retreatment; Retrospective Studies; Risk Factors; Survival Rate; Thalidomide; Treatment Failure; Tretinoin; Valproic Acid | 2017 |
[The observation of tacrolimus eye drops preventing the early immunological rejection after penetrating keratoplasty for fungal keratitis].
Topics: Adult; Cyclosporine; Eye Infections, Fungal; Female; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Intraocular Pressure; Keratitis; Keratoplasty, Penetrating; Male; Middle Aged; Ophthalmic Solutions; Postoperative Period; Recurrence; Retrospective Studies; Risk Factors; Tacrolimus; Treatment Outcome | 2017 |
Effectiveness and nephrotoxicity of a 2-year medium dose of cyclosporine in pediatric patients with steroid-dependent nephrotic syndrome: determination of the need for follow-up kidney biopsy.
Topics: Age Factors; Biopsy; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney; Male; Nephrotic Syndrome; Predictive Value of Tests; Recurrence; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2018 |
Novel treatment regimen of Vogt-Koyanagi-Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents.
Topics: Acute Disease; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Off-Label Use; Prednisone; Recurrence; Retrospective Studies; Treatment Outcome; Uveomeningoencephalitic Syndrome; Visual Acuity | 2018 |
Long-Term Outcomes of Kidney Transplant Recipients With Primary Idiopathic Focal Segmental Glomerulosclerosis.
Topics: Adult; Combined Modality Therapy; Cyclosporine; Female; Glomerulosclerosis, Focal Segmental; Graft Survival; Humans; Immunologic Factors; Kidney Transplantation; Male; Middle Aged; Plasma Exchange; Postoperative Period; Proteinuria; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Survival Rate; Treatment Outcome | 2017 |
Intravenous immunoglobulin as salvage therapy for refractory thrombotic thrombocytopenic purpura.
Topics: Adult; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Middle Aged; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Recurrence; Registries; Retrospective Studies; Salvage Therapy; Splenectomy; Treatment Outcome; Vidarabine; Vincristine; Young Adult | 2018 |
Comparative study of porcine anti-human lymphocyte immunoglobulin and rabbit anti-human thymocyte immunoglobulin as a first-line treatment of acquired severe aplastic anemia.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Animals; Antilymphocyte Serum; Child; Cyclosporine; Female; Humans; Immunologic Factors; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Middle Aged; Progression-Free Survival; Rabbits; Recurrence; Retrospective Studies; Severity of Illness Index; Swine; Young Adult | 2018 |
Cyclosporine for the treatment of lupus nephritis in patients with systemic lupus erythematosus.
Topics: Adult; Biopsy; Cyclosporine; Disease Progression; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome; Young Adult | 2018 |
Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy.
Topics: Acute Kidney Injury; Adult; C-Reactive Protein; Chicago; Colectomy; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Postoperative Complications; Prednisolone; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult | 2018 |
Response to cyclosporine A and corticosteroids in adult patients with acquired pure red cell aplasia: serial experience at a single center.
Topics: Adult; Aged; Aged, 80 and over; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Induction Chemotherapy; Male; Middle Aged; Prednisone; Recurrence; Red-Cell Aplasia, Pure; Retrospective Studies; Salvage Therapy; Treatment Failure; Treatment Outcome | 2018 |
Clinical Features of Chronic Spontaneous Urticaria that Predict Disease Prognosis and Refractoriness to Standard Treatment.
Topics: Adult; Age of Onset; Aged; Chronic Disease; Cyclosporine; Disease Progression; Drug Resistance; Female; Histamine H1 Antagonists; Humans; Immunosuppressive Agents; Male; Middle Aged; Omalizumab; Recurrence; Retrospective Studies; Risk Factors; Time Factors; Treatment Failure; Urticaria | 2018 |
Treatment of recurrent focal segmental glomerulosclerosis post-kidney transplantation in Australian and New Zealand children: A retrospective cohort study.
Topics: Adolescent; Australia; Child; Child, Preschool; Cyclosporine; Female; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Kidney Transplantation; Longitudinal Studies; Male; Methylprednisolone; New Zealand; Plasma Exchange; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome | 2018 |
Comparison of two dosages of rabbit antithymocyte globulin (r-ATG) in treating children with severe aplastic anemia.
Topics: Adolescent; Anemia, Aplastic; Antilymphocyte Serum; Child; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Male; Recurrence; Retrospective Studies; Treatment Outcome | 2018 |
Recurrence of anti-MDA5 antibody-positive clinically amyopathic dermatomyositis after long-term remission: A case report.
Topics: Administration, Intravenous; Aged; Anti-Inflammatory Agents; Asian People; Autoantibodies; Biomarkers; Cyclophosphamide; Cyclosporine; Dermatomyositis; Female; Ferritins; Humans; Immunosuppressive Agents; Interferon-Induced Helicase, IFIH1; Lung Diseases, Interstitial; Methylprednisolone; Recurrence; Tomography, X-Ray Computed; Treatment Outcome | 2018 |
Feline pemphigus foliaceus in non-specialist veterinary practice: a retrospective analysis.
Topics: Animals; Cat Diseases; Cats; Cyclosporine; Female; Glucocorticoids; Immunosuppressive Agents; Male; Pemphigus; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome | 2018 |
Significance of Molecular Monitoring of T Cells for the Decision of Treatment Strategy for Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis.
Topics: Adolescent; Biological Monitoring; Cyclosporine; Decision Making; Ferritins; Herpesvirus 4, Human; Humans; Immunotherapy; Lymphohistiocytosis, Hemophagocytic; Male; Monitoring, Immunologic; Receptors, Interleukin-2; Recurrence; T-Lymphocytes; Therapeutics | 2019 |
Cyclophosphamide versus cyclosporine A therapy in steroid-resistant nephrotic syndrome: a retrospective study with a mean 5-year follow-up.
Topics: Child; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Humans; Male; Nephrotic Syndrome; Recurrence; Remission Induction; Retrospective Studies; Steroids | 2018 |
Addition of cyclosporine/tacrolimus for pediatric relapsed lupus nephritis during mycophenolate mofetil maintenance therapy.
Topics: Adolescent; Antibiotics, Antineoplastic; Child; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney; Lupus Nephritis; Male; Mycophenolic Acid; Recurrence; Remission Induction; Retrospective Studies; Tacrolimus | 2019 |
TNF-α inhibitor-induced psoriasis: A decade of experience at the Cleveland Clinic.
Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Child; Cyclosporine; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Methotrexate; Middle Aged; Psoriasis; Recurrence; Retrospective Studies; Risk Factors; Sex Factors; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2020 |
Effect of cyclosporine A versus tacrolimus on the response to antiviral therapy after hepatitis C genotype-4 recurrence post-liver transplantation: A prospective cohort trial.
Topics: Adult; Aged; Antiviral Agents; Calcineurin Inhibitors; Cyclosporine; Drug Interactions; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Recurrence; Ribavirin; Sofosbuvir; Tacrolimus; Young Adult | 2019 |
Successful Treatment of Recurrent Focal Segmental Glomerulosclerosis After Transplantation in Children: A Single-Center Experience.
Topics: Abatacept; Adolescent; Child; Child, Preschool; Cyclosporine; Female; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Plasmapheresis; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Tacrolimus; Transplant Recipients | 2019 |
Development of hemolytic paroxysmal nocturnal hemoglobinuria without graft loss following hematopoietic stem cell transplantation for acquired aplastic anemia.
Topics: Adolescent; Anemia, Aplastic; Bone Marrow Cells; Chimerism; Cyclosporine; Diabetes Mellitus, Type 1; Graft Survival; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Hemolysis; Humans; Immunosuppressive Agents; Male; Membrane Proteins; Mutation; Neutrophils; Recurrence; Thrombocytopenia; Thrombosis; Treatment Outcome | 2019 |
Impact of cyclosporine A concentration on acute graft-vs-host disease incidence after haploidentical hematopoietic cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Cyclophosphamide; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Recurrence; Risk Factors; Time-to-Treatment; Transplantation Conditioning; Transplantation, Haploidentical; Treatment Outcome; Young Adult | 2019 |
Immunosuppressive therapy (IST) in adult patients with acquired aplastic anemia (AA): A single-center experience over the past 15 years.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Drug Therapy, Combination; Erythrocyte Indices; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Middle Aged; Recurrence; Retrospective Studies; Severity of Illness Index; Survival Analysis; Treatment Outcome; Young Adult | 2019 |
Therapeutic options and prognosis of chronic idiopathic erythroderma in older adults.
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Aged, 80 and over; Chronic Disease; Cyclosporine; Dermatitis, Exfoliative; Dermatologic Agents; Female; Humans; Male; Prognosis; Recurrence; Retrospective Studies; Treatment Outcome; Ultraviolet Therapy | 2019 |
Cyclosporine 0.1% (Ikervis
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal, Humanized; Conjunctivitis; Cyclosporine; Dermatitis, Atopic; Female; Fluorometholone; Glucocorticoids; Humans; Immunosuppressive Agents; Interleukin-4 Receptor alpha Subunit; Male; Middle Aged; Recurrence | 2019 |
Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids.
Topics: Acute Disease; Adolescent; Adult; Child; Child, Preschool; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Fluorescein Angiography; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Prognosis; Recurrence; Retrospective Studies; Treatment Outcome; Uveomeningoencephalitic Syndrome; Visual Acuity; Young Adult | 2013 |
Successful treatment of class IV+V lupus nephritis with combination therapy of high-dose corticosteroids, tacrolimus and intravenous cyclophosphamide.
Topics: Adolescent; Antihypertensive Agents; Biphenyl Compounds; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Humans; Hypertension, Renal; Immunosuppressive Agents; Infusions, Intravenous; Irbesartan; Lupus Erythematosus, Systemic; Lupus Nephritis; Nephrotic Syndrome; Prednisolone; Pulse Therapy, Drug; Recurrence; Ribonucleosides; Severity of Illness Index; Tacrolimus; Tetrazoles | 2013 |
Immunosuppressive therapy in adults with aplastic anaemia: single-institution experience from India.
Topics: Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Febrile Neutropenia; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Immunotherapy; India; Male; Middle Aged; Recurrence; Retrospective Studies; Survival Rate; Tertiary Care Centers; Treatment Outcome; Young Adult | 2013 |
[HCV reinfection after liver transplantation - management and first experiences with telaprevir-based triple therapy].
Topics: Adult; Antiviral Agents; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Postoperative Complications; Recombinant Proteins; Recurrence; Ribavirin; Tacrolimus; Viral Load | 2013 |
Higher therapeutic CsA levels early post transplantation reduce risk of acute GVHD and improves survival.
Topics: Adolescent; Adult; Alleles; Calcineurin Inhibitors; Cord Blood Stem Cell Transplantation; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Multivariate Analysis; Recurrence; Retrospective Studies; Risk Factors; Siblings; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Young Adult | 2014 |
Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children.
Topics: Adolescent; Anemia, Aplastic; Animals; Antilymphocyte Serum; Cell Transformation, Neoplastic; Child; Child, Preschool; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Horses; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Male; Prognosis; Rabbits; Recurrence; Retrospective Studies; Risk Factors; Severity of Illness Index; Treatment Outcome | 2014 |
[Complete remission of repeated recurrent membranous nephropathy after non-myeloablative allogeneic peripheral blood stem cell transplantation].
Topics: Allografts; Cyclosporine; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Middle Aged; Myelodysplastic Syndromes; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Treatment Outcome | 2013 |
Successful telaprevir treatment in combination of cyclosporine against recurrence of hepatitis C in the Japanese liver transplant patients.
Topics: Aged; Antiviral Agents; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Hepacivirus; Hepatitis C; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver; Liver Transplantation; Male; Middle Aged; Oligopeptides; Protease Inhibitors; Recurrence; RNA; Treatment Outcome | 2014 |
Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome.
Topics: Adolescent; Adult; Allografts; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Disease-Free Survival; Down Syndrome; Genetic Predisposition to Disease; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Kaplan-Meier Estimate; Living Donors; Myeloablative Agonists; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Registries; Remission Induction; Retrospective Studies; Salvage Therapy; Tacrolimus; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation | 2014 |
Analysis of various factors on the relapse of acute neurological attacks in Behçet's disease.
Topics: Acute Disease; Adult; Behcet Syndrome; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Surveys and Questionnaires | 2014 |
Protracted febrile myalgia syndrome in a kidney transplant recipient with familial Mediterranean fever.
Topics: Adult; Amyloidosis; Blood Sedimentation; Colchicine; Cyclosporine; Familial Mediterranean Fever; Fever; Humans; Kidney Transplantation; Male; Myalgia; Recurrence | 2015 |
Efficacy of cyclosporine combination therapy for new-onset minimal change nephrotic syndrome in adults.
Topics: Adult; Anti-Inflammatory Agents; Cyclosporine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Length of Stay; Male; Methylprednisolone; Middle Aged; Nephrosis, Lipoid; Recurrence; Retrospective Studies; Severity of Illness Index; Young Adult | 2015 |
Successful treatment of palmoplantar nail lichen planus with cyclosporine.
Topics: Adult; Antifungal Agents; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Lichen Planus; Long-Term Care; Onychomycosis; Recurrence | 2014 |
[Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
Topics: Adolescent; Adrenal Cortex Hormones; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Child; Child, Preschool; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infant; Kidney; Male; Nephrotic Syndrome; Prednisone; Proteinuria; Recurrence; Retrospective Studies; Treatment Outcome | 2014 |
[Salvage therapy for severe aplastic anemia after allogenenic hematopoietic cell transplant].
Topics: Anemia, Aplastic; Cyclosporine; Hematopoietic Stem Cell Transplantation; Humans; Recurrence; Salvage Therapy | 2014 |
Pharmacodynamic monitoring of immunosuppressive effects indicates reduced cyclosporine activity during telaprevir therapy.
Topics: Antiviral Agents; Biomarkers; Cyclosporine; Dose-Response Relationship, Immunologic; Drug Interactions; Drug Monitoring; End Stage Liver Disease; Female; Gene Expression Regulation; Granulocyte-Macrophage Colony-Stimulating Factor; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-2; Liver Transplantation; Male; Middle Aged; Oligopeptides; Predictive Value of Tests; Recurrence; Retrospective Studies; RNA, Messenger; RNA, Viral; Time Factors; Treatment Outcome; Viral Load | 2014 |
Residual genomic profile after cyclosporine treatment may offer insights into atopic dermatitis reoccurrence.
Topics: Biomarkers, Pharmacological; Cells, Cultured; Claudins; Clinical Protocols; Cyclosporine; Dermatitis, Atopic; Follow-Up Studies; Genome; Humans; Immunosuppressive Agents; Interferon-gamma; Leptin; Recurrence; T-Lymphocyte Subsets; Th2 Cells; Transcriptome; Treatment Outcome; Ultraviolet Therapy | 2014 |
Are alternative donors really still "alternative?".
Topics: Bone Marrow Transplantation; Cyclosporine; Gene Expression; Graft vs Host Disease; Haplotypes; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Recurrence; Siblings; Survival Analysis; Transplantation, Homologous; Unrelated Donors | 2014 |
Reduced-dose telaprevir-based triple antiviral therapy for recurrent hepatitis C after living donor liver transplantation.
Topics: Aged; Anemia; Antiviral Agents; Cohort Studies; Cyclosporine; End Stage Liver Disease; Female; Glomerular Filtration Rate; Haplotypes; Hemoglobins; Hepacivirus; Hepatitis C, Chronic; High-Throughput Nucleotide Sequencing; Humans; Japan; Liver Transplantation; Living Donors; Male; Middle Aged; Mutation; Oligopeptides; Recurrence; RNA, Viral; Treatment Outcome | 2014 |
Cyclosporine is superior to tacrolimus in liver transplant recipients with recurrent psoriasis.
Topics: Adult; Cyclosporine; End Stage Liver Disease; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Psoriasis; Recurrence; Risk Factors; Tacrolimus; Transplant Recipients; Treatment Outcome | 2014 |
Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada disease.
Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD20; Audiometry; Cyclosporine; Dexamethasone; Female; Hearing Loss; Hearing Loss, Sensorineural; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methylprednisolone; Panuveitis; Prednisolone; Prednisone; Prognosis; Recurrence; Remission Induction; Rituximab; Uveitis; Uveomeningoencephalitic Syndrome | 2015 |
Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
Topics: Aged; Aged, 80 and over; Biopsy; Creatinine; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Glomerulonephritis; Glomerulonephritis, Membranoproliferative; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Japan; Kidney; Male; Methylprednisolone; Mycophenolic Acid; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisolone; Proteinuria; Recurrence; Registries; Retrospective Studies; Ribonucleosides; Treatment Outcome | 2015 |
Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Blood Platelets; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Neutrophils; Recurrence; Retrospective Studies; Siblings; Survival Analysis; Tissue Donors; Transplantation, Homologous | 2015 |
Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation.
Topics: Adult; Antiviral Agents; Coinfection; Cyclosporine; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Immunosuppression Therapy; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Recurrence; Ribavirin; Tacrolimus; Viral Load | 2015 |
Varicella zoster virus-associated generalized pustular psoriasis in a baby with heterozygous IL36RN mutation.
Topics: Cyclosporine; Dermatologic Agents; Herpesvirus 3, Human; Heterozygote; Humans; Infant; Interleukins; Male; Mutation; Psoriasis; Recurrence | 2014 |
Early intensified intravenous cyclosporine therapy predicts favorable response to immunosuppressive therapy with rabbit antithymocyte globulin in patients with severe aplastic anemia.
Topics: Administration, Oral; Adult; Aged; Anemia, Aplastic; Animals; Antilymphocyte Serum; Cyclosporine; Drug Combinations; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Prognosis; Rabbits; Recurrence; Survival Rate; Young Adult | 2015 |
Mycophenolate-based graft versus host disease prophylaxis is not inferior to methotrexate in myeloablative-related donor stem cell transplantation.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Survival Analysis; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous | 2015 |
A comparative study of reduced dose alemtuzumab in matched unrelated donor and related donor reduced intensity transplants.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Middle Aged; Recurrence; Retrospective Studies; Transplantation Chimera; Transplantation Conditioning; Unrelated Donors | 2015 |
Improving long-term outcomes in idiopathic membranous nephropathy using a distinctive cyclosporine regimen.
Topics: Adult; Aged; Cyclosporine; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Male; Middle Aged; Recurrence; Retrospective Studies; Survival Analysis; Treatment Outcome | 2016 |
Belatacept in recurrent focal segmental glomerulosclerosis after kidney transplantation.
Topics: Abatacept; Adult; Allografts; Biopsy; Cyclosporine; Female; Follow-Up Studies; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Plasmapheresis; Postoperative Complications; Recurrence; Treatment Outcome | 2015 |
Chédiak-Higashi syndrome: brain MRI and MR spectroscopy manifestations.
Topics: Brain; Chediak-Higashi Syndrome; Child; Contrast Media; Cyclosporine; Dexamethasone; Diffusion Magnetic Resonance Imaging; Echo-Planar Imaging; Follow-Up Studies; Gadolinium; Humans; Image Enhancement; Immunosuppressive Agents; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Methotrexate; Recurrence; Treatment Outcome | 2015 |
Chronological assessment of airway lesions in relapsing polychondritis by positron emission tomography.
Topics: Adult; Bronchoscopy; Chest Pain; Costal Cartilage; Cyclosporine; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Methotrexate; Multimodal Imaging; Polychondritis, Relapsing; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Tomography, X-Ray Computed; Trachea | 2015 |
Long-term follow-up study of porcine anti-human thymocyte immunoglobulin therapy combined with cyclosporine for severe aplastic anemia.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Animals; Antilymphocyte Serum; Child; Clonal Evolution; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Middle Aged; Odds Ratio; Recurrence; Severity of Illness Index; Swine; Time Factors; Treatment Outcome; Young Adult | 2016 |
Spontaneous clearance of hepatitis C genotype 4 after liver retransplantation.
Topics: Adult; Cyclosporine; Female; Genotype; Graft Rejection; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Recurrence; Remission, Spontaneous; Reoperation; RNA, Viral | 2015 |
Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease.
Topics: Adult; Behcet Syndrome; Chronic Disease; Cyclosporine; Female; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Male; Recombinant Proteins; Recurrence; Remission Induction; Treatment Outcome; Turkey; Uveitis; Visual Acuity | 2015 |
Outcome of a novel immunosuppressive strategy of cyclosporine, levamisole and danazol for severe aplastic anemia.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Child; Child, Preschool; Clonal Evolution; Cyclosporine; Danazol; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Levamisole; Male; Middle Aged; Prognosis; Recurrence; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult | 2015 |
Transplantation-Associated Thrombotic Microangiopathy in Patients Treated With Sirolimus and Cyclosporine as Salvage Therapy for Graft-Versus-Host Disease.
Topics: Acute Disease; Adult; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Recurrence; Retrospective Studies; Salvage Therapy; Sirolimus; Thrombotic Microangiopathies | 2015 |
Topical cyclosporine A 0.05% for recurrent anterior uveitis.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Ophthalmic Solutions; Recurrence; Retrospective Studies; Treatment Outcome; Uveitis, Anterior | 2016 |
A misdiagnosed myasthenia gravis with anti-muscle-specific tyrosine kinase antibodies with possible childhood onset.
Topics: Autoantibodies; Biomarkers; Cyclosporine; Diagnostic Errors; Female; Humans; Immunosuppressive Agents; Miller Fisher Syndrome; Muscle, Skeletal; Myasthenia Gravis; Predictive Value of Tests; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic; Recurrence; Treatment Outcome; Young Adult | 2015 |
A new rescue regimen with plasma exchange and rituximab in high-risk membranous glomerulonephritis.
Topics: Administration, Oral; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Plasma Exchange; Prednisolone; Recurrence; Remission Induction; Retrospective Studies; Rituximab | 2015 |
Retrospective Multicentric Study of 25 Kimura Disease Patients: Emphasis on Therapeutics and Shared Features with Cutaneous IgG4-Related Disease.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Angiolymphoid Hyperplasia with Eosinophilia; Cyclosporine; Dermatologic Surgical Procedures; Eosinophilia; Female; Humans; Immunoglobulin E; Immunoglobulin G; Immunologic Factors; Immunosuppressive Agents; Interferon-alpha; Male; Middle Aged; Plasma Cells; Recurrence; Retrospective Studies; Thalidomide; Young Adult | 2015 |
[Efficacy analysis of unrelated cord blood transplantation for 58 acute myelogenous leukemia patients].
Topics: Acute Disease; Adolescent; Cyclosporine; Disease-Free Survival; Fetal Blood; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Leukemia, Myeloid, Acute; Mycophenolic Acid; Quality of Life; Recurrence; Remission Induction; Retrospective Studies | 2015 |
Immunosuppressive Therapy for Aplastic Anaemia.
Topics: Adult; Anemia, Aplastic; Antilymphocyte Serum; Child; Cyclosporine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Opportunistic Infections; Outcome Assessment, Health Care; Patient Selection; Recurrence; Remission Induction | 2015 |
Long-term outcomes with multi-targeted immunosuppressive protocol in children with severe proliferative lupus nephritis.
Topics: Administration, Intravenous; Adolescent; Age Factors; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Follow-Up Studies; Hospitalization; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Logistic Models; Lupus Nephritis; Male; Methylprednisolone; Mycophenolic Acid; Pulse Therapy, Drug; Recurrence; Remission Induction; Risk Factors; Severity of Illness Index; Singapore; Time Factors; Treatment Outcome | 2016 |
[Clinical features of patients with juvenile and adult dermatomyositis].
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Cyclosporine; Dermatomyositis; Female; Follow-Up Studies; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Muscle Weakness; Recurrence; Retrospective Studies; Young Adult | 2015 |
New Zealand Society of Gastroenterology Guidelines for the Management of Refractory Ulcerative Colitis.
Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Appendectomy; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Fecal Microbiota Transplantation; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Leukapheresis; Mercaptopurine; Mesalamine; Methotrexate; New Zealand; Pediatrics; Piperidines; Proctocolectomy, Restorative; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Recurrence; Severity of Illness Index; Tacrolimus; Tumor Necrosis Factor-alpha | 2015 |
Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
Topics: Adolescent; Blood Platelets; Child; Child, Preschool; Chronic Disease; Cyclosporine; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Mycophenolic Acid; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Splenectomy; Treatment Outcome | 2016 |
Efficacy and safety of topical cyclosporine A 0.05% in vernal keratoconjunctivitis.
Topics: Administration, Topical; Adolescent; Adrenal Cortex Hormones; Adult; Child; Cohort Studies; Conjunctivitis, Allergic; Cornea; Cyclosporine; Drug Administration Schedule; Eye; Female; Humans; Immunosuppressive Agents; Male; Recurrence; Young Adult | 2016 |
Therapeutic Effect of 0.1% Topical Tacrolimus for Childhood Interstitial Keratitis Refractory to Cyclosporine.
Topics: Acyclovir; Administration, Topical; Betamethasone; Child; Cyclosporine; Drug Substitution; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Keratitis; Male; Recurrence; Tacrolimus; Treatment Outcome | 2016 |
Endoscopic and histologic response to cyclosporine in ulcerative colitis and their impact on disease outcome: A cohort study.
Topics: Acute Disease; Administration, Intravenous; Adolescent; Adult; Aged; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Female; France; Humans; Immunosuppressive Agents; Intestinal Mucosa; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Severity of Illness Index; Young Adult | 2016 |
Predominant Neurologic Manifestations Seen in a Patient With a Biallelic Perforin1 Mutation (PRF1; p.R225W).
Topics: Adult; Brain Stem; Child, Preschool; Codon; Cyclosporine; Demyelinating Diseases; Dexamethasone; Exons; Female; Ferritins; Frontal Lobe; Humans; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Magnetic Resonance Imaging; Male; Methotrexate; Movement Disorders; Muscle Weakness; Mutation, Missense; Perforin; Recurrence; Respiratory Tract Infections | 2017 |
Blood concentration of aminothiols in children with relapse of nephrotic syndrome.
Topics: Adolescent; Biomarkers; Biopsy, Needle; Child; Child, Preschool; Chromatography, High Pressure Liquid; Cohort Studies; Cross-Sectional Studies; Cyclosporine; Dipeptides; Disease Progression; Female; Follow-Up Studies; Glutathione; Homocysteine; Humans; Immunohistochemistry; Male; Nephrotic Syndrome; Recurrence; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Sulfhydryl Compounds; Treatment Outcome | 2016 |
Changes in ABCB1 mRNA Expression in Peripheral Blood Cells before and after Renal Transplantation.
Topics: Adult; Aged; ATP Binding Cassette Transporter, Subfamily B; Cyclosporine; Cytomegalovirus Infections; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Leukocytes, Mononuclear; Male; Middle Aged; Recurrence; RNA, Messenger | 2016 |
Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.
Topics: Adolescent; Age Factors; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunologic Factors; Immunosuppressive Agents; Japan; Kaplan-Meier Estimate; Male; Nephrotic Syndrome; Prednisolone; Proportional Hazards Models; Recurrence; Retrospective Studies; Risk Factors; Rituximab; Time Factors; Treatment Outcome | 2017 |
A case of intravenous immunoglobulin-dependent chronic inflammatory demyelinating polyneuropathy of pure motor form responsive to mycophenolate mofetil therapy.
Topics: Aged; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Guillain-Barre Syndrome; Humans; Immunoglobulins, Intravenous; Kidney Diseases; Male; Mycophenolic Acid; Recurrence; Secondary Prevention; Time Factors; Treatment Outcome | 2016 |
Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection.
Topics: Antibodies, Monoclonal; Basiliximab; Biopsy; Cyclosporine; Drug Therapy, Combination; Genotype; Graft Rejection; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Polymerase Chain Reaction; Recombinant Fusion Proteins; Recurrence; Retrospective Studies; RNA, Viral; Survival Rate; Tacrolimus | 2016 |
Example of the drug interaction between ciclosporin and orlistat, resulting in relapse of Evan's syndrome.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Anti-Obesity Agents; Cyclosporine; Drug Interactions; Humans; Immunosuppressive Agents; Lactones; Male; Orlistat; Recurrence; Thrombocytopenia | 2016 |
Diagnosis and management of acquired thrombotic thrombocytopenic purpura in southeast China: a single center experience of 60 cases.
Topics: ADAMTS13 Protein; Adolescent; Adult; Aged; Antibodies, Monoclonal; China; Cyclosporine; Disease Management; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Recurrence; Rituximab; Vincristine; Young Adult | 2016 |
Quiz Page December 2016: Anuria on the Second Day Following Kidney Transplantation.
Topics: Adolescent; Anuria; Cyclosporine; Female; Glomerulosclerosis, Focal Segmental; Graft Rejection; Humans; Immunosorbent Techniques; Immunosuppressive Agents; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Mycophenolic Acid; Plasmapheresis; Postoperative Complications; Prednisolone; Recurrence; Renal Dialysis | 2016 |
Risk Factors of Recurrence of Diabetic Nephropathy in Renal Transplants.
Topics: Adult; Anti-Inflammatory Agents; Biopsy; Cyclosporine; Diabetic Nephropathies; Female; Humans; Immunosuppressive Agents; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prednisone; Recurrence; Retrospective Studies; Risk Factors; Tacrolimus | 2016 |
Successful Preemptive Kidney Transplantation With Rituximab Induction in a Patient With Focal Segmental Glomerulosclerosis and Massive Nephrotic Syndrome: A Case Report.
Topics: Adult; Cyclosporine; Female; Glomerulosclerosis, Focal Segmental; Humans; Immunologic Factors; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Nephrotic Syndrome; Proteinuria; Receptors, Urokinase Plasminogen Activator; Recurrence; Rituximab; Tacrolimus | 2016 |
Risk Factors, Clinical Features, and Treatment Outcomes of Recurrent Mooren Ulcers in China.
Topics: Adult; Aged; Aged, 80 and over; China; Corneal Ulcer; Cyclosporine; Dexamethasone; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Ophthalmologic Surgical Procedures; Recurrence; Retrospective Studies; Risk Factors; Tacrolimus; Treatment Outcome; Visual Acuity; Young Adult | 2017 |
Three patients treated with sofosbuvir plus ledipasvir for recurrent hepatitis C after liver transplantation.
Topics: Aged; Antiviral Agents; Benzimidazoles; Cyclosporine; Drug Interactions; Drug Therapy, Combination; Female; Fluorenes; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Recurrence; RNA, Viral; Sofosbuvir; Viral Load | 2017 |
Successful use of the anti-CD25 antibody daclizumab in an adult patient with hemophagocytic lymphohistiocytosis.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cyclophosphamide; Cyclosporine; Daclizumab; Doxorubicin; Ferritins; Humans; Immunoglobulin G; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Killer Cells, Natural; Lymphohistiocytosis, Hemophagocytic; Lymphoma, Large-Cell, Anaplastic; Male; Middle Aged; Prednisone; Recurrence; T-Lymphocyte Subsets; Vincristine | 2008 |
Clinicopathologic correlation and outcome of C1q nephropathy.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Complement C1q; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Glomerulonephritis, Membranoproliferative; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Immunosuppressive Agents; Infant; Kidney Failure, Chronic; Male; Middle Aged; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisolone; Recurrence; Time Factors; Treatment Outcome; Young Adult | 2008 |
Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine.
Topics: Adolescent; Anemia, Aplastic; Antilymphocyte Serum; Child; Child, Preschool; Cohort Studies; Cyclosporine; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Recurrence; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome | 2008 |
Outcome of treatment of mooren ulcer with topical cyclosporine a 2%.
Topics: Administration, Topical; Adult; Aged; Corneal Ulcer; Cyclosporine; Epithelium, Corneal; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Ophthalmic Solutions; Recurrence; Retrospective Studies; Treatment Outcome; Visual Acuity; Wound Healing | 2008 |
Serpiginous choroiditis.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Choroiditis; Cyclosporine; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Immunosuppressive Agents; Infliximab; Middle Aged; Mycobacterium tuberculosis; Prednisone; Recurrence; Tuberculosis, Gastrointestinal; Tumor Necrosis Factor-alpha | 2008 |
[Mycophenolate mofetil and cyclosporine in the treatment of steroid-dependent nephrotic syndrome with frequent relapses].
Topics: Child; Cyclosporine; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Nephrotic Syndrome; Recurrence; Steroids; Time Factors | 2008 |
Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes.
Topics: Adult; Antilymphocyte Serum; Cyclosporine; Diabetes Mellitus, Type 1; Etanercept; Everolimus; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Middle Aged; Receptors, Tumor Necrosis Factor; Recurrence; Sirolimus; Treatment Outcome; Tumor Necrosis Factor-alpha | 2008 |
Recurrence of hepatitis-associated aplastic anemia after a 10-year interval.
Topics: Adolescent; Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Hepatitis; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Recurrence; Time Factors | 2008 |
Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Behcet Syndrome; Cyclosporine; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Infusions, Intravenous; Methotrexate; Prednisone; Recurrence; Retinal Vasculitis; Retrospective Studies; Treatment Outcome; Visual Acuity; Young Adult | 2008 |
Outcomes of older patients (> or = 60 years) with acquired aplastic anaemia treated with immunosuppressive therapy.
Topics: Aged; Anemia, Aplastic; Animals; Antilymphocyte Serum; Chi-Square Distribution; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Middle Aged; Recurrence; Retrospective Studies; Risk; Treatment Outcome | 2008 |
Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assess
Topics: Adolescent; Adult; Anemia, Aplastic; Child; Child, Preschool; Chimerism; Cyclosporine; Fanconi Anemia; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Male; Middle Aged; Polymerase Chain Reaction; Prognosis; Proportional Hazards Models; Recurrence; Stem Cell Transplantation; Survival Rate; Tandem Repeat Sequences; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2009 |
Immunosuppressive treatment for aplastic anemia: are we hitting the ceiling?
Topics: Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Recurrence; Sirolimus; Treatment Outcome | 2009 |
[Angioimmunoblastic T-cell lymphoma complicated by recurrent drug-induced agranulocytosis].
Topics: Acetaminophen; Aged; Agranulocytosis; Analgesics, Non-Narcotic; Cyclosporine; Humans; Immunoblastic Lymphadenopathy; Immunosuppressive Agents; Lymphoma, T-Cell; Male; Recurrence | 2009 |
Predictive factors of outcome in patients transplanted for hepatitis B.
Topics: Adult; Aged; Cardiovascular Diseases; Cyclosporine; Female; Graft Survival; Hepatitis B; Humans; Immunoglobulins; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Recurrence; Regression Analysis; Risk Factors; Survival Analysis; Survivors; Tacrolimus; Treatment Outcome; Young Adult | 2009 |
Cyclosporine therapy in refractory/relapsed patients with thrombotic thrombocytopenic purpura.
Topics: Cyclosporine; Humans; Immunosuppressive Agents; Purpura, Thrombotic Thrombocytopenic; Recurrence; Remission Induction; Treatment Outcome | 2009 |
Impact of immunosuppressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis.
Topics: Adult; Azathioprine; Cyclosporine; Female; Glomerulonephritis; Hepatitis B Surface Antigens; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Markov Chains; Middle Aged; Monte Carlo Method; Mycophenolic Acid; Recurrence; Risk Factors; Tacrolimus; Transplantation, Homologous; Treatment Failure | 2009 |
Antithymocyte globulin and cyclosporin in children with acquired aplastic anemia.
Topics: Anemia, Aplastic; Antilymphocyte Serum; Child; Cyclosporine; Humans; Immunosuppressive Agents; Platelet Transfusion; Recurrence | 2009 |
Efficacy of cyclosporine A treatment in relapsing febrile lobular panniculitis associated with small vessel vasculitis.
Topics: Biopsy; Blood Vessels; Child; Chronic Disease; Cyclosporine; Humans; Immunosuppressive Agents; Male; Panniculitis, Nodular Nonsuppurative; Recurrence; Skin; Treatment Outcome; Vasculitis | 2010 |
Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation.
Topics: Adult; Aged; Antiviral Agents; Cyclosporine; Female; Hepatitis C; Humans; Immunosuppressive Agents; Liver Failure; Liver Transplantation; Male; Middle Aged; Odds Ratio; Recurrence; Regression Analysis; Tacrolimus; Treatment Outcome | 2009 |
[Neurological symptoms in patient with focal segmental glomerulosclerosis treated with cyclosporin A--case report].
Topics: Biopsy; Brain Diseases; Child; Cyclosporine; Drug Therapy, Combination; Glomerulosclerosis, Focal Segmental; Headache; Hematuria; Humans; Kidney; Male; Methylprednisolone; Nausea; Nephrotic Syndrome; Prednisone; Recurrence | 2009 |
Conjunctival lichen planus in a patient with herpes simplex virus keratitis.
Topics: Administration, Topical; Androstadienes; Cicatrix; Conjunctival Diseases; Cyclosporine; Female; Humans; Keratitis, Herpetic; Lichen Planus; Loteprednol Etabonate; Middle Aged; Ophthalmic Solutions; Recurrence | 2009 |
Growth in boys with idiopathic nephrotic syndrome on long-term cyclosporin and steroid treatment.
Topics: Adult; Body Height; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Growth; Growth Disorders; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Nephrotic Syndrome; Recurrence; Retrospective Studies; Steroids; Time Factors; Treatment Outcome | 2009 |
Role of medical rescue therapy in the management of acute severe ulcerative colitis: the surgical perspective.
Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Colitis, Ulcerative; Colonic Pouches; Cyclosporine; Digestive System Surgical Procedures; Drug Resistance; Gastrointestinal Agents; Humans; Infliximab; Patient Selection; Proctocolectomy, Restorative; Recurrence; Severity of Illness Index; Treatment Outcome | 2009 |
Long-term efficacy and safety of conversion to tacrolimus in heart transplant recipients with ongoing or recurrent acute cellular rejection.
Topics: Acute Disease; Adult; Biopsy; Cyclosporine; Female; Graft Rejection; Graft Survival; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Recurrence; Retrospective Studies; Tacrolimus; Time Factors; Treatment Outcome | 2010 |
De novo phyllodes tumor in an adolescent female after liver transplantation.
Topics: Adolescent; Breast Neoplasms; Cyclosporine; Female; Hepatolenticular Degeneration; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Magnetic Resonance Imaging; Phyllodes Tumor; Recurrence; Remission Induction; Tacrolimus; Ultrasonography | 2011 |
Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Cerebral Hemorrhage; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Male; Meningoencephalitis; Middle Aged; Myeloablative Agonists; Nervous System Diseases; Peripheral Blood Stem Cell Transplantation; Peripheral Nervous System Diseases; Postoperative Complications; Recurrence; Retrospective Studies; Risk Factors; Stroke; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation; Young Adult | 2009 |
Inhibitory effects of cyclosporine on human regulatory T cells in vitro.
Topics: CD4-Positive T-Lymphocytes; Cell Culture Techniques; Cyclosporine; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Hepatitis C; Humans; Immunophenotyping; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Liver Transplantation; Recurrence; T-Lymphocytes, Regulatory | 2009 |
CsA exposure is associated with acute GVHD and relapse in children after SCT.
Topics: Acute Disease; Adolescent; Area Under Curve; Child; Child, Preschool; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Recurrence; Retrospective Studies; Survival Rate; Treatment Outcome | 2010 |
Long-term outcome of focal segmental glomerulosclerosis after pediatric renal transplantation.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Cyclosporine; Disease Progression; Female; Glomerulosclerosis, Focal Segmental; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Male; Methylprednisolone; Nephrectomy; Plasmapheresis; Proteinuria; Recurrence; Risk Factors; Survival Analysis; Treatment Outcome; Young Adult | 2010 |
Successful treatment of collapsing focal segmental glomerulosclerosis with a combination of rituximab, steroids and ciclosporin.
Topics: Administration, Oral; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Child, Preschool; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Edema; Glomerulosclerosis, Focal Segmental; Humans; Hypoalbuminemia; Immunosuppressive Agents; Male; Methylprednisolone; Prednisolone; Proteinuria; Pulse Therapy, Drug; Recurrence; Rituximab; Time Factors; Treatment Outcome | 2010 |
Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine.
Topics: Adolescent; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD19; Child; Child, Preschool; Cyclosporine; Drug Resistance; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infant; Lymphocytes; Male; Nephrosis, Lipoid; Prednisolone; Recurrence; Rituximab; Steroids; Treatment Outcome | 2010 |
Childhood autoimmune liver disease: indications and outcome of liver transplantation.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Child; Cholangitis, Sclerosing; Cyclosporine; Female; Graft Rejection; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver; Liver Failure, Acute; Liver Transplantation; Male; Prothrombin Time; Recurrence; Retrospective Studies; Steroids; Survival Analysis; Survival Rate; Syndrome; Tacrolimus; Treatment Outcome | 2010 |
Intravenous immunoglobulin in recurrent-relapsing inflammatory optic neuropathy.
Topics: Adrenal Cortex Hormones; Adult; Cyclosporine; Female; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Optic Nerve Diseases; Prospective Studies; Recurrence; Treatment Outcome; Visual Acuity; Visual Fields | 2010 |
Cyclosporine A protects against primary biliary cirrhosis recurrence after liver transplantation.
Topics: Adult; Aged; Cyclosporine; Female; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Probability; Recurrence | 2010 |
Reduced intensity conditioning prior to allogeneic stem cell transplantation in first complete remission is effective in patients with acute myeloid leukemia and an intermediate-risk karyotype.
Topics: Adult; Aged; Chromosome Aberrations; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycophenolic Acid; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2010 |
Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients.
Topics: Adolescent; Child; Child, Preschool; Cohort Studies; Cyclosporine; Dose-Response Relationship, Drug; Epstein-Barr Virus Infections; Female; Follow-Up Studies; Heart Transplantation; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Infant; Lymphoproliferative Disorders; Male; Proportional Hazards Models; Recurrence; Risk Assessment; Tacrolimus; Time Factors; Viral Load; Young Adult | 2010 |
Long-term effect of rituximab in maintaining remission of recurrent and plasmapheresis-dependent nephrotic syndrome post-renal transplantation - case report.
Topics: Antibodies, Monoclonal, Murine-Derived; Child; Cyclophosphamide; Cyclosporine; HLA Antigens; Humans; Immunologic Factors; Immunosuppressive Agents; Male; Nephrotic Syndrome; Peritoneal Dialysis; Plasmapheresis; Recurrence; Remission Induction; Rituximab; Time Factors; Treatment Outcome | 2011 |
Kimura's disease: case report of an Italian young male and response to oral cyclosporine A in an 8 years follow-up.
Topics: Administration, Oral; Adult; Angiolymphoid Hyperplasia with Eosinophilia; Cyclosporine; Glucocorticoids; Humans; Immunosuppressive Agents; Lymph Nodes; Male; Prednisone; Recurrence; Treatment Outcome; Withholding Treatment | 2013 |
Cyclosporine A inhibits in vitro replication of betaretrovirus associated with primary biliary cirrhosis.
Topics: Animals; Antiviral Agents; Cell Line, Tumor; Cyclosporine; Dose-Response Relationship, Drug; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Lopinavir; Mammary Tumor Virus, Mouse; Mice; Pyrimidinones; Recurrence; RNA-Directed DNA Polymerase; RNA, Viral; Tacrolimus; Viral Load; Virus Replication | 2010 |
Two distinct FSGS lesions caused by distinct etiology confirmed in a single patient in pre- and post-transplantation.
Topics: Arteriosclerosis; Child, Preschool; Cyclosporine; Glomerulosclerosis, Focal Segmental; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Middle Aged; Nephrotic Syndrome; Proteinuria; Recurrence; Treatment Outcome; Vesico-Ureteral Reflux | 2010 |
Pyodermatitis-pyostomatitis vegetans after subtotal colectomy for ulcerative colitis.
Topics: Azathioprine; Colectomy; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Diagnosis, Differential; Female; Humans; Mesalamine; Middle Aged; Prednisolone; Pyoderma; Recurrence; Stomatitis; Treatment Outcome | 2010 |
Impact of recipient statin treatment on graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Topics: Adult; Aged; Chronic Disease; Cyclosporine; Drug Interactions; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Incidence; Male; Middle Aged; Recurrence; Retrospective Studies; Risk; T-Lymphocytes; Transplantation, Homologous; Young Adult | 2010 |
Posterior reversible encephalopathy syndrome.
Topics: Child; Child, Preschool; Cyclosporine; Female; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Posterior Leukoencephalopathy Syndrome; Recurrence; Risk Factors | 2010 |
Case report: successful use of short-term add-on tocilizumab for multirefractory systemic flare of adult-onset Still's disease.
Topics: Antibodies, Monoclonal, Humanized; Cyclosporine; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Methylprednisolone; Middle Aged; Prednisolone; Pulse Therapy, Drug; Recurrence; Remission Induction; Still's Disease, Adult-Onset; Tacrolimus | 2013 |
Is there a role for autologous stem cell transplantation for patients with acute myelogenous leukemia? A retrospective analysis.
Topics: Adult; Antibodies, Monoclonal; Antigens, CD; Antigens, Neoplasm; CD52 Antigen; Chromosome Aberrations; Cyclosporine; Disease-Free Survival; Female; Glycoproteins; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Karyotyping; Leukemia, Myeloid, Acute; Male; Recurrence; Retrospective Studies; Risk Factors; Siblings; South Africa; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome | 2011 |
Fundus autofluorescence and spectral domain optical coherence tomography in recurrent serpiginous choroiditis: case report.
Topics: Adult; Anti-Inflammatory Agents; Choroiditis; Cyclosporine; Female; Fluorescence; Fundus Oculi; Humans; Prednisone; Recurrence; Retinal Pigment Epithelium; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2011 |
Clinical evaluation of chronic nephrotoxicity of long-term cyclosporine A treatment in adult patients with steroid-dependent nephrotic syndrome.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Analysis of Variance; Biomarkers; Blood Pressure; Cyclosporine; Drug Administration Schedule; Female; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Humans; Japan; Kidney; Magnesium; Male; Middle Aged; Nephrotic Syndrome; Recurrence; Time Factors; Treatment Outcome; Young Adult | 2011 |
Single daily high-dose mizoribine therapy for children with steroid-dependent nephrotic syndrome prior to cyclosporine administration.
Topics: Child; Child, Preschool; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Infant; Japan; Male; Nephrotic Syndrome; Recurrence; Ribonucleosides; Steroids; Time Factors; Treatment Outcome | 2011 |
[Long-term outcome of children treated with the ISKDC regimen for the first episode of INS].
Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Infant; Kidney; Male; Nephrotic Syndrome; Practice Guidelines as Topic; Prednisolone; Prognosis; Recurrence; Retrospective Studies; Time Factors | 2010 |
Giant cell hepatitis with autoimmune hemolytic anemia in early childhood: long-term outcome in 16 children.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Bilirubin; Coombs Test; Cyclosporine; Female; Follow-Up Studies; gamma-Globulins; Giant Cells; Glucocorticoids; Hepatitis; Hepatocytes; Hepatomegaly; Humans; Immunologic Factors; Immunosuppressive Agents; Infant; Jaundice; Liver; Liver Transplantation; Male; Multiple Organ Failure; Prednisone; Recurrence; Remission Induction; Rituximab; Sepsis; Splenectomy; Splenomegaly; Transaminases; Treatment Outcome | 2011 |
Relapse of aplastic anemia in children after immunosuppressive therapy: a report from the Japan Childhood Aplastic Anemia Study Group.
Topics: Adolescent; Anemia, Aplastic; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Infant; Infant, Newborn; Japan; Male; Prospective Studies; Recurrence; Risk Factors | 2011 |
Relapse of aplastic anemia responsive to sirolimus combined with cyclosporine.
Topics: Anemia, Aplastic; Antilymphocyte Serum; Child; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Recurrence; Sirolimus; Treatment Outcome | 2011 |
University of Modena experience in HIV-positive patients undergoing liver transplantation.
Topics: Adult; Antiretroviral Therapy, Highly Active; Carcinoma, Hepatocellular; CD4 Lymphocyte Count; Cyclosporine; Drug Substitution; End Stage Liver Disease; Female; Graft Rejection; Graft Survival; Hepatitis C, Chronic; HIV; HIV Infections; Hospitals, University; Humans; Immunosuppressive Agents; Italy; Kaplan-Meier Estimate; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Recurrence; RNA, Viral; Severity of Illness Index; Sirolimus; Tacrolimus; Time Factors; Treatment Outcome; Viral Load | 2011 |
Hot topic in hepatitis C virus research: the type of immunosuppression does not matter.
Topics: Antiviral Agents; Calcineurin Inhibitors; Cyclosporine; Graft Rejection; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Liver Transplantation; Mycophenolic Acid; Receptors, Interleukin-2; Recurrence; Risk Factors; Tacrolimus; TOR Serine-Threonine Kinases | 2011 |
Ulcerative colitis: Rescue immune suppression for severe colitis--worth the risk?
Topics: Antibodies, Monoclonal; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Infliximab; Recurrence; Severity of Illness Index; Treatment Outcome | 2011 |
[Acute lymphoblastic leukemia complicated with varicella zoster virus meningoencephalitis and visceral dissemination after related bone marrow transplantation].
Topics: Acute Kidney Injury; Acyclovir; Adult; Antiviral Agents; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Encephalitis, Varicella Zoster; Graft vs Host Disease; Herpesvirus 3, Human; Humans; Immunosuppressive Agents; Male; Pneumonia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Time Factors; Virus Activation | 2011 |
T-cell depletion in GVHD: less is more?
Topics: Adolescent; Adult; Antilymphocyte Serum; Chronic Disease; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Recurrence; Survival Rate; Time Factors; Transplantation Conditioning; Transplantation, Homologous | 2011 |
Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome.
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal, Murine-Derived; Cyclosporine; Humans; Immunologic Factors; Immunosuppressive Agents; Male; Nephrosis, Lipoid; Prednisolone; Recurrence; Remission Induction; Rituximab; Time Factors; Treatment Outcome | 2011 |
Hot-topic debate on hepatitis C virus: the type of immunosuppression matters.
Topics: Adrenal Cortex Hormones; Calcineurin Inhibitors; Cyclosporine; Graft Rejection; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Liver Transplantation; Mycophenolic Acid; Recurrence; Risk Factors; Sirolimus | 2011 |
Methotrexate dose delivery is more important than ciclosporin level in graft-versus-host disease prophylaxis following T-replete reduced-intensity sibling allogeneic stem cell transplant.
Topics: Adult; Aged; Cause of Death; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Recurrence; Siblings; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2011 |
Triple therapy with single daily dose of cyclosporine in Japanese patients with idiopathic membranous nephropathy.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Biopsy; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immunosuppressive Agents; Incidence; Japan; Kidney; Male; Middle Aged; Prednisolone; Prospective Studies; Recurrence; Retrospective Studies; Treatment Outcome | 2011 |
Selective modulation of nuclear factor of activated T-cell function in restenosis by a potent bipartite peptide inhibitor.
Topics: Amino Acid Motifs; Animals; Apolipoproteins E; Calcineurin; Carotid Artery Injuries; Carotid Artery, Common; Carotid Stenosis; Cell Proliferation; Chlorocebus aethiops; COS Cells; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; HEK293 Cells; Humans; Hyperplasia; Immunosuppressive Agents; Jurkat Cells; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Molecular; Molecular Structure; Mutagenesis, Site-Directed; NFATC Transcription Factors; Peptides; Peritonitis; Recurrence; Signal Transduction; Structure-Activity Relationship; T-Lymphocytes; Transfection | 2012 |
Good response to infliximab in a patient with deep vein thrombosis associated with Behçet disease.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Azathioprine; Behcet Syndrome; Cyclosporine; Drug Resistance; Drug Substitution; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Recurrence; Treatment Outcome; Venous Thrombosis | 2012 |
Excellent outcome of matched unrelated donor transplantation in paediatric aplastic anaemia following failure with immunosuppressive therapy: a United Kingdom multicentre retrospective experience.
Topics: Adolescent; Anemia, Aplastic; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Kaplan-Meier Estimate; Male; Opportunistic Infections; Recurrence; Retrospective Studies; Transplantation Chimera; Transplantation Conditioning; Treatment Failure; Treatment Outcome; Unrelated Donors | 2012 |
Radiation-free allogeneic conditioning with fludarabine, carmustine, and thiotepa for acute lymphoblastic leukemia and other hematologic malignancies necessitating enhanced central nervous system activity.
Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal, Humanized; Carmustine; Central Nervous System; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Survival Analysis; Thiotepa; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2012 |
Multicenter experience using total lymphoid irradiation and antithymocyte globulin as conditioning for allografting in hematological malignancies.
Topics: Adult; Aged; Antilymphocyte Serum; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility; HLA Antigens; Humans; Male; Middle Aged; Mycophenolic Acid; Recurrence; Severity of Illness Index; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2012 |
Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome.
Topics: Adolescent; Chi-Square Distribution; Child; Child, Preschool; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Prospective Studies; Recurrence; Remission Induction; Tacrolimus; Time Factors; Treatment Outcome | 2012 |
A case of adult-onset Still's disease complicated by hemophagocytic syndrome and interstitial pneumonia with pneumomediastinum/recurrent pneumothorax.
Topics: Antirheumatic Agents; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Lung Diseases, Interstitial; Lymphohistiocytosis, Hemophagocytic; Mediastinal Emphysema; Middle Aged; Pneumothorax; Prednisolone; Recurrence; Still's Disease, Adult-Onset; Thoracic Surgical Procedures; Treatment Outcome | 2012 |
Practical management of boceprevir and immunosuppressive therapy in liver transplant recipients with hepatitis C virus recurrence.
Topics: Aged; Antiviral Agents; Cyclosporine; Disease Management; Drug Therapy, Combination; Everolimus; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Proline; Recombinant Proteins; Recurrence; Ribavirin; Sirolimus; Tacrolimus; Viral Load | 2012 |
The immunosuppressant cyclosporin A inhibits recurrent seizures in an experimental model of temporal lobe epilepsy.
Topics: 4-Aminopyridine; Animals; Cyclosporine; Electroencephalography; Epilepsy, Temporal Lobe; Hippocampus; Immunosuppressive Agents; In Vitro Techniques; Kainic Acid; Male; Mice; Mice, Inbred C57BL; Recurrence; Seizures | 2012 |
Low-density lipoprotein apheresis therapy for steroid- and cyclosporine-resistant idiopathic membranous nephropathy.
Topics: Adult; Aged; Blood Component Removal; Cyclosporine; Drug Resistance; Female; Glomerulonephritis, Membranous; Humans; Lipoproteins, LDL; Male; Recurrence; Steroids; Treatment Outcome; Water-Electrolyte Balance | 2012 |
Readministration of calcineurin inhibitors for ulcerative colitis.
Topics: Adolescent; Adult; Aged; Calcineurin Inhibitors; Child; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Recurrence; Tacrolimus; Treatment Outcome; Young Adult | 2012 |
Cyclosporine A and reduced-intensity conditioning allogeneic stem cell transplantation for relapsed angioimmunoblastic T cell lymphoma with hemophagocytic syndrome.
Topics: Cyclosporine; Female; Humans; Immunoblastic Lymphadenopathy; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Lymphoma, T-Cell; Middle Aged; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Recurrence; Transplantation Conditioning; Transplantation, Homologous | 2012 |
Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome.
Topics: Adolescent; Antibodies, Monoclonal, Murine-Derived; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Drug Resistance; Female; Humans; Immunologic Factors; Immunosuppressive Agents; Infant; Japan; Kaplan-Meier Estimate; Male; Nephrotic Syndrome; Patient Satisfaction; Prednisolone; Recurrence; Retrospective Studies; Rituximab; Surveys and Questionnaires | 2013 |
The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Animals; Antilymphocyte Serum; Clonal Evolution; Cyclosporine; Drug Evaluation; Female; Horses; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kaplan-Meier Estimate; Lymphocyte Count; Male; Middle Aged; Rabbits; Recurrence; Republic of Korea; Retrospective Studies; Species Specificity; T-Lymphocytes; Treatment Outcome; Young Adult | 2013 |
Conversion of cyclosporine to tacrolimus for refractory or persistent myocardial rejection.
Topics: Blood Pressure; Cholesterol; Creatinine; Cyclosporine; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Recurrence; Retrospective Studies; Tacrolimus | 2002 |
Recurrent acute myositis after allogeneic bone marrow transplantation for myelodysplasia.
Topics: Bone Marrow Transplantation; Cyclosporine; Female; Humans; Immune System; Leukemia, Myeloid, Acute; Middle Aged; Myositis; Neural Tube Defects; Recurrence; Transplantation, Homologous | 2002 |
Iatrogenesis or bad luck? relapse of an LMP1-positive follicular lymphoma after immunosuppression for hepatitis-associated aplastic anaemia.
Topics: Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Fatal Outcome; Hepatitis, Viral, Human; Herpesvirus 4, Human; Humans; Iatrogenic Disease; Immunosuppression Therapy; Lymphoma, Follicular; Male; Middle Aged; Recurrence; Skin Neoplasms; Viral Matrix Proteins; Virus Activation | 2002 |
Nephrotoxic acute renal failure in a renal transplant patient with recurrent lymphocele treated with povidone-iodine irrigation.
Topics: Acute Kidney Injury; Adult; Cyclosporine; Diagnosis, Differential; Drainage; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphocele; Povidone-Iodine; Recurrence; Renal Dialysis; Therapeutic Irrigation | 2002 |
Prevalence of arterial hypertension and its morbidity in children and adolescents 3 years after renal transplantation with mycophenolate mofetil-based immunosuppression.
Topics: Adolescent; Antihypertensive Agents; Azathioprine; Child; Cyclosporine; Graft Rejection; Humans; Hypertension; Immunosuppression Therapy; Kidney Transplantation; Morbidity; Mycophenolic Acid; Prevalence; Recurrence; Retrospective Studies | 2002 |
Risk factors for late kidney allograft failure.
Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Cyclosporine; Female; Glomerulonephritis; Graft Survival; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Transplantation, Homologous; Treatment Failure | 2002 |
Recurrent graft pancreatitis in a pancreatico-renal allograft recipient does not affect endocrine function.
Topics: Adult; Chronic Disease; Cyclosporine; Humans; Immunosuppressive Agents; Islets of Langerhans; Kidney Transplantation; Male; Pancreas Transplantation; Pancreatitis; Postoperative Complications; Recurrence | 2002 |
Late response to cyclosporine in refractory thrombotic thrombocytopenic purpura.
Topics: Adult; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Recurrence; Steroids; Treatment Outcome | 2002 |
Significance of mycophenolate mofetil treatment in patients with HCV reinfection after liver transplantation: impact on clinical course and histologic damage.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Mycophenolic Acid; Recurrence; Retrospective Studies; Tacrolimus; Viral Load | 2002 |
Azathioprine without oral ciclosporin in the long-term maintenance of remission induced by intravenous ciclosporin in severe, steroid-refractory ulcerative colitis.
Topics: Administration, Oral; Adult; Azathioprine; Colectomy; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Prednisolone; Recurrence; Remission Induction; Treatment Outcome | 2002 |
A case of chronic renal allograft failure by effects of elderly donor.
Topics: Adult; Age Factors; Aged; Cyclosporine; Glomerulonephritis, IGA; Graft Rejection; Humans; Kidney Transplantation; Male; Postoperative Complications; Recurrence; Risk Factors; Tissue Donors; Transplantation, Homologous | 2002 |
G-CSF-primed haploidentical marrow transplantation without ex vivo T cell depletion: an excellent alternative for high-risk leukemia.
Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow; Cell Lineage; Child; Cyclosporine; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Haplotypes; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Lenograstim; Leukemia; Life Tables; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Recombinant Proteins; Recurrence; Risk Factors; Survival Analysis; T-Lymphocytes; Treatment Outcome | 2002 |
A study of clinical characteristics and treatment of Mooren's ulcer.
Topics: Adolescent; Adult; Aged; Combined Modality Therapy; Corneal Transplantation; Corneal Ulcer; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Recurrence; Visual Acuity | 1998 |
Reduced-intensity bone marrow transplantation from an alternative unrelated donor for myelodysplastic syndrome of first-donor origin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Myelodysplastic Syndromes; Recurrence; Remission Induction; Tissue Donors; Transplantation Chimera; Transplantation Conditioning | 2003 |
Monitoring of donor cell chimerism for the detection of relapse and early immunotherapeutic intervention in acute lymphoblastic leukemias.
Topics: Child; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Graft vs Leukemia Effect; Humans; Immunosuppressive Agents; Immunotherapy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Stem Cell Transplantation; Transplantation Chimera; Transplantation, Homologous | 2002 |
Comparison of tacrolimus with cyclosporin as primary immunosuppression in patients with hepatitis C virus infection after liver transplantation.
Topics: Cyclosporine; Female; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Retrospective Studies; Tacrolimus | 2003 |
Efficacy of mycophenolate mofetil on recurrent glomerulonephritis after renal transplantation.
Topics: Adult; Aged; Cyclosporine; Drug Therapy, Combination; Female; Glomerulonephritis; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Recurrence | 2003 |
[Complicated ulcerative colitis].
Topics: Adult; Anti-Bacterial Agents; Biological Factors; Colitis, Ulcerative; Colonic Pouches; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Humans; Hydrocortisone; Immunosuppressive Agents; Male; Patient Care Team; Prednisolone; Pulse Therapy, Drug; Recurrence; Treatment Refusal | 2003 |
Induction of complete remission of hypoplastic leukemia with antithymocyte globulin.
Topics: Adolescent; Anemia, Aplastic; Antilymphocyte Serum; Apoptosis; Bone Marrow Examination; Cyclosporine; Diagnosis, Differential; Etoposide; Humans; Leukemia; Male; Pancytopenia; Recurrence; Remission Induction | 2003 |
Prolonged cyclosporin-A treatment for severe chronic urticaria.
Topics: Chronic Disease; Cyclosporine; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Recurrence; Severity of Illness Index; Urticaria | 2003 |
The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation.
Topics: Adult; Aged; Bile Ducts; Cyclosporine; Female; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Recurrence; Tacrolimus | 2003 |
Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Child; Child, Preschool; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Survival Analysis; Thalidomide; Transplantation, Homologous | 2003 |
[Pyoderma gangrenosum and orbital pseudotumor].
Topics: Aged; Anti-Bacterial Agents; Biopsy; Cyclosporine; Disease Progression; Doxycycline; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Orbit; Orbital Pseudotumor; Postoperative Complications; Prednisolone; Pyoderma Gangrenosum; Recurrence; Scalp; Skin; Wound Healing | 2003 |
Post-operative conversion from cyclosporine to tacrolimus in heart transplantation: a single-center experience.
Topics: Adult; Biomarkers; Blood Glucose; Blood Pressure; California; Cholesterol; Creatinine; Cyclosporine; Diastole; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Ischemia; Postoperative Care; Postoperative Complications; Recurrence; Steroids; Survival Analysis; Systole; Tacrolimus; Time Factors; Treatment Outcome | 2003 |
Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation.
Topics: Adult; Aged; Cyclosporine; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Interferon-alpha; Kidney Transplantation; Leukocytes, Mononuclear; Liver; Male; Middle Aged; Recurrence; Renal Dialysis; RNA; RNA, Viral | 2003 |
Acute headache as a presenting symptom of tacrolimus encephalopathy.
Topics: Acute Disease; Adult; Brain; Brain Diseases; Cyclosporine; Cystic Fibrosis; Diagnosis, Differential; Drug Therapy, Combination; Female; Headache; Humans; Image Enhancement; Immunosuppressive Agents; Lung Transplantation; Magnetic Resonance Imaging; Neurologic Examination; Postoperative Complications; Prednisone; Recurrence; Tacrolimus | 2003 |
Long-term outcome of live donor kidney transplantation for renal amyloidosis.
Topics: Adolescent; Adult; Amyloidosis; Cyclosporine; Familial Mediterranean Fever; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Hypertension; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Life Tables; Male; Middle Aged; Recurrence; Treatment Outcome | 2003 |
Mylotarg, fludarabine, cytarabine (ara-C), and cyclosporine (MFAC) regimen as post-remission therapy in acute myelogenous leukemia.
Topics: Acute Disease; Adult; Aged; Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Cytarabine; Female; Gemtuzumab; Humans; Leukemia, Myeloid; Male; Middle Aged; Recurrence; Remission Induction; Vidarabine | 2003 |
[Successful treatment of bronchiolitis obliterans organizing pneumonia with cyclosporin and steroids].
Topics: Aged; Anti-Inflammatory Agents; Cryptogenic Organizing Pneumonia; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lung; Prednisolone; Recurrence; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
Acute posterior leukoencephalopathy in a patient with nephrotic syndrome.
Topics: Brain Diseases; Cyclosporine; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Nephrotic Syndrome; Occipital Lobe; Parietal Lobe; Prednisolone; Proteinuria; Recurrence; Tomography, X-Ray Computed | 2003 |
[An analysis of relapse and risk factors of autoimmune hemolytic anemia and Evans syndrome].
Topics: Adolescent; Adult; Aged; Anemia, Hemolytic, Autoimmune; Autoantibodies; Child; Cyclosporine; Female; Humans; Male; Middle Aged; Prednisone; Recurrence; Risk Factors; Syndrome; Thrombocytopenia | 2003 |
Effect of a drug combination treatment on ocular perfusion in recurrent idiopathic intermediate uveitis.
Topics: Adult; Blood Flow Velocity; Ciliary Arteries; Cortisone; Cyclosporine; Drug Therapy, Combination; Eye; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Ophthalmic Artery; Perfusion; Prospective Studies; Recurrence; Regional Blood Flow; Retinal Artery; Ultrasonography, Doppler, Color; Uveitis, Intermediate; Visual Acuity | 2003 |
A prospective cross-over study comparing the effect of mycophenolate versus azathioprine on allograft function and viral load in liver transplant recipients with recurrent chronic HCV infection.
Topics: Azathioprine; Creatinine; Cross-Over Studies; Cyclosporine; Female; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Recurrence; Viral Load | 2004 |
Acquired amegakaryocytic thrombocytopenia purpura and eosinophilic fasciitis: a long relapsing and remitting course.
Topics: Antilymphocyte Serum; Bone Marrow; Cyclosporine; Eosinophilia; Fasciitis; Humans; Immunosuppressive Agents; Male; Megakaryocytes; Middle Aged; Platelet Count; Purpura, Thrombocytopenic; Recurrence | 2004 |
Recurrence of severe steroid dependency in cyclosporin A-treated childhood idiopathic nephrotic syndrome.
Topics: Adrenal Cortex Hormones; Child; Child, Preschool; Cyclosporine; Follow-Up Studies; Humans; Immunosuppressive Agents; Infant; Nephrotic Syndrome; Recurrence; Substance-Related Disorders; Time Factors | 2004 |
Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate.
Topics: Adult; Aged; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Graft vs Leukemia Effect; Histocompatibility Testing; Humans; Male; Methotrexate; Middle Aged; Recurrence | 2004 |
Long-term efficacy of oral microemulsion cyclosporin for refractory ulcerative colitis.
Topics: Administration, Oral; Azathioprine; Colitis, Ulcerative; Cyclosporine; Emulsions; Female; Humans; Immunosuppressive Agents; Male; Recurrence | 2004 |
Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation.
Topics: Adult; Aged; Calcineurin; Cyclosporine; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Recurrence; Tacrolimus | 2004 |
Quality of life improvement in treatment of psoriasis with intermittent short course cyclosporin (Neoral).
Topics: Adolescent; Adult; Chronic Disease; Cyclosporine; Dermatologic Agents; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Psoriasis; Quality of Life; Recurrence; Severity of Illness Index; Sickness Impact Profile; Treatment Outcome; United Kingdom | 2004 |
Healing of severe ulcerative necrobiosis lipoidica with cyclosporin.
Topics: Cyclosporine; Dermatologic Agents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Middle Aged; Necrobiosis Lipoidica; Recurrence; Skin Ulcer; Wound Healing | 2004 |
Restoration of immunity and reactivation of hepatitis B virus after immunosuppressive therapy in a patient with severe aplastic anaemia.
Topics: Adult; Anemia, Aplastic; Antilymphocyte Serum; Antiviral Agents; Carrier State; Cyclosporine; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Lamivudine; Male; Recurrence | 2004 |
Single-dose daily administration of cyclosporin A for relapsing nephrotic syndrome.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Drug Administration Schedule; Humans; Male; Nephrotic Syndrome; Pilot Projects; Prospective Studies; Recurrence | 2004 |
Review of 26 cases of classical pyoderma gangrenosum: clinical and therapeutic features.
Topics: Adolescent; Adult; Aged; Cyclosporine; Female; Humans; Immunosuppressive Agents; Incidence; Male; Medical Records; Middle Aged; Pyoderma Gangrenosum; Recurrence; Retrospective Studies; Spain | 2004 |
[Calcineurin-inhibitor-free immunosuppression in early renal transplantation].
Topics: Adult; Calcineurin Inhibitors; Comorbidity; Cyclosporine; Drug Therapy, Combination; Fever; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Male; Mycophenolic Acid; Prednisone; Pyelonephritis; Recurrence; Sirolimus; Ureteral Diseases; Urinary Bladder Fistula; Urinary Fistula | 2004 |
[Steroid-responsive nephrotic syndrome in IgA nephropathy].
Topics: Biopsy; Cyclophosphamide; Cyclosporine; Diabetes Mellitus; Drug Therapy, Combination; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Male; Middle Aged; Nephrotic Syndrome; Osteoporosis; Prednisone; Proteinuria; Recurrence | 2004 |
[Idiopathic membranous nephropathy associated with anti-calcineurin toxicity. Prognosis and other immunosuppressive treatments].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcineurin Inhibitors; Calcium Channel Blockers; Creatinine; Cyclosporine; Drug Therapy, Combination; Glomerulonephritis, Membranous; Humans; Hypercholesterolemia; Hypertension; Hypolipidemic Agents; Immunosuppressive Agents; Kidney Diseases; Lisinopril; Lovastatin; Male; Nephrotic Syndrome; Prednisone; Recurrence; Verapamil | 2004 |
Cyclosporin for severe ulcerative colitis attacks.
Topics: Administration, Oral; Adolescent; Adult; Colectomy; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome | 2003 |
Joint lavage for treating recurrent knee involvement in patients with juvenile idiopathic arthritis.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Azathioprine; Child; Clinical Trials as Topic; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections, Intra-Articular; Knee Joint; Male; Methotrexate; Recurrence; Retrospective Studies; Therapeutic Irrigation; Treatment Outcome | 2004 |
[Ulcerative colitis. Acute episode].
Topics: Acute Disease; Administration, Oral; Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Mesalamine; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Time Factors | 2004 |
Recurrent infusion phlebitis induced by cyclosporine.
Topics: Adult; Anti-Inflammatory Agents; Colitis, Ulcerative; Cyclosporine; Humans; Hydrocortisone; Immunosuppressive Agents; Infusions, Intravenous; Male; Phlebitis; Recurrence | 2004 |
Gamma/delta T-cell lymphoma as a recurrent complication after transplantation.
Topics: Adolescent; Cyclosporine; Disease-Free Survival; Female; Humans; Immunoglobulins; Immunohistochemistry; Immunophenotyping; Immunosuppressive Agents; Infant; Liver Transplantation; Lymphoma, T-Cell; Prednisone; Receptors, Antigen, T-Cell; Receptors, Antigen, T-Cell, gamma-delta; Recurrence; Time Factors; Treatment Outcome | 2004 |
[Immunological aspects of corneal graft rejection and own experience in immunosuppressive therapy in high risk patients].
Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Child; Corneal Transplantation; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Recurrence; Retrospective Studies; Risk Assessment; Visual Acuity | 2004 |
Intermittent oral cyclosporin for recurrent herpes simplex-associated erythema multiforme.
Topics: Administration, Oral; Adult; Cyclosporine; Drug Administration Schedule; Erythema Multiforme; Herpes Simplex; Humans; Immunosuppressive Agents; Male; Recurrence | 2005 |
Cyclosporine treatment of anal furunculosis in 26 dogs.
Topics: Animals; Anus Diseases; Cyclosporine; Dog Diseases; Dogs; Female; Furunculosis; Immunosuppressive Agents; Male; Recurrence; Severity of Illness Index; Time Factors; Treatment Outcome | 2005 |
Recurrent colonization of successively implanted tracheoesophageal vocal prostheses by a member of the Fusarium solani species complex.
Topics: Aged; Culture Media; Cyclosporine; DNA, Fungal; Fusarium; Humans; Larynx, Artificial; Male; Molecular Sequence Data; Mycoses; Phylogeny; Prostheses and Implants; Recurrence; Sequence Analysis, DNA | 2005 |
Development of ulcerative colitis after heart transplantation during immunosuppressive therapy.
Topics: Biopsy; Colectomy; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Disease Progression; Heart Failure; Heart Transplantation; Humans; Ileostomy; Immunosuppressive Agents; Intestinal Mucosa; Long-Term Care; Male; Middle Aged; Polymerase Chain Reaction; Postoperative Complications; Predictive Value of Tests; Prednisolone; Recurrence; Reoperation | 2005 |
The use of cyclosporine in a boy with a prior episode of posterior encephalopathy.
Topics: Anti-Inflammatory Agents; Child; Cyclosporine; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Nephrotic Syndrome; Neurotoxicity Syndromes; Prednisolone; Recurrence; Remission Induction | 2005 |
Pregnancy improves neutropenia in T-cell large granular lymphocyte leukaemia.
Topics: Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Leukemia, Prolymphocytic, T-Cell; Leukocyte Count; Neutropenia; Pregnancy; Pregnancy Complications, Neoplastic; Progesterone; Recurrence; Retrospective Studies | 2005 |
Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Busulfan; Cohort Studies; Comorbidity; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Methylprednisolone; Middle Aged; Mycophenolic Acid; Patient Selection; Postoperative Complications; Recurrence; Renal Dialysis; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2005 |
Unusual post-transplantation recurrence of focal segmental glomerulosclerosis which resolved with cyclosporine but not with sirolimus.
Topics: Adult; Cyclosporine; Drug Resistance; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Recurrence; Retreatment; Sirolimus; Treatment Outcome | 2005 |
Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation.
Topics: Adult; Age Factors; Aged; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Graft Survival; Hepatitis C; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Recurrence; Tacrolimus | 2005 |
Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease.
Topics: Adolescent; Adult; Aged; Bone Marrow Transplantation; CD3 Complex; Child; Chimerism; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cells; Humans; Leukemia; Leukocytes; Lymphocytes; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Recurrence; Risk; Stem Cell Transplantation; Time Factors; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2005 |
Cyclosporine A and mycophenolate mofetil vs cyclosporine A and methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblings.
Topics: Adolescent; Adult; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Leukemia; Living Donors; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myelodysplastic Syndromes; Recurrence; Retrospective Studies; Siblings; Stem Cell Transplantation; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2005 |
Complete remission of post-transplant FSGS recurrence by long-term plasmapheresis.
Topics: Administration, Oral; Child; Cyclophosphamide; Cyclosporine; Dose-Response Relationship, Drug; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Injections, Intravenous; Kidney Transplantation; Male; Plasmapheresis; Recurrence; Remission Induction; Severity of Illness Index; Time Factors | 2005 |
Effects of calcineurin inhibitors on an in vitro assay for chronic urticaria.
Topics: Basophils; Calcineurin Inhibitors; Cells, Cultured; Chronic Disease; Complement C5a; Cyclosporine; Diphenhydramine; Dose-Response Relationship, Immunologic; Histamine H1 Antagonists; Histamine Release; Humans; Hydroxyzine; Immunoglobulin G; Immunosuppressive Agents; Leukocytes; Methotrexate; Recurrence; Tacrolimus; Urticaria | 2005 |
The impact of cyclosporin A on acute graft-versus-host disease after allogeneic bone marrow transplantation in children and adolescents with acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Graft vs Leukemia Effect; Humans; Immunosuppressive Agents; Infant; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Transplantation, Homologous | 2005 |
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting.
Topics: Amantadine; Antiviral Agents; Azathioprine; Cyclosporine; Female; Hepatitis C; Humans; Immunosuppressive Agents; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Recurrence; Reproducibility of Results; RNA, Viral; Treatment Failure; Viral Load | 2005 |
Lipopolysaccharide injection induces relapses of experimental autoimmune encephalomyelitis in nontransgenic mice via bystander activation of autoreactive CD4+ cells.
Topics: Amino Acid Sequence; Animals; Antigens, CD; B7-1 Antigen; B7-2 Antigen; Bystander Effect; CD4-Positive T-Lymphocytes; Cell Communication; Cells, Cultured; Cyclosporine; Encephalomyelitis, Autoimmune, Experimental; Injections, Intravenous; Lipopolysaccharides; Lymphocyte Activation; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Molecular Sequence Data; Recurrence; Salmonella typhimurium; T-Lymphocytes, Helper-Inducer | 2005 |
Oral mizoribine pulse therapy for patients with steroid-resistant and frequently relapsing steroid-dependent nephrotic syndrome.
Topics: Administration, Oral; Anti-Inflammatory Agents; Child; Child, Preschool; Cyclosporine; Drug Resistance; Female; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Prednisolone; Recurrence; Ribonucleosides | 2005 |
Cyclosporine controls epidermolysis bullosa acquisita co-occurring with acquired factor VIII deficiency.
Topics: Adult; Cyclosporine; Dose-Response Relationship, Drug; Epidermolysis Bullosa; Hemophilia A; Humans; Immunosuppressive Agents; Male; Recurrence; Treatment Outcome | 2005 |
Recurrence of nephrotic syndrome after renal transplantation: influence of increased immunosuppression.
Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Kidney Transplantation; Male; Methylprednisolone; Nephrotic Syndrome; Postoperative Complications; Prednisone; Proteinuria; Recurrence; Remission Induction; Retrospective Studies; Time Factors; Treatment Outcome | 2005 |
[Treatment guidelines for the idiopathic nephrotic syndrome in children].
Topics: Child; Clinical Trials as Topic; Cyclophosphamide; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Immunosuppressive Agents; Methylprednisolone; Nephrotic Syndrome; Prednisolone; Pulse Therapy, Drug; Recurrence; Ribonucleosides | 2005 |
Aplastic anemia: management of adult patients.
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Bone Transplantation; Child; Cyclosporine; Female; Hepatitis; Humans; Immunosuppressive Agents; Incidence; Middle Aged; Patient Selection; Pregnancy; Pregnancy Complications; Recurrence; Salvage Therapy; Severity of Illness Index; Transplantation, Homologous; Young Adult | 2005 |
[Recurrent Impetigo Herpetiformis: successfully managed with ciclosporine. Report of one case].
Topics: Adult; Cyclosporine; Dermatitis Herpetiformis; Dermatologic Agents; Female; Humans; Impetigo; Pregnancy; Pregnancy Complications, Infectious; Recurrence | 2005 |
The challenge of progressive hepatitis C following liver transplantation.
Topics: Cyclosporine; Disease Progression; Graft Rejection; Graft Survival; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; In Vitro Techniques; Liver Failure; Liver Transplantation; Postoperative Complications; Recurrence; Sensitivity and Specificity | 2006 |
Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression.
Topics: Adult; Aged; Biopsy; Cohort Studies; Cyclosporine; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver; Liver Transplantation; Male; Middle Aged; Prednisone; Recurrence; Severity of Illness Index; Steroids; Tacrolimus; Time Factors; Treatment Outcome | 2006 |
Immunosuppression and outcomes of patients transplanted for hepatitis C.
Topics: Adrenal Cortex Hormones; Cyclosporine; Hepacivirus; Hepatitis C; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver; Liver Transplantation; Muromonab-CD3; Mycophenolic Acid; Recurrence; RNA, Messenger; RNA, Viral; Tacrolimus; Treatment Outcome | 2006 |
Recurrence of proteinuria following renal transplantation in congenital nephrotic syndrome of the Finnish type.
Topics: Albumins; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Autoantibodies; Capillary Permeability; Cyclophosphamide; Cyclosporine; Daclizumab; Humans; Hypoalbuminemia; Immunoglobulin G; Immunosuppressive Agents; Infant, Newborn; Kidney Glomerulus; Kidney Transplantation; Living Donors; Male; Membrane Proteins; Mutation; Mycophenolic Acid; Nephrectomy; Nephrotic Syndrome; Peritoneal Dialysis; Prednisone; Proteinuria; Recurrence | 2006 |
Cyclosporine versus tacrolimus in patients with HCV infection after liver transplantation: effects on virus replication and recurrent hepatitis.
Topics: Adult; Cohort Studies; Cyclosporine; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; RNA, Viral; Tacrolimus; Virus Replication | 2006 |
Treatment of herpes simplex virus stromal keratitis unresponsive to topical prednisolone 1% with topical cyclosporine 0.05%.
Topics: Administration, Topical; Adult; Corneal Stroma; Cyclosporine; Humans; Immunosuppressive Agents; Keratitis, Herpetic; Ophthalmic Solutions; Prednisolone; Prospective Studies; Recurrence; Treatment Outcome; Visual Acuity | 2006 |
Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation.
Topics: Adolescent; Adult; Aged; Cyclosporine; Drug Administration Schedule; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Recurrence; Retrospective Studies; Time Factors | 2006 |
Successful treatment with allogeneic peripheral blood stem cell transplantation and granulocyte transfusion for severe aplastic anemia with sinusitis.
Topics: Adult; Anemia, Aplastic; Blood Transfusion, Autologous; Cyclosporine; Female; Granulocytes; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Recurrence; Sinusitis; Transplantation, Homologous; Treatment Outcome | 2006 |
An evaluation of cyclosporine alone for the treatment of early recurrences of thombotic thrombocytopenic purpura.
Topics: ADAM Proteins; ADAMTS13 Protein; Cyclosporine; Humans; L-Lactate Dehydrogenase; Purpura, Thrombocytopenic; Recurrence | 2006 |
Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Animals; Antilymphocyte Serum; Child; Combined Modality Therapy; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Rabbits; Recurrence; Retrospective Studies; Survival Analysis; Treatment Failure; Treatment Outcome | 2006 |
Bilateral psoas abscesses post-peripheral blood stem cell transplantation.
Topics: Adult; Cyclosporine; Drainage; Female; Humans; Meropenem; Peripheral Blood Stem Cell Transplantation; Psoas Abscess; Recurrence; Remission Induction; Sensitivity and Specificity; Thienamycins; Tomography, X-Ray Computed; Transplantation, Homologous; Vancomycin | 2006 |
Recurrent Kimura's disease: excellent response to cyclosporine.
Topics: Adult; Angiolymphoid Hyperplasia with Eosinophilia; Cyclosporine; Humans; Male; Recurrence | 2006 |
Granulomatous interstitial nephritis treated with a tumour necrosis factor-alpha inhibitor.
Topics: Antibodies, Monoclonal; Child, Preschool; Cyclosporine; Diagnostic Errors; Dwarfism; Granuloma; Hematuria; Humans; Immunosuppressive Agents; Infliximab; Male; Nephritis, Interstitial; Nephrosis, Lipoid; Nephrotic Syndrome; Obesity; Prednisolone; Proteinuria; Puberty, Delayed; Recurrence; Remission Induction; Tacrolimus; Tumor Necrosis Factor-alpha | 2006 |
Recurrence of proteinuria 10 years post-transplant in NPHS2-associated focal segmental glomerulosclerosis after conversion from cyclosporin A to sirolimus.
Topics: Adolescent; Cyclosporine; Female; Glomerulosclerosis, Focal Segmental; Graft Rejection; Humans; Immunosuppressive Agents; Intracellular Signaling Peptides and Proteins; Kidney Transplantation; Living Donors; Membrane Proteins; Mutation; Nephrotic Syndrome; Proteinuria; Recurrence; Renal Insufficiency; Risk Factors; Sirolimus; Time Factors | 2006 |
Cyclosporin-A in the treatment of nephrotic syndrome: the importance of monitoring C0 (trough) and C2 (two hours after its administration) blood levels.
Topics: Cyclosporine; Female; Humans; Immunosuppressive Agents; Inactivation, Metabolic; Male; Middle Aged; Monitoring, Physiologic; Nephrotic Syndrome; Recurrence; Remission Induction | 2006 |
Combined treatment of steroids and cyclosporine in Kimura disease.
Topics: Angiolymphoid Hyperplasia with Eosinophilia; Child; Cyclosporine; Cytokines; Humans; Immunosuppressive Agents; Male; Recurrence; Steroids; T-Lymphocytes, Helper-Inducer | 2006 |
[Reduced-intensity stem cell transplantation using allogeneic peripheral blood stem cells from the same donor for relapsed leukemia after bone marrow transplantation].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child, Preschool; Cyclosporine; Graft vs Host Disease; Humans; Infant; Male; Melphalan; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Tissue Donors; Transplantation Conditioning; Vidarabine | 2006 |
Single-dose daily treatment with cyclosporin A for relapsing nephrotic syndrome: report of a case showing poor response.
Topics: Child; Cyclosporine; Drug Administration Schedule; Humans; Male; Nephrotic Syndrome; Prednisolone; Recurrence | 2006 |
Expression of multidrug resistance P-glycoprotein on lymphocytes from nephrotic children treated with cyclosporine A and ACE-inhibitor.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; ATP Binding Cassette Transporter, Subfamily B, Member 1; Case-Control Studies; CD3 Complex; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Female; Flow Cytometry; Humans; Lymphocyte Count; Male; Nephrotic Syndrome; Recurrence; Remission Induction; Statistics, Nonparametric; T-Lymphocytes | 2007 |
High-sensitivity C-reactive protein (hs-CRP) level in children with nephrotic syndrome.
Topics: Adolescent; C-Reactive Protein; Child; Child, Preschool; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Prednisone; Recurrence | 2007 |
Pharmacodynamic monitoring of cyclosporine a in renal allograft recipients shows a quantitative relationship between immunosuppression and the occurrence of recurrent infections and malignancies.
Topics: Adult; Aged; Analysis of Variance; Cyclosporine; Drug Monitoring; Female; Gene Expression Regulation; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infections; Interferon-gamma; Interleukin-2; Kidney Transplantation; Male; Middle Aged; Neoplasms; NFATC Transcription Factors; Postoperative Complications; Recurrence | 2006 |
Mycophenolate mofetil substitution for cyclosporine-dependent myasthenia gravis and nephrotoxicity.
Topics: Adult; Cyclosporine; Diabetic Nephropathies; Drug Evaluation; Female; Humans; Hypertension, Renal; Immunosuppressive Agents; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Myasthenia Gravis; Mycophenolic Acid; Plasma Exchange; Prednisolone; Recurrence; Thymectomy | 2007 |
Concurrent relapsing central nervous system and ocular involvement in a case of life-threatening Adamantiades-Behçet Disease (ABD).
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Azathioprine; Behcet Syndrome; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Recurrence; Retinal Vasculitis; Vitreous Body | 2006 |
Cyclosporin A can achieve immune tolerance in a patient with severe haemophilia B and refractory inhibitors.
Topics: Blood Coagulation Factor Inhibitors; Blood Coagulation Factors; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Factor IX; Hemophilia B; Humans; Immune Tolerance; Immunosuppressive Agents; Isoantibodies; Male; Nephrotic Syndrome; Recurrence | 2007 |
Recurrence of focal segmental glomerulosclerosis after renal transplantation: a case report.
Topics: Cyclosporine; Female; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Plasmapheresis; Recurrence; Treatment Outcome | 2007 |
Immunosuppressive therapy with anti-thymocyte globulin and cyclosporine A in selected children with hypoplastic refractory cytopenia.
Topics: Antilymphocyte Serum; Blood Transfusion; Child; Combined Modality Therapy; Cyclosporine; Disease Progression; Disease-Free Survival; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Leukocyte Count; Myelodysplastic Syndromes; Prednisone; Prospective Studies; Recurrence; Remission Induction; Statistics, Nonparametric; T-Lymphocytes; Treatment Outcome | 2007 |
Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: a long-term retrospective cohort study.
Topics: Administration, Oral; Adult; Chi-Square Distribution; Cohort Studies; Colectomy; Colitis, Ulcerative; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Female; Follow-Up Studies; Humans; Incidence; Infusions, Intravenous; Male; Middle Aged; Prednisolone; Probability; Recurrence; Retrospective Studies; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Time Factors; Treatment Outcome | 2007 |
Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
Topics: Adrenal Cortex Hormones; Adult; Aged; Cyclosporine; Cytotoxins; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Kidney Function Tests; Male; Middle Aged; Nephrotic Syndrome; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome | 2007 |
[A case report of a recurrence of Mooren's ulcer after cataract surgery].
Topics: Autoantigens; Autoimmune Diseases; Combined Modality Therapy; Conjunctiva; Conjunctivitis; Cornea; Corneal Transplantation; Corneal Ulcer; Cyclosporine; Female; Humans; Immunosuppressive Agents; Middle Aged; Molecular Mimicry; Neutrophils; Phacoemulsification; Postoperative Complications; Recurrence; S100 Proteins; S100A12 Protein; Visual Acuity | 2007 |
Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Pemphigus; Prednisone; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome | 2007 |
[Successful therapy of ulcerated necrobiosis lipoidica non diabeticorum with cyclosporine A].
Topics: Aged; Combined Modality Therapy; Cyclosporine; Debridement; Diagnosis, Differential; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Leg Ulcer; Necrobiosis Lipoidica; Recurrence; Retreatment | 2007 |
Elevated interleukin-4 expression in severe recurrent hepatitis C virus after liver transplantation.
Topics: Adrenal Cortex Hormones; Adult; Biopsy; Cyclosporine; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interleukin-2; Interleukin-4; Liver Transplantation; Male; Middle Aged; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tacrolimus; Transcription, Genetic | 2007 |
Long-term efficacy and tolerance of tacrolimus for the treatment of uveitis.
Topics: Adolescent; Adult; Azathioprine; Child; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisone; Recurrence; Retrospective Studies; Tacrolimus; Treatment Outcome; Uveitis | 2007 |
[A patient with interstitial pneumonia associated with dermatomyositis who relapsed after reducing cyclosporin-A treatment].
Topics: Aged; Cyclosporine; Dermatomyositis; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Recurrence | 2007 |
[Cyclosporine-induced gingival hyperplasia: report of one case].
Topics: Biofilms; Calcium Channel Blockers; Cyclosporine; Gingiva; Gingival Hyperplasia; Humans; Immunosuppressive Agents; Male; Middle Aged; Nifedipine; Recurrence; Severity of Illness Index | 2007 |
Combined treatment approach of gingivectomy and CO2 laser for cyclosporine-induced gingival overgrowth.
Topics: Adult; Combined Modality Therapy; Cyclosporine; Female; Gingival Overgrowth; Gingivectomy; Humans; Immunosuppressive Agents; Laser Therapy; Male; Middle Aged; Recurrence | 2007 |
Methylprednisolone and cyclosporin therapy in a patient with nephrotic proteinuria.
Topics: Adolescent; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Glomerulonephritis, Membranoproliferative; Humans; IgA Vasculitis; Male; Methylprednisolone; Proteinuria; Recurrence; Severity of Illness Index; Treatment Outcome; Urinalysis | 2007 |
Successful treatment of refractory thrombotic thrombocytopenic purpura with cyclosporine and corticosteroids in a patient with systemic lupus erythematosus and antibodies to ADAMTS13.
Topics: ADAM Proteins; Antibody Formation; Blood Chemical Analysis; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Middle Aged; Purpura, Thrombotic Thrombocytopenic; Recurrence; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2007 |
Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Cohort Studies; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Drug Evaluation; Female; Follow-Up Studies; Health Surveys; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Japan; Male; Middle Aged; Myelodysplastic Syndromes; Preleukemia; Recurrence; Red-Cell Aplasia, Pure; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome | 2007 |
Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients.
Topics: Adrenal Cortex Hormones; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Immunotherapy; Infections; Injections, Spinal; Lymphohistiocytosis, Hemophagocytic; Lymphoproliferative Disorders; Male; Methotrexate; Methylprednisolone; Recurrence; Retrospective Studies; Treatment Outcome | 2007 |
Adult minimal-change disease: clinical characteristics, treatment, and outcomes.
Topics: Acute Kidney Injury; Adult; Aged; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Drug Resistance; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Male; Middle Aged; Nephrosis, Lipoid; Recurrence; Retrospective Studies; Steroids; Treatment Outcome | 2007 |
Cyclosporin and plasma exchange in thrombotic thrombocytopenic purpura: long-term follow-up with serial analysis of ADAMTS13 activity.
Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Combined Modality Therapy; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Recurrence; Treatment Outcome | 2007 |
Rebound of psoriasis after efalizumab discontinuation, despite being on high-dose cyclosporine.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatologic Agents; Dose-Response Relationship, Drug; Humans; Male; Psoriasis; Recurrence; Remission Induction; Time Factors; Withholding Treatment | 2007 |
Recurrent lymphomatoid papulosis associated with nephrotic syndrome. An occurrence of uncertain origin.
Topics: Child; Cyclosporine; Dose-Response Relationship, Drug; Glucocorticoids; Humans; Immunosuppressive Agents; Lymphomatoid Papulosis; Male; Nephrotic Syndrome; Prednisone; Proteinuria; Recurrence | 2009 |
Tacrolimus and cyclosporin doses and blood levels in hepatitis C and alcoholic liver disease patients after liver transplantation.
Topics: Adult; Aged; Biopsy; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Graft Rejection; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Diseases, Alcoholic; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Tacrolimus; Treatment Outcome | 2008 |
Cyclosporin A response and dependence in children with acquired aplastic anaemia: a multicentre retrospective study with long-term observation follow-up.
Topics: Adolescent; Anemia, Aplastic; Child; Child, Preschool; Cyclosporine; Disease Progression; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Epidemiologic Methods; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Infant; Male; Recurrence; Treatment Outcome | 2008 |
Hypothermia in VGKC antibody-associated limbic encephalitis.
Topics: Aged; Atrophy; Autoantibodies; Azathioprine; Cyclosporine; Dominance, Cerebral; Epilepsy, Temporal Lobe; Female; Hippocampus; Humans; Hypothalamus; Hypothermia; Immunization, Passive; Immunosuppressive Agents; Limbic Encephalitis; Low Back Pain; Magnetic Resonance Imaging; Male; Middle Aged; Plasma Exchange; Potassium Channels, Voltage-Gated; Prednisolone; Recurrence; Retreatment; Temporal Lobe; Thymoma; Thymus Neoplasms | 2008 |
Pyoderma gangrenosum--rebel without a cure?
Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatologic Agents; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Middle Aged; Mycophenolic Acid; Pyoderma Gangrenosum; Recurrence; Thalidomide; Treatment Failure | 2008 |
Topical cyclosporine a in the treatment of superior limbic keratoconjunctivitis: a long-term follow-up.
Topics: Administration, Topical; Adult; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Limbus Corneae; Middle Aged; Ophthalmic Solutions; Recurrence; Treatment Outcome | 2008 |
Is single-daily low-dose cyclosporine therapy really effective in children with idiopathic frequent-relapsing nephrotic syndrome?
Topics: Adolescent; Child; Child, Preschool; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Infant; Male; Nephrotic Syndrome; Prospective Studies; Recurrence; Treatment Outcome | 2008 |
Interfering with interferon: re-igniting the debate on calcineurin inhibitor choice and antiviral therapy for hepatitis C virus recurrence.
Topics: Antiviral Agents; Calcineurin Inhibitors; Cyclosporine; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Interferons; Recurrence; Signal Transduction; Tacrolimus; Virus Replication | 2008 |
Long-term follow-up after cyclophosphamide and cyclosporine-A therapy in steroid-dependent and -resistant nephrotic syndrome.
Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Drug Resistance; Female; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Proteinuria; Recurrence; Retrospective Studies; Steroids; Time Factors; Treatment Outcome | 2008 |
Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.
Topics: Antibody Specificity; Cyclosporine; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Liver Transplantation; Lymphocytes; Nucleocapsid; Recurrence; T-Lymphocytes; Tacrolimus; Viral Load | 2008 |
Antithymocyte globulin and cyclosporin in children with acquired aplastic anemia.
Topics: Anemia, Aplastic; Antilymphocyte Serum; Child; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Recurrence; Treatment Outcome | 2008 |
Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes.
Topics: Adult; Apgar Score; Azathioprine; Case-Control Studies; Cesarean Section; Colectomy; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Drug Therapy, Combination; Female; Hospitalization; Humans; Hydrocortisone; Immunosuppressive Agents; Infant, Newborn; Infusions, Intravenous; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Recurrence | 2008 |
[Low dosage cyclosporin A therapy in pyoderma gangrenosum. Experiences with 6 patients].
Topics: Adult; Aged; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pyoderma Gangrenosum; Recurrence; Wound Healing | 1995 |
Immunopharmacologic modulation of experimental allergic encephalomyelitis: low-dose cyclosporin-A treatment causes disease relapse and increased systemic T and B cell-mediated myelin-directed autoimmunity.
Topics: Animals; Antibody-Producing Cells; Autoimmunity; B-Lymphocytes; Brain; Cyclosporine; Down-Regulation; Encephalomyelitis, Autoimmune, Experimental; Guinea Pigs; Interferon-gamma; Lymph Nodes; Lymphocyte Activation; Mitoxantrone; Myelin Basic Protein; Rats; Rats, Inbred Lew; Recurrence; T-Lymphocytes | 1993 |
Adhesion molecule expression (ICAM-1, VCAM-1, E-selectin and PECAM) in human kidney allografts.
Topics: Adolescent; Adult; Aged; Antigens, Differentiation, Myelomonocytic; Cell Adhesion Molecules; Cyclosporine; E-Selectin; Female; Gene Expression Regulation; Glomerulonephritis; Graft Rejection; Humans; Intercellular Adhesion Molecule-1; Kidney Diseases; Kidney Transplantation; Kidney Tubular Necrosis, Acute; Male; Middle Aged; Platelet Endothelial Cell Adhesion Molecule-1; Postoperative Complications; Pyelonephritis; Recurrence; Vascular Cell Adhesion Molecule-1 | 1993 |
Conversion to rescue therapy with FK 506: data from eight liver transplant patients.
Topics: Adult; Bilirubin; Child; Child, Preschool; Cyclosporine; Drug Monitoring; Follow-Up Studies; Graft Rejection; Hepatitis C; Humans; Liver Transplantation; Middle Aged; Recurrence; Reoperation; Tacrolimus; Treatment Failure; Treatment Outcome | 1994 |
Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis.
Topics: Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Cyclosporine; Drug Administration Schedule; Graft Rejection; Graft Survival; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunosuppression Therapy; Liver Failure; Liver Transplantation; Postoperative Complications; Prednisolone; Receptors, Interleukin-2; Recurrence; Reoperation; Retrospective Studies; Survival Rate; Tacrolimus; Time Factors; Treatment Outcome | 1994 |
[Intermittent-dose ara-C/daunomycin therapy combined with cyclosporin-A and G-CSF led to a fourth remission in a patient with acute promyelocytic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Cytarabine; Daunorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Promyelocytic, Acute; Middle Aged; Recurrence; Remission Induction | 1995 |
[Pyoderma gangrenosum as a precursor of myeloid leukemia].
Topics: Adult; Combined Modality Therapy; Cyclosporine; Dapsone; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Methylprednisolone; Paraneoplastic Syndromes; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, Second; Pyoderma Gangrenosum; Recurrence; Skin Transplantation | 1995 |
Treatment of recalcitrant cardiac allograft rejection with methotrexate. Cardiac Transplant Team.
Topics: Administration, Oral; Azathioprine; Bacterial Infections; Case-Control Studies; Combined Modality Therapy; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Leukocyte Count; Lymphatic Irradiation; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisone; Recurrence; Retrospective Studies; Transplantation, Homologous | 1995 |
Efficacy of intravenous cyclosporine for steroid refractory attacks of ulcerative colitis.
Topics: Adolescent; Adult; Aged; Colitis, Ulcerative; Cyclosporine; Drug Combinations; Female; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Recurrence; Remission Induction; Retrospective Studies; Treatment Failure; Treatment Outcome | 1995 |
Benign familial chronic pemphigus (Hailey-Hailey disease) responds to cyclosporin.
Topics: Adult; Aged; Cyclosporine; Female; Follow-Up Studies; Humans; Male; Pemphigus, Benign Familial; Recurrence | 1995 |
Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection.
Topics: Adrenal Cortex Hormones; Alanine Transaminase; Azathioprine; Bilirubin; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Humans; Immunosuppression Therapy; Liver Transplantation; Methylprednisolone; Prednisone; Recurrence; Tacrolimus; Transplantation, Homologous | 1993 |
Cyclosporin in the treatment of corticosteroid resistant autoimmune chronic active hepatitis.
Topics: Adolescent; Azathioprine; Cyclosporine; Drug Administration Schedule; Drug Resistance, Multiple; Hepatitis, Chronic; Humans; Male; Prednisolone; Recurrence; Remission Induction | 1995 |
Severe recurrence of type I membranoproliferative glomerulonephritis after transplantation: remission on steroids and cyclophosphamide.
Topics: Adult; Creatinine; Cyclophosphamide; Cyclosporine; Dipyridamole; Glomerulonephritis, Membranoproliferative; Humans; Kidney Transplantation; Male; Prednisolone; Proteinuria; Recurrence | 1995 |
Darier-White syndrome and cyclosporin.
Topics: Cyclosporine; Darier Disease; Etretinate; Follow-Up Studies; Humans; Male; Middle Aged; Recurrence; Remission Induction | 1995 |
Cyclosporine for the treatment of fulminant ulcerative colitis in children. Immediate response, long-term results, and impact on surgery.
Topics: Abdominal Pain; Administration, Oral; Adolescent; Adult; Child; Colectomy; Colitis, Ulcerative; Combined Modality Therapy; Cyclosporine; Diarrhea; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Injections, Intravenous; Male; Methylprednisolone; Parenteral Nutrition; Patient Discharge; Proctocolectomy, Restorative; Recurrence; Remission Induction | 1995 |
Recurrence of membranous nephropathy after renal transplantation. Incidence and risk factors in 1614 patients.
Topics: Adult; Aged; Cyclosporine; Glomerulonephritis, Membranous; Graft Rejection; HLA-DR3 Antigen; Humans; Kidney Transplantation; Middle Aged; Recurrence; Risk Factors; Survival Analysis | 1995 |
Complete regression of recurrent diffuse malignant lymphoma after withdrawal of cyclosporin A in a renal transplant recipient.
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppression Therapy; Kidney Transplantation; Lymphoma, B-Cell; Middle Aged; Prednisolone; Recurrence; Time Factors; Tomography, X-Ray Computed | 1994 |
Use of OKT3 monoclonal antibody as induction therapy for control of rejection in liver transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Cyclosporine; Female; Graft Rejection; Humans; Liver Transplantation; Male; Middle Aged; Muromonab-CD3; Recurrence; Survival Rate | 1995 |
Local therapy of corneal allograft rejection with cyclosporine.
Topics: Administration, Topical; Adolescent; Adult; Child; Cornea; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Ophthalmic Solutions; Prognosis; Recurrence; Transplantation, Homologous | 1995 |
Recurrence of focal-segmental glomerulosclerosis in kidney transplant patients on ciclosporin.
Topics: Adolescent; Adult; Child; Cyclosporine; Female; Glomerulosclerosis, Focal Segmental; Humans; Kidney Transplantation; Male; Middle Aged; Recurrence; Renal Dialysis | 1994 |
Relapsing polychondritis occurring de novo in a renal transplant patient.
Topics: Azathioprine; Cyclosporine; Humans; Kidney Transplantation; Male; Middle Aged; Polychondritis, Relapsing; Prednisone; Recurrence | 1994 |
Severe immune thrombocytopenic purpura relapse after alpha-interferon in chronic myeloid leukemia, successfully treated with cyclosporine.
Topics: Cyclosporine; Female; Humans; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Recurrence | 1994 |
Long-term cyclosporin A treatment of minimal-change nephrotic syndrome of childhood.
Topics: Adolescent; Child; Creatinine; Cyclosporine; Female; Humans; Longitudinal Studies; Male; Nephrosis, Lipoid; Prednisolone; Recurrence | 1994 |
Recurrent acute inflammatory demyelinating polyradiculitis after allogeneic bone marrow transplantation.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Demyelinating Diseases; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Polyradiculopathy; Prednisone; Recurrence; Transplantation, Homologous | 1994 |
Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemia.
Topics: Adolescent; Adult; Aged; Alleles; Anemia, Aplastic; Autoimmune Diseases; Cyclosporine; Female; Genes, MHC Class II; Genetic Predisposition to Disease; Haplotypes; HLA-DQ alpha-Chains; HLA-DQ Antigens; HLA-DQ beta-Chains; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Incidence; Japan; Male; Middle Aged; Polymorphism, Single-Stranded Conformational; Recurrence; Remission Induction | 1994 |
Design strategies in multiple sclerosis clinical trials. The Cyclosporine Multiple Sclerosis Study Group.
Topics: Clinical Trials, Phase III as Topic; Cyclosporine; Follow-Up Studies; Humans; Multiple Sclerosis; Neurologic Examination; Recurrence; Research Design; Severity of Illness Index; Survival Analysis; Treatment Outcome | 1994 |
Long-term efficacy and safety of cyclosporine in renal-transplant recipients.
Topics: Adult; Creatinine; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Kidney; Kidney Transplantation; Male; Recurrence; Renal Insufficiency; Retrospective Studies | 1994 |
The efficacy of cyclosporin-a in the treatment of Behçet's disease.
Topics: Administration, Oral; Adult; Behcet Syndrome; Cyclosporine; Drug Evaluation; Humans; Immunosuppressive Agents; Male; Recurrence; Retinal Vessels; Treatment Outcome; Vasculitis; Visual Acuity | 1994 |
Causes of early and late renal allograft failure in the cyclosporine era.
Topics: Cyclosporine; Follow-Up Studies; Graft Rejection; Humans; Kidney Transplantation; Recurrence; Transplantation, Homologous; Treatment Failure; Treatment Refusal | 1994 |
Reactivation of latent cytomegalovirus in allografts: comparison of lung graft and kidney graft in rats.
Topics: Animals; Azathioprine; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Graft Rejection; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Lung Transplantation; Prednisone; Rats; Rats, Inbred BN; Rats, Inbred Lew; Recurrence; Transplantation, Homologous | 1994 |
Successful bone marrow transplant for a patient with T-lymphoblastic lymphoma in second remission preconditioned by total-body irradiation plus melphalan and etoposide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclosporine; Etoposide; Graft vs Host Disease; Humans; Male; Melphalan; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Whole-Body Irradiation | 1994 |
Immunoblastic lymphadenopathy in a five-month-old girl: successful treatment with immunosuppressants.
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunoblastic Lymphadenopathy; Immunosuppressive Agents; Infant; Interferon-alpha; Lymph Nodes; Mercaptopurine; Methotrexate; Recurrence; Remission Induction | 1994 |
Short-term treatment with cyclosporin in severe psoriasis: four years of experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Cyclosporine; Female; Humans; Male; Middle Aged; Psoriasis; Recurrence; Remission Induction | 1994 |
Efficacy of liver transplantation for alcoholic cirrhosis with respect to recidivism and compliance.
Topics: Adult; Aged; Alcoholism; Cyclosporine; Employment; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppression Therapy; Liver Cirrhosis, Alcoholic; Liver Transplantation; Male; Marital Status; Middle Aged; Patient Compliance; Recurrence | 1994 |
Liver transplantation for Langerhans' cell histiocytosis and immunomodulation of disease pre- and posttransplant.
Topics: Child, Preschool; Combined Modality Therapy; Cyclosporine; Diabetes Insipidus; Female; Histiocytosis, Langerhans-Cell; Humans; Immunosuppression Therapy; Infant; Liver Transplantation; Male; Recurrence; Time Factors | 1994 |
Outcome of renal transplantation in 34 cases of childhood hemolytic-uremic syndrome and the role of cyclosporine.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Female; Graft Survival; Hemolytic-Uremic Syndrome; Humans; Kidney Transplantation; Male; Recurrence; Risk Factors | 1994 |
Acitretin does not prevent psoriasis relapse related to cyclosporin A tapering.
Topics: Acitretin; Chronic Disease; Cyclosporine; Female; Humans; Male; Middle Aged; Pilot Projects; Psoriasis; Recurrence; Remission Induction | 1994 |
Prompt remission of post-renal transplant nephrotic syndrome with high-dose cyclosporine.
Topics: Biopsy; Child, Preschool; Creatinine; Cyclosporine; Female; Glomerulosclerosis, Focal Segmental; Graft Rejection; Humans; Kidney; Kidney Transplantation; Methylprednisolone; Nephrotic Syndrome; Proteinuria; Recurrence | 1994 |
[Tyndallometry in monitoring therapy of sympathetic ophthalmia].
Topics: Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Lasers; Male; Methylprednisolone; Middle Aged; Ophthalmia, Sympathetic; Recurrence; Signal Processing, Computer-Assisted | 1994 |
The efficacy of combined treatment with prednisone and cyclosporine in patients with pemphigus: preliminary study.
Topics: Administration, Oral; Adult; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Gingival Hypertrophy; Humans; Hypertension; Length of Stay; Male; Middle Aged; Osteoporosis; Pemphigus; Prednisone; Recurrence; Remission Induction | 1994 |
Cyclosporin for the treatment of severe ulcerative colitis.
Topics: Adult; Aged; Colitis, Ulcerative; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Recurrence | 1994 |
In what order should one introduce cyclophosphamide or chlorambucil, cyclosporine or levamisole in a child with steroid-dependent frequently relapsing nephrotic syndrome?
Topics: Child; Chlorambucil; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Glucocorticoids; Humans; Levamisole; Nephrotic Syndrome; Recurrence | 1993 |
Late recurrence of systemic vasculitis after kidney transplantation involving the kidney allograft.
Topics: Adult; Cyclophosphamide; Cyclosporine; Female; Granulomatosis with Polyangiitis; Humans; Kidney; Kidney Transplantation; Prednisone; Recurrence; Vasculitis | 1993 |
Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation.
Topics: Adult; Age Factors; Bone Marrow Transplantation; Cohort Studies; Cyclosporine; Family Health; Female; Graft vs Host Disease; HLA Antigens; Humans; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prognosis; Recurrence; Retrospective Studies; Surveys and Questionnaires; Survival Rate; Time Factors; Tissue Donors | 1993 |
Tubular proteinuria in steroid sensitive multi-relapsing nephrotic syndrome.
Topics: Acetylglucosaminidase; Adolescent; Child; Child, Preschool; Cyclosporine; Humans; Kidney Function Tests; Kidney Tubules; Nephrotic Syndrome; Prednisolone; Recurrence; Retinol-Binding Proteins | 1993 |
Treatment of recurrent focal segmental glomerulosclerosis with high-dose cyclosporine A and plasmapheresis.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Follow-Up Studies; Glomerulosclerosis, Focal Segmental; Humans; Kidney Transplantation; Plasmapheresis; Recurrence; Retrospective Studies; Time Factors; Transplantation, Homologous | 1993 |
Cyclosporin A in the treatment of relapsing polychondritis with severe recurrent eye involvement.
Topics: Cyclosporine; Female; Humans; Middle Aged; Polychondritis, Relapsing; Recurrence; Scleritis | 1993 |
Superantigen can reactivate bacterial cell wall-induced arthritis.
Topics: Animals; Antigens, Bacterial; Arthritis, Infectious; Bacterial Proteins; Bacterial Toxins; Cyclosporine; Enterotoxins; Exotoxins; Female; Interleukin 1 Receptor Antagonist Protein; Membrane Proteins; Polysaccharides, Bacterial; Rats; Rats, Inbred Lew; Recurrence; Sialoglycoproteins; Staphylococcus aureus; Superantigens; T-Lymphocytes | 1993 |
Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporin A.
Topics: Administration, Oral; Adult; Crohn Disease; Cyclosporine; Female; Humans; Infusions, Intravenous; Intestinal Fistula; Middle Aged; Rectal Fistula; Recurrence; Time Factors; Vaginal Fistula | 1993 |
Treatment of aplastic anemia with a monoclonal antibody directed against the interleukin-2 receptor.
Topics: Adult; Anemia, Aplastic; Antibodies, Monoclonal; Cyclosporine; Female; Humans; Injections, Intravenous; Methylprednisolone; Receptors, Interleukin-2; Recurrence | 1993 |
Cyclosporine in the treatment of nonmicrobial inflammatory ophthalmic disease.
Topics: Aged; Cyclosporine; Humans; Male; Ophthalmia, Sympathetic; Prednisone; Recurrence | 1993 |
Therapeutic use of topical cyclosporine.
Topics: Administration, Topical; Adolescent; Adult; Aged; Child; Child, Preschool; Chronic Disease; Conjunctivitis, Allergic; Corneal Diseases; Cyclosporine; Female; Follow-Up Studies; Humans; Keratoplasty, Penetrating; Male; Middle Aged; Ophthalmic Solutions; Prognosis; Recurrence; Risk Factors | 1993 |
Cyclosporin therapy in steroid-dependent nephrotic syndrome.
Topics: Adolescent; Child; Cyclosporine; Female; Humans; Kidney; Male; Nephrotic Syndrome; Recurrence; Remission Induction; Treatment Outcome | 1993 |
Long-term ciclosporin treatment in children with steroid-dependent nephrotic syndrome.
Topics: Adolescent; Body Height; Child; Child, Preschool; Cyclosporine; Female; Humans; Longitudinal Studies; Male; Nephrotic Syndrome; Prednisolone; Recurrence | 1993 |
A prescreening system for potential antiproliferative agents: implications for local treatment strategies of postangioplasty restenosis.
Topics: Actins; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Arteriosclerosis; Cell Division; Cells, Cultured; Colchicine; Cyclosporine; Dalteparin; Doxorubicin; Drug Evaluation, Preclinical; Etoposide; Female; Femoral Artery; Fibrinolytic Agents; Gout Suppressants; Humans; Immunosuppressive Agents; Male; Microtubules; Middle Aged; Muscle, Smooth, Vascular; Recurrence; Vimentin | 1995 |
Donor buffy coat infusions for a patient with myelodysplastic syndrome who relapsed following allogeneic bone marrow transplantation.
Topics: Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Leukocyte Transfusion; Male; Middle Aged; Myelodysplastic Syndromes; Prednisolone; Recurrence | 1995 |
Donor leucocyte transfusions for relapse in myelodyplastic syndrome after allogeneic bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Leukocyte Transfusion; Male; Myelodysplastic Syndromes; Prednisolone; Recurrence; Transplantation, Autologous | 1996 |
Failure of immunosuppressive therapy to prevent relapse of celiac sprue.
Topics: Celiac Disease; Cyclosporine; Duodenum; Humans; Immunosuppressive Agents; Male; Middle Aged; Recurrence; Treatment Failure | 1995 |
Heart transplantation for chronic Chagas' heart disease.
Topics: Actuarial Analysis; Adolescent; Adult; Azathioprine; Cause of Death; Chagas Cardiomyopathy; Child; Cyclosporine; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Lymphoma; Male; Methylprednisolone; Middle Aged; Myocarditis; Parasitemia; Prednisone; Recurrence; Sarcoma, Kaposi; Survival Rate; Treatment Outcome | 1996 |
Recurrent and de novo glomerulonephritis postrenal transplantation.
Topics: Adolescent; Adult; Autoantibodies; Basement Membrane; Cyclosporine; Female; Follow-Up Studies; Glomerulonephritis; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Glomerulus; Kidney Transplantation; Male; Proteinuria; Pyelonephritis; Recurrence; Time Factors; Tissue Donors; Transplantation, Homologous; Twins, Monozygotic | 1996 |
Accelerated acute rejection in renal allograft.
Topics: Acute Disease; Age Factors; Azathioprine; Cadaver; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Prednisone; Recurrence; Retrospective Studies; Risk Factors; Time Factors; Tissue Donors | 1996 |
Membranous nephropathy: recurrence after kidney transplantation.
Topics: Adult; Cyclosporine; Fluorescent Antibody Technique; Glomerulonephritis, Membranous; Humans; Kidney; Kidney Transplantation; Male; Microscopy, Electron; Middle Aged; Postoperative Care; Postoperative Complications; Prednisone; Proteinuria; Recurrence; Renal Dialysis | 1996 |
Mycophenolate mofetil in liver transplantation.
Topics: Administration, Oral; Adolescent; Adult; Cyclosporine; Cytomegalovirus Infections; Diarrhea; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Leukopenia; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Recurrence | 1996 |
Long-term Cyclosporine A (Sandimmun) therapy for steroid resistant nephrotic syndrome in children.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Cyclosporine; Drug Resistance; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infant; Male; Nephrotic Syndrome; Proteinuria; Recurrence; Remission Induction; Steroids | 1996 |
Recurrence of immunoglobulin A nephropathy after renal transplantation in the cyclosporine era.
Topics: Adult; Case-Control Studies; Cyclosporine; Female; Follow-Up Studies; Glomerulonephritis, IGA; Graft Survival; Humans; IgA Vasculitis; Immunosuppressive Agents; Incidence; Kidney; Kidney Transplantation; Male; Recurrence; Retrospective Studies; Time Factors | 1996 |
[Natural history of treated hemorrhagic rectocolitis].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Antirheumatic Agents; Colectomy; Colitis, Ulcerative; Colorectal Neoplasms; Combined Modality Therapy; Cyclosporine; Humans; Recurrence | 1996 |
Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients.
Topics: Administration, Oral; Alagille Syndrome; Child, Preschool; Cyclosporine; Dosage Forms; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Methylprednisolone; Recurrence; Tacrolimus; Time Factors | 1996 |
Relapsing Wegener's granulomatosis: successful treatment with cyclosporin-A.
Topics: Adult; Cyclophosphamide; Cyclosporine; Follow-Up Studies; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Male; Plasma Exchange; Prednisolone; Recurrence; Remission Induction; Splenectomy; Tomography, X-Ray Computed | 1996 |
"Recurrence" of cyclosporine nephropathy in a heart transplant recipient.
Topics: Cyclosporine; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Recurrence | 1996 |
Cyclosporine pharmacokinetics and risk of recurrent rejection in recipients of simultaneous pancreas/kidney transplants.
Topics: Adult; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Recurrence; Risk | 1996 |
Successful treatment of lymphomatoid granulomatosis using cyclosporin-A after failure of intensive chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Doxorubicin; Etoposide; Humans; Immunosuppressive Agents; Lung Diseases; Lymphomatoid Granulomatosis; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Recurrence; Remission Induction; Salvage Therapy; Vincristine | 1996 |
Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantatio
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Leukemia; Methotrexate; Middle Aged; Recurrence; Transplantation, Homologous; Treatment Outcome | 1996 |
Hepatitis B recurrence in relation to immunosuppression and acute allograft rejection.
Topics: Acute Disease; Carcinoma, Hepatocellular; Cause of Death; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Hepatitis B; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Liver Neoplasms; Liver Transplantation; Recurrence; Retrospective Studies | 1996 |
Long-term follow-up in hepatitis C patients with respect to immunosuppression.
Topics: Carcinoma, Hepatocellular; Cyclosporine; Graft Rejection; Hepatitis C; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Liver Neoplasms; Liver Transplantation; Postoperative Complications; Recurrence; Retrospective Studies; Survival Rate; Tacrolimus | 1996 |
Chagas disease and transplantation.
Topics: Adult; Antilymphocyte Serum; Argentina; Azathioprine; Cadaver; Chagas Disease; Child; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Methylprednisolone; Parasitemia; Postoperative Complications; Prednisone; Prospective Studies; Recurrence; Retrospective Studies; Tissue Donors | 1996 |
[Autoimmune enteropathy--difficulties in diagnosis and treatment].
Topics: Autoimmune Diseases; Child, Preschool; Cyclosporine; Diarrhea; Hepatitis C; Humans; Intestinal Diseases; Male; Prednisone; Recurrence | 1996 |
The treatment of relapsed or refractory intermediate grade non-Hodgkin's lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Infusions, Intravenous; Interferon-alpha; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Transplantation, Autologous | 1997 |
[Value of cyclosporine in the treatment of the recurrence of nephrosis after renal transplantation].
Topics: Child, Preschool; Cyclosporine; Female; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Nephrotic Syndrome; Recurrence | 1996 |
Cyclosporine monitoring with levels 6 hours after the morning dose in patients with noninfectious uveitis.
Topics: Adult; Aged; Creatine; Cyclosporine; Drug Monitoring; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Middle Aged; Prospective Studies; Recurrence; Technetium Tc 99m Pentetate; Uveitis | 1997 |
Recurrent type I membranoproliferative glomerulonephritis after renal transplantation and protective role of cyclosporine in acute crescentic transformation.
Topics: Cyclosporine; Female; Glomerulonephritis, Membranoproliferative; Graft Survival; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Living Donors; Middle Aged; Recurrence | 1997 |
Successful treatment of severe recurrent Reiter's syndrome with cyclosporine.
Topics: Arthritis, Reactive; Cyclosporine; Humans; Immunosuppressive Agents; Male; Middle Aged; Recurrence; Skin Diseases | 1997 |
Hepatitis-associated aplastic anemia.
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Child; Cyclosporine; Female; Hepatitis; Hepatitis B; Humans; Immunosuppressive Agents; Leukocyte Count; Male; Recurrence; Retrospective Studies; Transaminases; Treatment Outcome | 1997 |
Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Reaction; Humans; Immunosuppressive Agents; Lymphocyte Transfusion; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Tissue Donors; Transplantation, Homologous | 1997 |
Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome.
Topics: Adult; Antilymphocyte Serum; Arterioles; Biopsy; Cadaver; Cyclosporine; Follow-Up Studies; Forecasting; Graft Survival; Hemolysis; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Living Donors; Middle Aged; Muromonab-CD3; Prognosis; Recurrence; Retrospective Studies; Thrombocytopenia; Thrombosis; Time Factors; Transplantation, Homologous; Treatment Outcome | 1997 |
Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
Topics: Actuarial Analysis; Adult; Animals; Antilymphocyte Serum; Azathioprine; Cadaver; Cohort Studies; Creatinine; Cyclosporine; Cytomegalovirus Infections; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunoglobulin G; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Kidney Transplantation; Leukopenia; Living Donors; Lymphocytes; Male; Meningism; Methylprednisolone; Middle Aged; Rabbits; Recurrence; Retreatment; Survival Rate | 1997 |
[Local cyclosporin A therapy of nummuli after epidemic keratoconjunctivitis--case report].
Topics: Adenovirus Infections, Human; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Middle Aged; Ophthalmic Solutions; Recurrence; Treatment Outcome; Visual Acuity | 1997 |
Association between liver transplantation for Langerhans cell histiocytosis, rejection, and development of posttransplant lymphoproliferative disease in children.
Topics: Adolescent; Age Factors; Antiviral Agents; Azathioprine; Child; Child, Preschool; Cyclosporine; Follow-Up Studies; Ganciclovir; Glucocorticoids; Graft Rejection; Herpesviridae Infections; Herpesvirus 4, Human; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Incidence; Liver Failure; Liver Transplantation; Lymphoproliferative Disorders; Methylprednisolone; Muromonab-CD3; Prednisone; Recurrence; Retrospective Studies; Risk Factors; Survival Rate; Tacrolimus; Tumor Virus Infections | 1997 |
A case of cytophagic histiocytic panniculitis: successful treatment of recurrent attacks with steroid pulse therapy and oral cyclosporin A.
Topics: Adult; Anti-Inflammatory Agents; Betamethasone; Bone Marrow; Cyclosporine; Drug Therapy, Combination; Ferritins; Humans; Immunosuppressive Agents; Male; Panniculitis, Nodular Nonsuppurative; Recurrence; Skin; Steroids | 1997 |
Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
Topics: Acute Disease; Antilymphocyte Serum; Arteriosclerosis; Azathioprine; Bacterial Infections; Biopsy; Cost-Benefit Analysis; Cyclosporine; Drug Administration Schedule; Drug Resistance; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Survival Rate; Treatment Outcome | 1997 |
Combination of cyclosporine, azathioprine and prednisolone for perianal fistulas in Crohn's disease.
Topics: Adult; Azathioprine; Crohn Disease; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Prednisolone; Rectal Fistula; Rectum; Recurrence; Substance Withdrawal Syndrome; Treatment Outcome | 1997 |
Complete cytogenetic response with host-derived hematopoiesis induced by cyclosporin A discontinuation in a patient with relapsed chronic myelogenous leukemia after bone marrow transplantation.
Topics: Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Female; Hematopoiesis; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Recurrence; Transplantation, Homologous | 1997 |
Recurrence of autoimmune hepatitis following liver transplantation.
Topics: Biopsy; Child; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Transplantation; Recurrence | 1995 |
Influence of steroid withdrawal on proteinuria in renal allograft recipients.
Topics: Acute Disease; Analysis of Variance; Anti-Inflammatory Agents; Azathioprine; Chi-Square Distribution; Chronic Disease; Creatinine; Cyclosporine; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prednisone; Proteinuria; Recurrence; Transplantation, Homologous | 1997 |
Association between hepatitis and rejection: upregulation of cytokines and extracellular matrix parameters.
Topics: Actuarial Analysis; Cyclosporine; Cytokines; Drug Therapy, Combination; Extracellular Matrix Proteins; Fibronectins; Gene Expression Regulation; Glutathione Transferase; Graft Rejection; Hepatitis C; Humans; Hyaluronic Acid; Immunosuppressive Agents; Interferon-gamma; Interleukin-6; Interleukin-8; Laminin; Liver Transplantation; Prednisolone; Recurrence; Retrospective Studies; Survival Rate; Tacrolimus; Time Factors | 1997 |
Study of malignancy among Egyptian kidney transplant recipients.
Topics: Azathioprine; Cyclosporine; Egypt; Female; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Neoplasms; Postoperative Complications; Recurrence; Retrospective Studies; Sarcoma, Kaposi; Skin Neoplasms | 1997 |
Renal transplantation in adults with autosomal recessive inheritance of hemolytic uremic syndrome.
Topics: Adult; Blood; Cadaver; Cyclosporine; Diarrhea; Female; Genes, Recessive; Genetic Markers; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Living Donors; Male; Peritoneal Dialysis, Continuous Ambulatory; Recurrence; Renal Dialysis; Time Factors; Transplantation, Homologous | 1997 |
Long-term results of cyclosporine-induced remission of relapsing nephrotic syndrome in children.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Recurrence; Remission Induction; Time Factors | 1997 |
Chronic relapsing thrombotic thrombocytopenic purpura: role of therapy with cyclosporine.
Topics: Chronic Disease; Cyclosporine; Humans; Immunosuppressive Agents; Male; Middle Aged; Plasma Exchange; Purpura, Thrombocytopenic, Idiopathic; Recurrence; Splenectomy | 1998 |
Myocarditis in children with dilated cardiomyopathy: incidence and outcome after dual therapy immunosuppression.
Topics: Anti-Inflammatory Agents; Biopsy; Cardiomyopathy, Dilated; Child, Preschool; Controlled Clinical Trials as Topic; Cyclosporine; Diastole; Echocardiography; Electrocardiography; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Incidence; Infant; Lymphocytes; Methylprednisolone; Myocardial Contraction; Myocarditis; Myocardium; Necrosis; Prednisolone; Prognosis; Recurrence; Treatment Outcome; Ventricular Function, Left | 1997 |
A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blast Crisis; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Disease Management; Disease-Free Survival; Female; Fusion Proteins, bcr-abl; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Leukocyte Transfusion; Male; Middle Aged; Neoplasm, Residual; Polymerase Chain Reaction; Recombinant Proteins; Recurrence; Remission Induction; Retrospective Studies; RNA, Messenger; RNA, Neoplasm; Salvage Therapy; Survival Analysis; Treatment Outcome | 1997 |
Successful use of cyclosporine A in the treatment of refractory thrombotic thrombocytopenic purpura.
Topics: Adolescent; Chronic Disease; Cyclosporine; Humans; Male; Plasma Exchange; Platelet Count; Purpura, Thrombotic Thrombocytopenic; Recurrence | 1998 |
[Case report of a recurrent nephrotic syndrome patient with sudden onset of blindness during treatment with cyclosporin A].
Topics: Adult; Blindness; Cyclosporine; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Recurrence | 1998 |
Influence of treatment with immunosuppressive drugs in mice chronically infected with Trypanosoma cruzi.
Topics: Animals; Antibodies, Helminth; Azathioprine; Betamethasone; Brain; Chagas Disease; Chronic Disease; Cyclosporine; Disease Models, Animal; Immunosuppressive Agents; Leukocyte Count; Lymphocyte Count; Mice; Mice, Inbred Strains; Recurrence; Transplantation | 1997 |
[The treatment with levamisole of frequently recurring steroid-sensitive idiopathic nephrotic syndrome in children].
Topics: Adjuvants, Immunologic; Adolescent; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Female; Humans; Immunosuppressive Agents; Levamisole; Male; Nephrotic Syndrome; Recurrence; Steroids | 1998 |
[Late manifestation of a fatal Behçet's disease with cardiac involvement and lethal outcome].
Topics: Aged; Anti-Inflammatory Agents; Azathioprine; Behcet Syndrome; Cardiomyopathy, Dilated; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Fatal Outcome; Humans; Immunosuppressive Agents; Male; Prednisolone; Recurrence; Skin; Ultrasonography | 1998 |
[Mooren ulcer. 4 severe bilateral disease courses with systemic cyclosporin A therapy].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Corneal Ulcer; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Ophthalmic Solutions; Recurrence; Visual Acuity | 1997 |
Prevention of diabetes recurrence after syngeneic islet transplantation in NOD mice by analogues of 1,25(OH)2D3 in combination with cyclosporin A: mechanism of action involves an immune shift from Th1 to Th2.
Topics: Animals; Calcitriol; Cyclosporine; Diabetes Mellitus, Type 1; Graft Rejection; Immunosuppressive Agents; Islets of Langerhans Transplantation; Mice; Mice, Inbred NOD; Recurrence; Th1 Cells; Th2 Cells; Transplantation, Isogeneic | 1998 |
[Treatment with cyclosporine of severe colitis in hemorrhagic rectocolitis. Apropos of 7 cases].
Topics: Acute Disease; Adult; Colitis; Colitis, Ulcerative; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Recurrence; Retrospective Studies; Time Factors | 1997 |
[Severe hepatic veno-occlusive disease (VOD) which was successfully treated with supportive therapy, but subsequently developed late-recurrence].
Topics: Adult; Bone Marrow Transplantation; Busulfan; Chronic Disease; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Recurrence; Respiratory Distress Syndrome; Tacrolimus | 1998 |
Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era.
Topics: Adult; Analysis of Variance; Antibodies; Antibodies, Antinuclear; Antiphospholipid Syndrome; Biopsy; Cadaver; Cell Count; Cell Size; Cyclosporine; Female; Follow-Up Studies; Glomerular Mesangium; Graft Rejection; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Glomerulus; Kidney Transplantation; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Recurrence; Renal Dialysis; Time Factors; Transplantation Conditioning | 1998 |
Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease.
Topics: Adult; Carcinoma, Squamous Cell; Chagas Cardiomyopathy; Chemoprevention; Chronic Disease; Cocarcinogenesis; Cyclosporine; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Lung Diseases; Lymphoproliferative Disorders; Male; Mutagens; Neoplasms; Neurilemmoma; Nitroimidazoles; Recurrence; Sarcoma, Kaposi; Skin Neoplasms; Survival Rate; Trypanocidal Agents | 1998 |
[Chronic relapsing experimental allergic encephalomyelitis in Lewis rats as a model of multiple sclerosis].
Topics: Animals; Chronic Disease; Cyclosporine; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Immunosuppressive Agents; Lumbosacral Region; Multiple Sclerosis; Rats; Rats, Inbred Lew; Rats, Inbred WKY; Recurrence; Spinal Cord | 1997 |
Short-term efficacy and long-term outcome of cyclosporine treatment in patients with severe ulcerative colitis.
Topics: Adult; Colectomy; Colitis, Ulcerative; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Prednisolone; Prospective Studies; Recurrence; Treatment Failure; Treatment Outcome | 1998 |
Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection.
Topics: Alanine Transaminase; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Genome, Viral; Graft Rejection; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Prednisone; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Time Factors | 1998 |
Importance of allograft biopsy in renal transplant recipients: correlation between clinical and histological diagnosis.
Topics: Adult; Aged; Biopsy, Needle; Cyclosporine; Diagnosis, Differential; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Recurrence; Tacrolimus | 1998 |
Indications for mycophenolate mofetil therapy in hepatitis C-patients undergoing liver transplantation.
Topics: Antibodies, Monoclonal; Cyclosporine; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Methylprednisolone; Muromonab-CD3; Mycophenolic Acid; Receptors, Interleukin-2; Recurrence; Reoperation; Retrospective Studies; Survival Rate; Tacrolimus; Time Factors | 1998 |
Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression.
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Prednisone; Recurrence; Reoperation; Retrospective Studies; Tacrolimus; Time Factors | 1998 |
Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation.
Topics: Biological Availability; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Mycophenolic Acid; Pancreas Transplantation; Recurrence; Retrospective Studies; Survival Rate; Tacrolimus | 1998 |
Recurrent Kaposi's sarcoma in a renal transplant recipient maintained on minimum doses of immunosuppression.
Topics: Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisone; Recurrence; Sarcoma, Kaposi; Skin Neoplasms | 1998 |
Risk factors for recurrence of hepatitis C after liver transplantation.
Topics: Adult; Biopsy; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Postoperative Complications; Predictive Value of Tests; Recurrence; Retrospective Studies; Risk Factors; RNA, Viral; Transaminases | 1998 |
Cyclosporin A acute encephalopathy and seizure syndrome in childhood: clinical features and risk of seizure recurrence.
Topics: Acute Disease; Adolescent; Brain; Brain Diseases; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Organ Transplantation; Recurrence; Tomography, X-Ray Computed | 1998 |
High performance liquid chromatography cyclosporine monitoring: a predictor of renal graft outcome.
Topics: Chromatography, High Pressure Liquid; Creatinine; Cyclosporine; Drug Monitoring; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Recurrence; Retrospective Studies; Treatment Outcome | 1998 |
High-rate hepatitis and low-rate rejection induced late morbidity and mortality in long-term follow-up after liver transplantation.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Hepatitis B; Hepatitis C; Humans; Immunosuppressive Agents; Infant; Liver Transplantation; Male; Middle Aged; Morbidity; Recurrence; Risk Factors; Survival Rate; Time Factors | 1998 |
Distribution of lymphocyte subtypes in liver transplant recipients with viral reinfection or de novo malignancy.
Topics: Antigens, CD; CD4-CD8 Ratio; Cyclosporine; Follow-Up Studies; Hepatitis B; HLA-DR Antigens; Humans; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Lymphocyte Subsets; Postoperative Complications; Recurrence; Retrospective Studies; Tacrolimus; Time Factors | 1998 |
Indication for mycophenolate mofetil therapy in hepatitis C patients undergoing liver transplantation.
Topics: Antibodies, Monoclonal; Antilymphocyte Serum; Cyclosporine; Graft Rejection; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Function Tests; Liver Transplantation; Mycophenolic Acid; Recurrence; Retrospective Studies; RNA, Viral; Time Factors; Virus Replication | 1998 |
Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxis.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Recurrence; Tissue Donors; Transplantation, Homologous | 1998 |
[Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
Topics: Administration, Oral; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Infusions, Intravenous; Prednisone; Recurrence; Treatment Outcome | 1998 |
Ganglioside changes in brain in chronic relapsing experimental allergic encephalomyelitis induced in the Lewis rat.
Topics: Animals; Brain; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Encephalomyelitis, Autoimmune, Experimental; Freund's Adjuvant; Gangliosides; Immunosuppressive Agents; Myelin Sheath; Rats; Rats, Inbred Lew; Recurrence | 1998 |
Cigarette smoking should not be prescribed for the treatment of ulcerative colitis.
Topics: Adrenal Cortex Hormones; Clinical Trials as Topic; Colitis, Ulcerative; Cyclosporine; Humans; Nicotine; Recurrence; Smoking; Sulfasalazine | 1998 |
Single center experience of 1500 kidney transplants.
Topics: Actuarial Analysis; Adolescent; Adult; Child; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Histocompatibility Testing; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Korea; Living Donors; Male; Middle Aged; Recurrence; Retrospective Studies; Survival Rate; Time Factors | 1998 |
Unbound cyclosporine and allograft rejection after heart transplantation.
Topics: Biomarkers; Biopsy; Blood Proteins; Cyclosporine; Endocardium; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Lymphatic Irradiation; Male; Middle Aged; Muromonab-CD3; Myocardium; Recurrence | 1999 |
Antileukemic effects of rapid cyclosporin withdrawal in patients with relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Glucocorticoids; Graft vs Host Disease; Graft vs Tumor Effect; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Transfusion; Male; Middle Aged; Prednisolone; Recurrence; Remission Induction; Salvage Therapy; Transplantation, Homologous | 1998 |
Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia: an Eastern Cooperative Oncology Group pilot study.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Cytarabine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; Gene Expression Regulation, Neoplastic; Genes, MDR; Humans; Leukemia, Myeloid; Leukopenia; Liver; Male; Middle Aged; Mitoxantrone; Recurrence; Remission Induction; Survival Rate; Treatment Outcome | 1999 |
Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party.
Topics: Adult; Age Factors; Anemia, Aplastic; Antilymphocyte Serum; Cause of Death; Cyclosporine; Data Interpretation, Statistical; Humans; Immunosuppressive Agents; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome | 1999 |
A renal allograft recipient with late recurrence of focal and segmental glomerulosclerosis after switching from cyclosporine to tacrolimus.
Topics: Adolescent; Cyclosporine; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Recurrence; Tacrolimus; Transplantation, Homologous | 1999 |
Tacrolimus vs Neoral in renal and renal/pancreas transplantation.
Topics: Creatinine; Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Opportunistic Infections; Pancreas Transplantation; Recurrence; Retrospective Studies; Tacrolimus | 1999 |
Circulating factor in patients with recurrent focal segmental glomerulosclerosis postrenal transplantation inhibits expression of inducible nitric oxide synthase and nitric oxide production by cultured rat mesangial cells.
Topics: Animals; Blood Proteins; Cell Survival; Cells, Cultured; Cyclosporine; Glomerular Mesangium; Glomerulosclerosis, Focal Segmental; Humans; Indomethacin; Kidney Transplantation; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Plasmapheresis; Rats; Recurrence; RNA, Messenger | 1999 |
Differential role of TNF-alpha and IFN-gamma in the brain of rats with chronic relapsing autoimmune encephalomyelitis.
Topics: Animals; Brain; Chronic Disease; Cyclosporine; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression; Guinea Pigs; Immunosuppressive Agents; Injections, Intraventricular; Interferon-gamma; Interleukin-10; Male; Polymerase Chain Reaction; Rats; Rats, Inbred Lew; Recurrence; RNA, Messenger; Spinal Cord; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 1999 |
Induction of a graft-versus-leukemia reaction by cyclosporin A withdrawal as immunotherapy for leukemia relapsing after allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Graft vs Tumor Effect; Humans; Immunosuppressive Agents; Immunotherapy; Leukemia; Male; Middle Aged; Recurrence; Retrospective Studies; Transplantation, Homologous | 1999 |
Long-term administration of cyclosporin A to HCV-antibody-positive patients with dermatologic diseases.
Topics: Aged; Aged, 80 and over; Cyclosporine; Dose-Response Relationship, Drug; Female; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; Humans; Immunosuppressive Agents; Male; Middle Aged; Recurrence; RNA, Viral; Skin Diseases; Time Factors | 1999 |
Cytophagic histiocytic panniculitis improved by combined CHOP and cyclosporin A treatment.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Cyclosporine; Doxorubicin; Drug Therapy, Combination; Fat Necrosis; Follow-Up Studies; Histiocytosis; Humans; Immunosuppressive Agents; Male; Panniculitis, Nodular Nonsuppurative; Phagocytosis; Prednisone; Recurrence; Vincristine | 1999 |
Efficacy of cyclosporin A in children with type 2 autoimmune hepatitis.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Infant; Liver Failure, Acute; Liver Function Tests; Male; Patient Selection; Recurrence; Retrospective Studies | 1999 |
More evidence of the failure of oral cyclosporine to maintain remission due to intravenous cyclosporine in IBD.
Topics: Administration, Oral; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infusions, Intravenous; Recurrence; Treatment Failure | 1999 |
Cyclosporine therapy in inflammatory bowel disease: short-term and long-term results.
Topics: Administration, Oral; Adolescent; Adult; Colectomy; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Recurrence; Time Factors; Treatment Outcome | 1999 |
Low-dose cyclosporine of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukaemia.
Topics: Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Histocompatibility Testing; Humans; Leukemia; Recurrence; Risk; Time Factors | 1999 |
Comparison of P-glycoprotein expression and function with in vitro sensitivity to anthracyclines in AML.
Topics: Acridines; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blast Crisis; Bone Marrow; Cell Survival; Cyclosporine; Daunorubicin; Gene Expression Regulation, Neoplastic; Humans; Isoquinolines; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Recurrence; Tetrahydroisoquinolines; Tumor Cells, Cultured | 1999 |
Effectiveness of periodontal therapy in patients with drug-induced gingival overgrowth. Long-term results.
Topics: Adult; Age Factors; Calcium Channel Blockers; Cyclosporine; Dental Plaque Index; Dental Prophylaxis; Female; Follow-Up Studies; Gingival Hemorrhage; Gingival Overgrowth; Gingivectomy; Gingivitis; Humans; Immunosuppressive Agents; Incidence; Longitudinal Studies; Male; Middle Aged; Nifedipine; Periodontal Index; Quality of Life; Recurrence; Regression Analysis; Surgical Flaps | 1999 |
Results at a single centre of immunosuppression with cyclosporine A in 66 children with aplastic anaemia.
Topics: Anemia, Aplastic; Child; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Recurrence; Retrospective Studies; Survival Analysis; Treatment Outcome | 1999 |
Effect of steroids amount on hepatitis C recurrence following orthtopic liver transplantation.
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Prednisone; Recurrence; Retrospective Studies; RNA, Viral; Time Factors | 1999 |
The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Recurrence; Risk Factors; Transplantation, Homologous; Whole-Body Irradiation | 2000 |
Intragraft localization of activated nuclear factor kappaB in recurrent hepatitis C virus disease following liver transplantation.
Topics: Adult; Aged; Cyclosporine; Dimerization; Female; Hepatitis C; Humans; Immunohistochemistry; Liver Transplantation; Male; Middle Aged; NF-kappa B; Recurrence; RNA, Viral; Tacrolimus | 2000 |
Steroid-sensitive nephrotic syndrome associated with Kimura disease.
Topics: Angiolymphoid Hyperplasia with Eosinophilia; Anti-Inflammatory Agents; Child; Cyclosporine; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Nephrotic Syndrome; Prednisolone; Recurrence; Steroids | 2000 |
Recurrent septicemia with lethal outcome during and after cyclosporine therapy in severe ulcerative colitis.
Topics: Colitis, Ulcerative; Cyclosporine; Dose-Response Relationship, Drug; Fatal Outcome; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Recurrence; Sepsis; Staphylococcal Infections | 2000 |
Non-pseudomonal malignant otitis externa and jugular foramen syndrome secondary to cyclosporin-induced hypertrichosis in a diabetic renal transplant patient.
Topics: Candidiasis; Cyclosporine; Diabetes Mellitus, Type 1; Fatal Outcome; Humans; Hypertrichosis; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Otitis Externa; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Tomography, Emission-Computed, Single-Photon | 2000 |
Hepatitis C after liver transplantation.
Topics: Cyclosporine; Disease Progression; Drug Therapy, Combination; Hepatitis C; Humans; Immunosuppressive Agents; Liver Failure; Liver Transplantation; Prognosis; Recurrence; Renal Insufficiency; Risk Factors; Sepsis; Tacrolimus; Treatment Outcome | 2000 |
Early treatment with cyclosporin in serpiginous choroidopathy maintains remission and good visual outcome.
Topics: Adult; Choroid Diseases; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Prednisolone; Recurrence; Remission Induction; Treatment Outcome | 2000 |
Treatment of FSGS with plasma exchange and immunadsorption.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Drug Resistance; Female; Glomerulosclerosis, Focal Segmental; Humans; Immunosorbent Techniques; Immunosuppressive Agents; Male; Plasma Exchange; Proteinuria; Recurrence; Retreatment; Treatment Outcome | 2000 |
Epoch-cyclosporin A induces high response rates in relapsed lymphomas.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Humans; Lymphoma; Male; Pilot Projects; Prednisone; Recurrence; Treatment Outcome; Vincristine | 2000 |
Mooren's ulcer in China: a study of clinical characteristics and treatment.
Topics: Administration, Topical; Adolescent; Adult; Age of Onset; Aged; China; Corneal Transplantation; Corneal Ulcer; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Recurrence; Retrospective Studies; Rupture, Spontaneous; Statistics, Nonparametric | 2000 |
Completely reversed acute rejection is not a significant risk factor for the development of chronic rejection in renal allograft recipients.
Topics: Acute Disease; Adrenal Cortex Hormones; Aged; Azathioprine; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Muromonab-CD3; Recurrence; Retrospective Studies; Risk Factors; Transplantation, Homologous | 2000 |
Recurrence of pyoderma gangrenosum within a chronic wound following microvascular free-tissue transfer.
Topics: Adult; Cyclosporine; Female; Foot Injuries; Humans; Immunosuppressive Agents; Postoperative Complications; Pyoderma Gangrenosum; Recurrence; Surgical Flaps; Wound Healing | 2000 |
Liver transplantation for alcoholic cirrhosis.
Topics: Adult; Alcoholism; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Liver Cirrhosis, Alcoholic; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Retrospective Studies; Survival Rate; Tacrolimus; Temperance; Time Factors | 2000 |
Impact of heavy proteinuria (>1 g/d) following renal transplantation.
Topics: Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Azathioprine; Biomarkers; Child; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulonephritis; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisone; Prognosis; Proteinuria; Recurrence; Retrospective Studies; Time Factors | 2000 |
Liver transplantation for patients with hepatitis B: prevention of hepatitis B recurrence by intravenous antihepatitis B immunoglobulin and lamivudine.
Topics: Adult; Antiviral Agents; Cyclosporine; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Humans; Immunization, Passive; Immunoglobulins; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Liver Transplantation; Male; Middle Aged; Monitoring, Physiologic; Recurrence; Time Factors; Treatment Outcome | 2000 |
Vogt-Koyanagi-Harada disease presenting initially as aseptic meningoencephalitis.
Topics: Adult; Cyclosporine; Cytoplasmic Granules; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Macrophages; Melanins; Meningitis, Aseptic; Meningoencephalitis; Methylprednisolone; Recurrence; Uveomeningoencephalitic Syndrome | 2000 |
Hemolytic-uremic syndrome in association with both cyclosporine and tacrolimus.
Topics: Biopsy; Cyclosporine; Endothelium, Vascular; Epoprostenol; Female; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Interleukin-2; Kidney; Kidney Transplantation; Middle Aged; Phosphoric Monoester Hydrolases; Polycystic Kidney, Autosomal Dominant; Postoperative Complications; Recurrence; Tacrolimus | 2000 |
Clinical outcome and pharmacokinetics after addition of low-dose cyclosporine to methotrexate: a case study of five patients with treatment-resistant inflammatory bowel disease.
Topics: Colitis, Ulcerative; Crohn Disease; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate; Recurrence; Treatment Outcome | 2000 |
[A case of high-age minimal change nephrotic syndrome relapse after 18-year remission and effective treatment with steroid and cyclosporin combined therapy].
Topics: Administration, Oral; Aged; Cyclosporine; Female; Humans; Methylprednisolone; Nephrosis, Lipoid; Prednisolone; Pulse Therapy, Drug; Recurrence; Remission Induction; Time Factors; Treatment Outcome | 2000 |
Interactive Grand Rounds. Case 3: management of cyclosporine-induced hirsutism and gingival overgrowth in a heart transplant recipient.
Topics: Adult; Cyclosporine; Female; Gingival Hyperplasia; Heart Transplantation; Hirsutism; Humans; Immunosuppressive Agents; Recurrence | 2000 |
[Cyclosporin A therapy in severe anterior scleritis. 5 severe courses without verification of associated systemic disease treated with cyclosporin A].
Topics: Adult; Aged; Aged, 80 and over; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluocortolone; Humans; Male; Recurrence; Scleritis; Treatment Outcome | 2000 |
Cyclosporin increases cellular idarubicin and idarubicinol concentrations in relapsed or refractory AML mainly due to reduced systemic clearance.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Daunorubicin; Female; Humans; Idarubicin; Immunosuppressive Agents; Leukemia, Myeloid; Male; Middle Aged; Pilot Projects; Prospective Studies; Recurrence | 2001 |
Donor lymphocyte infusion followed by interferon-alpha plus low dose cyclosporine A for modulation of donor CD3 cells activity with monitoring of minimal residual disease and cellular chimerism in a patient with first hematologic relapse of chronic myelog
Topics: Adolescent; Bone Marrow Transplantation; CD3 Complex; Cyclosporine; Female; Graft vs Leukemia Effect; Humans; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Transfusion; Neoplasm, Residual; Recurrence; Transplantation Chimera; Transplantation, Homologous | 2001 |
Role of immunosuppression in recurrence after liver transplantation for diethylnitrosamine-induced tumors in rats.
Topics: Animals; Cyclosporine; Diethylnitrosamine; Graft Survival; Immunosuppressive Agents; Liver Neoplasms, Experimental; Liver Transplantation; Male; Neoplasm Metastasis; Rats; Rats, Inbred BN; Rats, Inbred Lew; Recurrence; Transplantation, Homologous; Transplantation, Isogeneic | 1994 |
Results of an outpatient-based stem cell allotransplant program using nonmyeloablative conditioning regimens.
Topics: Adolescent; Adult; Ambulatory Care; Busulfan; Child; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Neural Tube Defects; Program Evaluation; Recurrence; Survival Analysis; Thalassemia; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2001 |
Cyclosporine therapy should be considered for maintenance of remission in patients with pemphigus.
Topics: Adrenal Cortex Hormones; Adult; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Pemphigus; Recurrence; Time Factors | 2001 |
Treatment of Behçet's disease--an update.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behcet Syndrome; Chlorambucil; Colchicine; Cyclophosphamide; Cyclosporine; Dapsone; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interferons; Levamisole; Male; Methotrexate; Pentoxifylline; Recombinant Proteins; Recurrence; Sulfasalazine; Thalidomide | 2001 |
Tacrolimus as a rescue immunosuppressant after heart transplantation.
Topics: Adult; Cyclosporine; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Recurrence; Retrospective Studies; Tacrolimus | 2001 |
Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation.
Topics: Administration, Oral; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Liver Transplantation; Middle Aged; Postoperative Complications; Recurrence; Reoperation; Retrospective Studies; Survival Rate; Tacrolimus; Time Factors | 2001 |
Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Nuclear Family; Recurrence; Retrospective Studies; Survival Rate; Whole-Body Irradiation | 2001 |
Immunomodulatory properties of a 1,25(OH)(2) vitamin D(3) analog combined with IFNbeta in an animal model of syngeneic islet transplantation.
Topics: Alkynes; Animals; Blood Glucose; Cholecalciferol; Cyclosporine; Diabetes Mellitus, Type 1; Graft Survival; Immunosuppression Therapy; Interferon-beta; Islets of Langerhans Transplantation; Mice; Mice, Inbred NOD; Recurrence; Stereoisomerism; Subrenal Capsule Assay; Transplantation, Isogeneic | 2001 |
Acute cardiac ongoing rejection: comparison between different strategies.
Topics: Acute Disease; Adolescent; Adult; Aged; Antilymphocyte Serum; Azathioprine; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Postoperative Complications; Prednisone; Recurrence; Retrospective Studies | 2001 |
Effectiveness of a second course of cyclophosphamide therapy in children with frequently relapsing nephrotic syndrome after cyclosporin A therapy.
Topics: Adolescent; Child; Cyclophosphamide; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Nephrosis, Lipoid; Recurrence | 2001 |
Polymyositis--an unusual manifestation of chronic graft-versus-host disease.
Topics: Adolescent; Bone Marrow Transplantation; Chronic Disease; Combined Modality Therapy; Cyclosporine; Diagnosis, Differential; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia, B-Cell; Polymyositis; Recurrence; Steroids; Treatment Outcome | 2001 |
Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Recurrence | 2001 |
Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Rheumatoid; Cyclophosphamide; Cyclosporine; Female; Humans; Immunosuppressive Agents; Leukemia, T-Cell; Male; Methotrexate; Middle Aged; Neutropenia; Prednisone; Recurrence; Red-Cell Aplasia, Pure; Remission Induction; T-Lymphocytes, Cytotoxic | 2001 |
Effect of induced GVHD in leukemia patients relapsing after allogeneic bone marrow transplantation: single-center experience of 33 adult patients.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Graft vs Leukemia Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy; Interferon-alpha; Leukemia; Leukocyte Transfusion; Male; Recurrence; Remission Induction; Retrospective Studies; Survival Rate; Transplantation, Homologous | 2001 |
What is proper treatment for Wegener granulomatosis?
Topics: Adult; Cyclophosphamide; Cyclosporine; Cystitis; Disease Progression; Female; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Neural Tube Defects; Recurrence; Treatment Refusal; Urinary Bladder Neoplasms | 2001 |
Results of a small series of renal graft biopsies in a Lebanese population.
Topics: Acute Disease; Biopsy; Cyclosporine; Glomerulonephritis; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Kidney Tubular Necrosis, Acute; Lebanon; Recurrence; Retrospective Studies; Transplantation, Homologous | 2001 |
One thousand renal transplants at Belfast City Hospital: post-graft neoplasia 1968-1999, comparing azathioprine only with cyclosporin-based regimes in a single centre.
Topics: Azathioprine; Cyclosporine; Female; Hospitals, Urban; Humans; Immunosuppressive Agents; Ireland; Kidney Transplantation; Male; Neoplasms; Recurrence; Risk Factors; Time Factors | 2000 |
[Effectiveness of cyclosporin A in the treatment of adult patients with aplastic anemia].
Topics: Adolescent; Adult; Anemia, Aplastic; Cyclosporine; Erythropoiesis; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Recurrence; Survival Analysis; Time Factors | 2001 |
The effect of treatment with Campath-1H in patients with autoimmune cytopenias.
Topics: Adolescent; Adult; Aged; Alemtuzumab; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Autoimmune Diseases; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Neutropenia; Pancytopenia; Pilot Projects; Purpura, Thrombocytopenic, Idiopathic; Recurrence; Red-Cell Aplasia, Pure; Treatment Outcome | 2001 |
Prediction of subsequent relapse in children with steroid-sensitive nephrotic syndrome.
Topics: Adolescent; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Forecasting; Glucocorticoids; Humans; Immunosuppressive Agents; Infant; Male; Nephrotic Syndrome; Prednisolone; Proportional Hazards Models; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Steroids; Survival Analysis | 2001 |
Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients.
Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Child; Cyclosporine; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Male; Recurrence; Retrospective Studies; Treatment Outcome | 2001 |
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies.
Topics: Adult; Aged; Anemia, Refractory, with Excess of Blasts; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphocyte Transfusion; Lymphoma, Mantle-Cell; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Polymerase Chain Reaction; Recurrence; Remission Induction; Survival Rate; Thiotepa; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2002 |
Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Acute Disease; Adult; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Cyclosporine; Feasibility Studies; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Infection Control; Leukemia, Myeloid; Prednisone; Premedication; Recurrence; Remission Induction; Transplantation Conditioning; Treatment Outcome; Vidarabine; Viral Load | 2002 |
Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections.
Topics: Adult; Antiviral Agents; Cidofovir; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA, Viral; Drug Evaluation; Eye Infections, Viral; Female; Foscarnet; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Pilot Projects; Polymerase Chain Reaction; Probenecid; Recurrence; Safety; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Uveitis, Anterior; Viral Load; Viremia; Vomiting | 2001 |
Long-term immunosuppressive treatment of serpiginous choroiditis.
Topics: Adult; Aged; Azathioprine; Choroiditis; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Fluorescein Angiography; Humans; Immunosuppressive Agents; Indocyanine Green; Longitudinal Studies; Male; Middle Aged; Recurrence; Treatment Outcome; Visual Acuity | 2001 |
Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome.
Topics: Adult; Age of Onset; Aged; Blood Urea Nitrogen; Creatinine; Cyclophosphamide; Cyclosporine; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Nephrosis, Lipoid; Prednisolone; Proteinuria; Recurrence; Remission Induction; Retrospective Studies; Time Factors | 2002 |
Treatment of autoimmune diabetes recurrence in non-obese diabetic mice by mouse interferon-beta in combination with an analogue of 1alpha,25-dihydroxyvitamin-D3.
Topics: Alkynes; Animals; Cholecalciferol; Combined Modality Therapy; Cyclosporine; Diabetes Mellitus, Type 1; Drug Synergism; Drug Therapy, Combination; Immunologic Factors; Immunosuppressive Agents; Interferon-beta; Islets of Langerhans Transplantation; Mice; Mice, Inbred NOD; Recurrence | 2002 |
[Cyclosporin A in therapy of chronic uveitis].
Topics: Administration, Oral; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Recurrence; Uveitis | 1992 |
HLA-identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcome.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; DNA, Neoplasm; Drug Therapy, Combination; Female; Fusion Proteins, bcr-abl; Graft vs Host Disease; Histocompatibility; HLA Antigens; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Prognosis; Recurrence; RNA, Messenger; Transcription, Genetic | 1992 |
Hematologic relapse of chronic myelogenous leukemia following allogeneic bone marrow transplantation: apparent graft-versus-leukemia effect following abrupt discontinuation of immunosuppression.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Cytotoxicity, Immunologic; Graft vs Host Disease; Humans; Immunosuppression Therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Subsets; Male; Middle Aged; Recurrence; Transplantation, Homologous | 1992 |
Long-term low-dose cyclosporin A in steroid dependent nephrotic syndrome of childhood.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Nephrotic Syndrome; Prednisone; Recurrence | 1992 |
Recurrent haemolytic uraemic syndrome in a boy with focal and segmental glomerulosclerosis.
Topics: Child, Preschool; Cyclosporine; Glomerulosclerosis, Focal Segmental; Hemolytic-Uremic Syndrome; Humans; Male; Recurrence | 1992 |
Short-term responsiveness of membranous glomerulopathy to cyclosporine.
Topics: Adult; Aged; Cyclosporine; Female; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Humans; Hypertension; Interferon-alpha; Interleukin-1; Interleukin-2; Leukocyte Count; Lymphocyte Activation; Male; Middle Aged; Nephrosis, Lipoid; Proteinuria; Recurrence; Remission Induction; T-Lymphocyte Subsets; Treatment Outcome; Tumor Necrosis Factor-alpha | 1992 |
Effective prevention of acute GVHD following allogeneic BMT with low leukaemic relapse using methotrexate and therapeutically monitored levels of cyclosporin A.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Recurrence | 1992 |
Ocular toxoplasmosis: the role of cellular immune defense in the development of recurrences. Results from animal experiments.
Topics: Animals; Antibodies, Protozoan; Antigens, Protozoan; Chorioretinitis; Cyclosporine; Disease Models, Animal; Female; Immunity, Cellular; Immunosuppression Therapy; Lymphocyte Activation; Male; Phytohemagglutinins; Rabbits; Recurrence; Toxoplasma; Toxoplasmosis, Ocular | 1992 |
[Therapeutic approach to the nephrotic syndrome in children].
Topics: Adolescent; Alkylating Agents; Angiotensin-Converting Enzyme Inhibitors; Child; Child, Preschool; Cyclosporine; Drug Administration Schedule; Female; Humans; Infant; Levamisole; Male; Nephrotic Syndrome; Prednisone; Recurrence | 1992 |
Treatment of pyoderma gangrenosum with cyclosporine.
Topics: Adult; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Gangrene; Humans; Male; Middle Aged; Pyoderma; Recurrence | 1992 |
Recurrence of membranous lupus glomerulonephritis two months after a renal cadaver transplant.
Topics: Adult; Azathioprine; Cyclosporine; Humans; Immunosuppression Therapy; Kidney Transplantation; Lupus Nephritis; Male; Platelet Count; Prednisone; Recurrence; Renal Dialysis | 1992 |
Recurrent focal glomerulosclerosis: natural history and response to therapy.
Topics: Adolescent; Adult; Age Factors; Aged; Angiotensin-Converting Enzyme Inhibitors; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Female; Follow-Up Studies; Glomerulosclerosis, Focal Segmental; Graft Survival; Humans; Kidney Transplantation; Male; Middle Aged; Plasmapheresis; Proteinuria; Recurrence; Renal Dialysis; Risk Factors; Time Factors; Treatment Outcome | 1992 |
Recurrence of disease in patients retransplanted for focal segmental glomerulosclerosis.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Female; Glomerulosclerosis, Focal Segmental; Humans; Kidney Transplantation; Male; Recurrence; Reoperation; Transplantation, Homologous | 1992 |
Neuropathological findings in chronic relapsing experimental allergic neuritis induced in the Lewis rat by inoculation with intradural root myelin and treatment with low dose cyclosporin A.
Topics: Anesthesia; Animals; Chronic Disease; Cyclosporine; Demyelinating Diseases; Female; Male; Myelin Sheath; Neuritis, Autoimmune, Experimental; Rats; Rats, Inbred Lew; Recurrence | 1992 |
SRI 62-834, a cyclic ether analogue of the phospholipid ET-18-OCH3, displays long-lasting beneficial effect in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat. Comparison with cyclosporin and (Val2)-dihydrocyclosporin effects in
Topics: Animals; Cell Movement; Central Nervous System; Chronic Disease; Cyclosporine; Cyclosporins; Disease Models, Animal; Drug Evaluation, Preclinical; Encephalomyelitis, Autoimmune, Experimental; Female; Furans; Immunosuppressive Agents; Lymph Nodes; Lymphocytes; Multiple Sclerosis; Phospholipid Ethers; Rats; Rats, Inbred Lew; Recurrence; Remission Induction | 1992 |
Cyclosporin A in aplastic anemia--report of a workshop.
Topics: Androgens; Anemia, Aplastic; Antilymphocyte Serum; Blood Platelets; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Immunosuppression Therapy; Isoantibodies; Recurrence | 1992 |
Paracentral rheumatoid corneal ulceration. Clinical features and cyclosporine therapy.
Topics: Aged; Antibodies, Monoclonal; Arthritis, Rheumatoid; Contact Lenses; Cornea; Corneal Ulcer; Cyclosporine; Female; HLA-DR Antigens; Humans; Immunoenzyme Techniques; Immunoglobulins; Keratoplasty, Penetrating; Lymphocytes; Male; Middle Aged; Recurrence; Tissue Adhesives; Visual Acuity | 1992 |
Cyclosporine: a therapy in inflammatory eye disease.
Topics: Adult; Aged; Arthritis, Reactive; Blood Pressure; Creatinine; Cyclosporine; Eye Diseases; Female; Follow-Up Studies; Hirsutism; Humans; Male; Middle Aged; Recurrence; Sarcoidosis; Treatment Outcome; Tremor; Uveitis; Uveomeningoencephalitic Syndrome; Visual Acuity | 1991 |
Follow-up of recurrent hepatitis B and delta infection in liver allograft recipients after treatment with recombinant interferon-alpha.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Cyclosporine; Female; Hepatitis B; Hepatitis B virus; Hepatitis D; Hepatitis Delta Virus; Humans; Immunosuppression Therapy; Interferon Type I; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Recombinant Proteins; Recurrence; Transplantation, Homologous; Virus Replication | 1991 |
The role of cyclosporine A in the treatment of pemphigus erythematosus.
Topics: Adult; Cyclosporine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pemphigus; Prednisone; Recurrence | 1991 |